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Abstract 
Foot and Mouth Disease (FMD) is a serious trans-boundary livestock disease and is 
present in many parts of the world. It can result in devastating economic impacts in 
affected countries or regions. It is endemic in South East Asia (SEA) including Lao 
PDR and Myanmar. Susceptible animals infected with FMD typically show clinical 
signs two to four days after exposure to the virus, and in some cases within 24 hours, 
especially in pigs.  However, some animals develop only mild lesions and in others 
lesions  may  not  be  visible.  Some  animals  become  persistently  infected  after 
recovery. This is the so-called ‘carrier’ state where the virus can still be recovered 
after 28 days post infection (PI) in the oesophageal-pharyngeal (OP) region.   
 
In  SEA,  the  Asian  swamp  buffalo  (ASB),  is  important  to  livestock  systems  and 
communities and therefore the presence of FMDV in persistently infected ASB, is 
potentially of importance in disease control. To investigate the presence and the role 
of FMD carriers in ASB, cross-sectional and longitudinal studies were conducted in 
both Lao PDR and Myanmar. The cross sectional studies were conducted to evaluate 
the  use  of  tests  to  detect  carriers  under  field  conditions  and  to  determine  the 
percentage of ASB that were seropositive after infection; and the longitudinal studies 
were  conducted  to  determine  the  proportion  of  ASB  that  remained  persistently 
infected  and  also  measure  the  duration  of  persistent  infection.  The  studies  were 
conducted at the sites of FMD outbreaks in 2008. These were due to FMD serotype 
O as confirmed by FMD laboratory reports from both FMD national laboratories and 
from the Regional Reference Laboratory (RRL) for FMD in Thailand.  
 
In this study, several tests to detect FMD carrier animals were used and results of the  !
xiii!
!
tests were compared. All laboratory diagnosis of samples collected from both Lao 
PDR and Myanmar were done at the Institute for Animal Health (IAH), Pirbright 
Laboratory, United Kingdom. The internationally accepted standard for confirmation 
of diagnosis of an FMD carrier animal is by recovery of live FMDV from OP fluid 
collected  by  probang  sampling.  This  is  a  highly  invasive  process  and  is  labour 
intensive and the recovery of the FMDV in carrier animals is usually intermittent. 
This  makes  OP  fluid  sampling  difficult  to  use  as  routine  diagnosis  for  carrier 
identification.  An  IgA  ELISA  based  test  has  been  developed  to  detect  FMDV-
specific immunoglobulin A (IgA) which is present in the serum and also in the saliva 
of animals after infection with and vaccination by FMDV. It has also been shown 
that the level of FMD-specific IgA was elevated in carrier animals and this IgA 
ELISA based test was developed to quantify this elevated level of FMD-specific 
salivary  IgA  in  persistently  infected  animals.  The  non-structural  protein  (NSP) 
ELISA which differentiates antibodies due to infection from vaccination and which 
have  been  previously  used  in  other  species  to  identify  animals  that  have  been 
infected with FMD and which may still be carrying live virus was validated and used 
in this study.  
 
This  study  is  the  first  to  validate  test  performances  of  the  above  tests  on  ASB 
population previously infected with FMDV. Using the Bayesian statistical analysis, 
the overall test sensitivity (Sn) of the four NSP ELISAs and the salivary IgA ELISA 
vary from 60% to 80% only but with high test specificity (Sp), which ranged from 
97% to 99%. To maximize detection, a strategy of combining two independent tests, 
one NSP ELISA (Priocheck) and the IgA ELISA was made.  Results of the test Se of 
the two combined tests showed an increase from 80% to 98% with test Sp of 99%. 
The  performance  of  the  virus  isolation  (VI)  and  the  real  time  RT-PCR  on  ASB !
xiv!
!
population  was  validated  using  101  OP  fluid  samples  collected  eight  months  PI. 
Results from VI showed that 14% of the 101 ASB were persistently FMD infected at 
eight months PI while only 10% of those were persistently FMD infected by real 
time RT-PCR. Using the strategy of combining two tests and to address specificity 
issue, only those samples that tested positive to both NSP ELISA and IgA ELISA 
(Priocheck +ve / IgA +ve) were considered as persistently FMD infected animals. 
The results showed a higher detection rate (32.7%) compared to VI and real time RT-
PCR (10% to 14%). 
 
This study also provided evidence of either silent infection, cross-infection, repeated 
reinfection,  or  virus  persistence  in  ASB  and  that  carrier  animals  may  have 
transmitted the virus to naïve animals in Lao PDR. In this case serotype A was 
isolated from carrier ASB and their contacts were positive for serotype A in the IgA 
ELISA test instead of the expected serotype O virus which was the cause of the 2008 
outbreak among cattle and ASB in Lao PDR.  
 
The study has also provided evidence for the presence of a carrier state in ASB for at 
least 20 months PI, which was the end of the study period. Based on these findings a 
follow  up  study  to  investigate  further  the  mechanisms  and  the  epidemiological 
significance of ASB carriers in the maintenance and transmission of FMD will be 
necessary to fully understand the epidemiology of FMD in SEA. This will require 
more controlled laboratory studies using the tools validated in this study to clarify the 
mechanism for establishment of carriers, the factors influencing transmission and to 
demonstrate the rates of transmission from carrier ASB. This will be a crucial issue 
in the control and eventual eradication of the disease in the SEA region. 
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Chapter 1 Introduction 
 
Foot-and-Mouth Disease (FMD) is an acute, febrile highly contagious viral infection 
primarily of cloven-hoofed of both domestic and wild animals (Alexandersen et al. 
2003; Bachrach 1968; Ferguson et al. 2001; Grubman and Baxt 2004). The disease is 
caused by the FMD virus (FMDV) which is classified as one of the three members of 
the Aphthovirus genus, within the family Picornaviridae (Alexandersen et al. 2002; 
McVicar JW 1969). Clinical disease may develop from two to fourteen days after 
infection depending on virus dose, strain and site of entry. It is characterized by 
lameness,  anorexia,  pyrexia,  salivation,  formation  of  vesicles  with  succeeding 
erosions  in  the  mouth,  nares,  muzzle,  feet,  reduced  milk  production  in  lactating 
animals  and  subsequent  weight  loss.  .  There  is  frequently  secondary  bacterial 
infection of the lesions resulting in further loss of condition. Mastitis may also be a 
sequel. In uncomplicated cases, resolution of the infection is usually complete by 14 
days after infection. Usually the mortality in adult animals is negligible but it may be 
considerable in young animals (Zhang and Alexandersen 2004) and reduced milk 
production can last for the length of the lactation (James and Rushton 2002). 
 
The causative agent of FMDV is distinguished immunologically into seven serotypes 
(O, A, C, SAT-1, SAT-2, SAT-3, and Asia 1) that can be further subdivided into 
more  than  65  subtypes.  Infection  with  a  virus  of  one  serotype  does  not  confer 
immunity to another (Salt et al. 1996). 
 
FMD  outbreaks  can  be  economically  devastating  in  countries  that  are  free  of 
infection and where the productivity levels are high and animals have high value. 
The  severe  impairment  of  production  and  the  slaughter  of  affected  animals  to !
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eradicate  the  virus  following  outbreaks  can  result  in  massive  economic  losses. 
Estimates of the cost of disease outbreaks (in US$) include $1.6 billion in Taiwan in 
1997 (Yang 1997) and during the peak of the 1995 FMD outbreak in the Philippines, 
the local pig producers lost US$45 million due to reduction in sales and buyer’s fear 
of eating infected pork (FMDCTF 1996). In the United Kingdom the cost of the 2001 
outbreak  was  more  than  $15  billion  (Kao  2003).  In  Australia  the  estimated 
cumulative  loss  to  the  national  economy  would  be  about  $2–3  billion  in  gross 
domestic  product  for  a  short  outbreak,  rising  to  $8–13  billion  for  a  12-month 
outbreak (Productivity Commission 2002) (AUSVETPLAN 2010) and $14 billion in 
the  United  States  (Paarlberg  2002).  In  countries  or  regions  where  the  disease  is 
endemic, the direct impact is far less appreciated and has often not been assessed in 
economic terms.  
 
The world distribution of FMD in 2009 (Figure1.1) differs significantly from that 
during the early 1960’s. In 2009, there were no FMD outbreaks in countries listed by 
the Office International Epizooties (OIE) as FMD-free without vaccination (King 
2010).  Although  these  significant  positive  changes  have  been  offset  by  the  re-
appearance of FMD in Chinese Taipei and Japan in early 2010, progress has been 
made  in  South  America  with  the  declaration  of  Columbia  as  a  zone  free  with 
vaccination. In South East Asia (SEA), the Philippines, had the last FMD outbreak in 
1995 and in May 2011, the entire country has finally been officially declared by OIE 
as FMD free country without vaccination (OIE 2011). !
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Intermediate,+sporadic++
Endemic+++ FMD+4Free+
Free.+Virus+present+in+game++parks
Free+with+vaccination+
Countries+with+multiples+zones:
FMD4free,+free+with+vaccination+or+not+free  
Figure 1.1 OIE status of FMD (2009) 
 
The seven FMD serotypes are widely distributed in most parts of the world, but some 
serotypes  are  confined  to  a  specific  region  or  country.  Serotypes  South  African 
Territory (SAT) 1 and 2 are found throughout Africa while SAT 3 is confined to 
Southern  Africa.  Serotypes  O,  A  and  C  are  the  types  that  have  been  present  in 
Europe and South America. The serotypes usually found in the Middle East are O, A, 
Asia 1 and SAT1, while serotypes O, A and Asia 1 are common throughout Asia 
(Davies 2002). In SEA, serotypes O, A and Asia 1 are diagnosed intermittently and 
serotype  C  which  has  never  been  reported  and  diagnosed  in  SEA  except  in  the 
Philippines  and  was  last  seen  in  the  country  in  early  1995.  In  Lao  PDR  and 
Myanmar,  serotype  O  has  been  endemic  for  the  last  ten  years  with  sporadic 
occurrences of serotype A. Serotype Asia 1 was last diagnosed in 1998 in Lao PDR, 
2005 in Myanmar and in 2007 in Vietnam (SEACFMD 2010).  
 
Apart from causing acute infection and disease, FMDV is able to cause persistent 
infection (carriers) in ruminants. Carriers may also occur in vaccinated ruminants 
exposed to live virus (Burrows 1966; Rossi et al. 1988; Straver et al. 1970). FMD !
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carrier animals are defined as those from which live virus can be isolated at more 
than 28 days post infection.  The proportion of animals that become carriers varies 
with the severity of virus challenge, but not the age or sex of the animal involved 
(Hedger 1970). The duration of the carrier state varies, and is probably host species 
and  virus  strain  dependent  (Woodbury  1995).  Virus  recovery  in  cattle  has  been 
shown 2.5 years after infection (Hedger 1970) and in sheep and goats there was no 
isolation more than 9 months after infection (Burrows 1968; McVicar JW 1969). 
Virus isolation from pigs has not been achieved more than 1 month after infection 
(Bekkum 1973). African cape buffalo have been shown to excrete virus for more 
than 5 years (Hedger RS 1971).   
 
There are still limited studies on the carrier state among water buffalos, and whether 
it  causes  or  can  cause  new  outbreaks  of  FMD.  Also,  studies  on  the  duration  of 
persistence among water buffaloes (Bubalus bubalis) have varied results. In Egypt, a 
study showed that duration of persistence lasted for up to 2 months (Moussa 1979).!
Gomes et al. 1997 found that persistent infection in the water buffalo during the first 
35 days after infection was similar to that in the cattle.!Alexandersen et al. 2002 
observed that persistence among water buffalo is still not defined.  
 
The mechanisms for the establishment and maintenance of the carrier state are not 
well understood, since persistence can occur in animals exposed to virus after either 
acute disease or vaccination (Grubman and Baxt 2004). Similarly, the role of carrier 
animals in the spread of FMDV is still controversial. The only direct evidence is that 
of transmission from African cape buffalo to cattle during outbreaks in Zimbabwe in 
the  late  1980s  and  early  1990s  (Dawe  et  al.  1994).  Another  study  in  Zimbabwe 
showed that carrier cattle have been reported to cause an outbreak some two years !
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post infection (Vosloo et al. 2002a). In this case cattle that were infected in 1987 
were thought to have caused an outbreak in 1989 on a property several hundred 
kilometres from the farm of origin. This report and other similar findings in Southern 
Africa have greatly influenced trade policies and control and eradication strategies 
for FMD. However, other field evidence does not support this claim and several 
controlled experiments were unable to show that carriers are able to initiate disease 
(Sutmoller and Casas 2002). However, under field situations where FMDV excretion 
from infected animals changes or maybe amplified due to certain but still undefined 
“trigger”  conditions,  transmission  to  in  contact  animals  cannot  be  discounted  
(Alexandersen et al. 2002). In Iraq, a severe outbreak was noticed in vaccinated 
cattle  when  recovered  sheep  came  into  contact  with  cattle  after  4-6  weeks 
(P.K.Uppal 2004).     
 
To  date,  there  has  been  no  experimental  evidence  indicating  that  carrier  water 
buffalo  (Bubalus  bubalis)  or  ASB  can  transmit  virus  to  uninfected  animals  in 
contrast to the carrier state in the African Cape buffalo (Syncerus caffer), where field 
studies have suggested they are likely to be a mechanism of FMD virus persistence 
in Africa. Some authors state that the epidemiological significance of the carrier state 
is ambiguous, although transmission of FMDV from persistently infected buffalo to 
susceptible buffalo (Bengis et al. 1986) and cattle (Hedger and Condy 1985) has 
been shown under controlled conditions. Field evidence suggests that transmission 
within buffalo herds may occur from carrier buffalo to buffalo calves (Bengis et al. 
1986).  
 
Parts of Asia are endemic for FMD and these areas also contain 95% of the world 
population  of  water  buffalo,  with  about  half  of  the  total  in  India !
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(http://en.wikipedia.org/wiki/File:KerbauJawa). In SEA, the most affected reported 
species are still cattle and buffalo (SEACFMD 2010).  
 
One possible reason for this is the type of husbandry that farmers in SEA practice. 
ASB and cattle share common grazing ground and water sources all year round. 
Some livestock owners share a single animal caretaker who herds their animals into a 
common location at night and then moves them together to grazing grounds during 
the day. This type of husbandry system poses a very potent risk of spreading the 
virus fast and those animals that are sub-clinically infected will be unlikely to be 
detected by a common caretaker.  
 
The South East Asia and China Foot and Mouth Disease (SEACFMD), the regional 
programme for the control and eradication of FMD has achieved significant progress 
in the aspects of diagnosis, harmonization of policies and good knowledge of the 
disease epidemiology in the region. However, for the FMD control programme to 
achieve its aim of disease free status in the region, an understanding of the possible 
role and significance of FMDV persistence (carrier state) in the region must also be 
known.  
 
Experience  has  shown  that  prolonged  infection  of  African  buffalo  may  be  a 
mechanism for FMDV persistence in Africa.  Considering the importance of ASB in 
SEA  farming  systems,  the  epidemiology  of  FMD  in  the  region  and  the  type  of 
husbandry that is being practiced, it is now important to conduct similar studies with 
ASB, and determine whether ASB play a role in the maintenance and spread of 
FMDV in the region.  
 !
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To address this issue cross sectional and longitudinal studies were carried out in 
previously FMD infected ASB in herds in Lao PDR and Myanmar.  A study was 
conducted on ASB, that were four to eight months post FMD infection, in Lao PDR 
and Myanmar in order to determine the prevalence of FMDV persistence in ASB 
after outbreak situations in the herd. A longitudinal study was also conducted on 
these animals using two additional sampling times at six months intervals in order to 
possibly determine the percentage positive, duration of FMDV persistence in ASB 
and to investigate the possibility of transmission of FMDV from persistently infected 
ASB to naïve ASB.   
The aims of this study were to:  
1.  Determine the prevalence of FMDV persistence (carriers) in ASB; 
2.  Evaluate  and  compare  diagnostic  tests  for  use  in  ASB  and  the  detection  of 
FMDV persistently infected ‘carrier’ animals; 
3.  Identify  the  duration  of  persistence  and  to  determine  the  possibility  of 
transmission of FMDV from persistently infected ‘carrier’ to naïve ASB. 
 
    
 
 
 
 
 
 
 
 
 
 !
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Chapter 2 Literature Review 
 
This chapter presents a review of literature relevant to the research project. It covers 
the  molecular  structure  of  the  virus,  world  distribution  with  emphasis  on  SEA, 
pathogenesis,  diagnosis,  and  the  carrier  state  of  FMDV,  occurrence  of  FMD  in 
Buffaloes (African Cape buffalo, Water buffalo and the Asian Swamp Buffalo) and 
discusses prevention and control of FMD.  
 
2.1 The Buffalo  
There are two types of buffalo; the African Cape buffalo (Syncerus caffer) and the 
Asian Buffalo (Bubalus bubalis). The Asian buffalo exists as two types; the wild 
type (e.g. Bubalus arnee) and the domestic type (e.g. Bubalus bubalis) which are 
referred to as water buffalo (Ligda 1998).  There are two major genetic divisions of 
water buffalo; first is the river buffalo (Bubalus bubalus) of the western half of Asia 
which is usually black or dark grey with tightly curled or drooping straight horns and 
they  prefer  to  wallow  in  clean  water;  and  second  is  the  Asian  swamp  buffalo 
(Bubalus  carabanensis)  of  the  eastern  half  of  Asia  which  are  slate  grey,  droopy 
necked and ox like with massive swept backed horns. They wallow in any water or 
mud puddle they can find or make (Ligda 1998) .  The focus of this study is FMD in 
Asian swamp buffalo (ASB).  
 
The  ASB  is  a  large  bovine-like  ruminant  animal,  frequently  used  for  draught 
purposes in local agriculture as well as a source of animal protein and is considered 
an  economically  important  animal.  They  provide  more  than  five  percent  of  the 
world’s milk supply and 20% to 30% of the farm power in SEA (Roth 2004).  The 
animal  also  plays  as  an  integral  part  of  the  region’s  traditional  village  farming !
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structure  because  they  are  well  suited  to  ploughing  the  muddy  paddy  fields  for 
planting rice and potatoes as they are better adapted than common cattle (Bos taurus 
or Bos indicus) to move in swamps. It is also considered as the “living tractor of the 
East” as it is relied upon for transportation in many parts of SEA.  Some families 
even rent their ASB to neighbours for planting and for draft power. In spite of these 
various significant roles that the ASB plays in SEA traditional farming structure and 
economy, and being the second most FMD affected species, to date no studies have 
yet  been  conducted  on  its  possible  role  and  significance  in  the  transmission  and 
maintenance of FMD virus in SEA.    
 
 2.2 The Virus! 
The earliest description of foot-and-mouth disease (FMD) was by Fracastorius in 
1546 (Rowlands 2008) and this was the first animal disease to be attributed to a 
virus, and the second virus to be discovered (Loeffler F. 1898). FMD virus (FMDV) 
is highly infectious and is also the first virus for which serotype differences were 
recognized (Rowlands 2008) and it is still one of the most economically important 
diseases of domestic livestock.  
 
The  viral  particle  contains  single-stranded  positive  sense  RNA  of  about  8200 
nucleotides, within an icosahedric non-enveloped capsid consisting of 60 copies of 
each of the four proteins VP1, VP2, VP3, and VP4 (Acharya et al. 1989), and belongs 
to the Aphthovirus genus of the Picornaviridae family. The Picornaviridae family is 
classified into 8 different genera (Figure 2.1) one of which, the genus Aphthovirus, 
includes  FMDV  as  well  as  bovine  rhinitis  B  and  equine  rhinitis  A  viruses.  The 
Aphthoviruses  are  affected  by  acid  pH  conditions,  quite  distinctly  from  the  other 
Picornoviruses  and  are  labile  below  pH  7.0.  The  genome  is  larger  than  other !
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Picornaviruses.  The  basic  structure  of  FMD  particles  is  described  and  shown  in 
Figures 2.2 to 2.4 (Crowther 2005).   
!
Classification of Picornaviruses 
!
! Genus   
! Enterovirus  Polio, coxsackie, human and animal 
enteroviruses 
! Rhinovirus  Human and animal rhinoviruses 
! Cardiovirus  Encephalo myocarditis virus 
!   Theiler’s Murine encephalo myelitis virus 
!  Hepatovirus  Hepatitis A virus 
!  Apthovirus  Foot and mouth disease 
!   Equine rhinitis A, bovine rhinitis B viruses 
! Parechovirus  Echovirus 22 
! Kobuvirus  Aichivirus 
! Teschovirus   Porcine teschovirus 
 
Figure 2.1 The name Picornavirus, is derived from 'Pico’ (Greek = very small) RNA 
Viruses. They are among the most diverse (more than 200 serotypes) and 'oldest' 
known viruses (has been referenced in temple records from Egypt ca. 1400 B.C.) 
(Anonymous 1998).  
 
 
 
!
Figure 2.2 Three Dimensional representation of an FMD particle. 
!
!!! !! ! ! !
!
 
The FMD particle is compared to a molecule of IgG (right) to give some 
estimation as to relative size. 
23/27nm!
10/12nm!!
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Figure 2.3 Icosahedral symmetry!of FMDV!!!!
! !!!!!!!!!!!!!!!!!!!
            
 
Figure 2.4 FMDV capsomere 
 
! !
The FMDV positive sense, single-stranded RNA genome of 8,200 nucleotides codes 
for twelve proteins, four of which are structural and make up the capsid of the virus 
and eight of which are non-structural, which together allow the virus to replicate in an 
infected cell. The structural genes are identified as 1A, 1B, 1C, and 1D and the non-
structural genes as L, 2A, 2B, 2C, 3A, 3B, 3C and 3D (Figure 2.5). 
 
 
Figure 2.5 Genome of FMD and proteins produced on replication (Rowlands 2008). 
 
 
FMDV  is  distinguished  immunologically  into  seven  serotypes  (O,  A,  C,  SAT-1, 
SAT-2, SAT-3, and Asia 1), which can be further subdivided into more than 65 !
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subtypes. The SAT stands for South African Territories and reflects the history of the 
nomenclature of the FMD viruses (Crowther 2005).  Infection with a virus of one 
serotype does not confer immunity to another (Salt et al. 1996).  
 
2.3 Host Specificity 
The virus typically infects cloven-hoofed species with domestic cattle being the most 
susceptible (Rowlands 2008), domestic buffalo, swine, sheep and goats and more 
than 30 species of wild ruminants such as deer, African Cape buffalo (Kitching et al. 
2005; Snowdon 1968) and impala (Aepyceros melampus) (Vosloo et al. 2009). 
 
There  are  insufficient  laboratory  and  field  based  studies  to  investigate  claims  on 
FMDV host specificity. One exception is the Cathay topotype of type O which is a 
pig adapted strain and has been isolated from a species other than pigs only once and 
this  was  in  cattle  from  the  Philippines  (Kitching  2002b).  When  this  virus  was 
experimentally inoculated intradermolingually into two cattle, it failed to infect one 
and only caused a local lesion on the other (Dunn and Donaldson 1997). This is an 
extreme  example  but  demonstrates  that  the  virus  itself  can  manifest  different 
infectivity  and  subsequent  clinical  appearance  in  different  susceptible  species 
(Kitching 2002b).   
 
The 1994 FMD outbreak in Bulgaria was caused by type O virus that was shown to 
have been derived from Middle East type O strains. This virus was claimed not to 
infect pigs on the basis that when a group of pigs was inadvertently fed milk from an 
infected  bovine  they  failed  to  develop  disease  (Kitching  2002b).  However,  the 
Veterinary Authorities of Israel did report isolating similar FMDV from wild pigs in 
the Jordan Valley, suggesting that adaptation of these middle east strains was by no 
means absolute (Kitching 2002b).  
 !
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The 2001 FMD outbreak in the UK was caused by the pan-Asian lineage of type O 
which was first seen and confirmed in pigs and most of the subsequent spread was by 
sheep. It was also diagnosed in calves which Netherlands imported from Ireland and 
then diagnosed in goats on a farm in the centre of the Netherlands (Sutmoller and 
Casas 2002). In South Africa, infection caused by SAT type FMDV showed that two 
outbreaks  of  FMD  in  cattle  were  caused  by  Cape  buffalo  that  escaped  from  the 
Kruger national park (Bruckner et al. 2002; Vosloo et al. 2002a). Also the SAT type 
FMDV are uniquely adapted to persistence in multispecies wildlife areas that have 
significant Cape buffalo populations (Thomson et al. 2003)  A study in Pakistan 
showed that the majority of the clinically infected animals with FMDV A/Iran/2005 
lineage were cattle, while FMDV O type infection showed an equal distribution of 
clinical FMD between bovine and water buffalo species (Klein et al. 2008). 
 
Based  on  the  above  data  from  both  experimental  and  field  studies,  the  host 
specificity differences proposed for some FMD serotypes may be complex and relate 
to geographical differences (topotypes) within these serotypes.  
 
2.3.1 Buffalo infection  
African Cape buffalo (Syncerus caffer) act as maintenance hosts for foot and mouth 
disease (FMD) in Southern Africa (Vosloo et al. 2002b). One of the earliest studies 
on FMDV in African buffalo was in Rhodesia (now Zimbabwe) and Botswana where 
more than one type of FMDV were isolated from groups of African Cape buffaloes 
(Hedger et al. 1969). Since 1948, all outbreaks of FMD in cattle in Botswana have 
been due to type SAT 1 and SAT 3 and in 1968 SAT 2 virus was isolated from 
clinically normal buffalo (Hedger et al. 1969). In a follow up study in Botswana, 
virus recovery in buffaloes was more common in animals aged one to three years 
(84%) than in animals aged four years or over (47%) and all three SAT types were 
isolated  in  each  age  group,  but  there  was  no  apparent  correlation  between  the 
incidence of virus type and age (Hedger 1972).  Infection in African Cape buffalo is 
usually sub-clinical and normally occurs in calves as soon as the maternal antibodies !
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wane (Hedger 1972; Thomson 1994; Thomson et al. 1992). The SAT type viruses 
are maintained by the African Cape buffalo (Syncerus caffer) (Condy et al. 1985; 
Hargreaves et al. 2004; Hedger 1972; Hedger et al. 1972; Thomson 1994; Thomson 
et al. 2003; Thomson et al. 1992). In Kruger National Park, South Africa, most Cape 
buffaloes are infected with all the three SAT types by the age of two years and the 
resultant  carrier  status  is  probably  lifelong  (Condy  et  al.  1985).  Transmission 
between  carrier  Cape  buffalo  and  susceptible  cattle  has  been  erratic  under 
experimental conditions, but these data, together with circumstantial evidence, have 
indicated that carrier buffalo may be the source of infection for other susceptible 
species (Vosloo et al. 2002b).  
 
In Asia, in the border between Yunnan province of China, Lao PDR and Myanmar, 
only FMD types O and Asia 1 were present in the past.  However, in 1995, FMD 
type  A  was  also  diagnosed  in  the  area  and  the  virus  found  its  way  to  Thailand 
following movement of cattle and ASB (SEACFMD 2010). It was suspected that the 
large  population  of  ASB  inhabiting  the  area  could  be  involved  in  the  virus 
maintenance (Rweyemamu et al. 2008). In Lao PDR, the majority of the outbreaks 
reported from 1998 to 2005 were in cattle (61%) followed by ASB (27%) (Khounsy 
et al. 2008) and a sero-prevalence study which was conducted from 1996 to 2005, 
showed  that  the  proportion  sero-positive  to  FMD  was  significantly  different  for 
different species. The sero-prevalence in ASB was highest (55%) followed by sero-
prevalence  in  pigs  (23%)  and  in  cattle  (22%)  (Blacksell  et  al.  2008).  The  2006 
Pakistan study also showed that the majority of the FMDV infections were caused by 
type A/Iran/2005 lineage, which seems to cause mainly subclinical disease in water 
buffaloes (Klein et al. 2008). In Thailand, the most probable sources of the outbreaks 
were co-mingling of cattle and/or ASB with livestock from infected neighbouring 
villages (Cleland et al. 1995).  Based on OIE SEACFMD five year (2006 to 2010) 
country  reports,  only  five  member  countries  (Cambodia,  Lao  PDR,  Myanmar, 
Thailand and Vietnam,) reported cases of FMD which involved ASB (SEACFMD 
2010).  !
15!
!
 
In Myanmar a new outbreak due to FMDV type A involving cattle and ASB, near the 
border of Bangladesh and Myanmar, were traced to have been possibly originated 
from  ASB,  which  grazed  on  the  Kyikyum  pasture,  which  is  located  on  the 
Bangladesh/Myanmar  border.  The  clinical  disease  was  only  diagnosed  when  it 
affected the cattle three months after it had presumably started in infected ASB and 
the strain was closely related to those from India (Oo 2011).   
 
2.4 Distribution 
FMD virus is widely distributed in the developing world, in particular Africa, South 
America, South Asia, South East-Asia (SEA) and East Asia. These are regions of the 
world that support 75 per cent of the world’s poor (Perry and Rich 2007; Thornton et 
al. 2002).  The seven recognized serotypes of FMD (O, A, C, Asia 1, SAT 1, 2 and 
3)  differ  in  distribution  across  the  world.  Serotypes  O  and  A  have  the  widest 
distribution, occurring in Africa, Asia and South America. Types SAT 1, 2 and 3 are 
currently restricted to Africa and Middle East only and Asia 1 to Asia. The last FMD 
outbreaks  due  to  type  C  were  in  1989  (Italy,  Europe),  1994  (Argentina,  South 
America),  1996  (India  and  the  Philippines,  Asia)  and  1996  (Kenya,  Africa)  It  is 
likely that many type C virus lineages existed in the past, but now have become 
extinct (Knowles and Samuel 2003). The capacity to invade free areas is common to 
all types and periodically SATs are introduced to the near East, and Asia 1 into 
western and eastern parts of Eurasia (Sumption et al. 2007). 
 
In SEA, FMD serotypes O, A and Asia 1 are endemic in six of the 10 SEA countries 
(Figure  2.6).  These  are  Cambodia,  Lao  PDR,  Malaysia,  Myanmar,  Thailand  and 
Vietnam. In Lao PDR and Myanmar, serotype O has been endemic for the last 10 
years with sporadic occurrence of serotype A. Serotype Asia 1 was last diagnosed in 
2005 in Myanmar and in 2007 in Vietnam. Serotype C has never been diagnosed in 
mainland SEA and was last seen in 1995 in the Philippines (SEACFMD 2010). Of 
the  remaining  4  SEA  countries,  Brunei  and  Singapore  have  always  been  free  of !
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FMD. Indonesia claimed FMD freedom in 1986 and it was recognised by OIE as 
FMD free in 1990 (SEACFMD 2010). In the Philippines, the last FMD outbreak was 
in 1995 and by 2010, most parts of the country except for central Luzon which is 
composed of 7 Provinces (Cavite, Laguna, Batangas, Rizal, Quezon, Pangasinan and 
Metro Manila) were declared by OIE as FMD free without vaccination (SEACFMD 
2010). In May 2011, the Philippines was officially declared by OIE as an FMD Free 
country without vaccination (OIE 2011).  
 
  
Figure 2.6 Map of SEA countries 
 
In recent years (SEACFMD 2010) FMDV types O (Mya-98 lineage) and A (Asia 
topotype  SEA  strain)  have  become  the  dominant  strains  in  SEA  and  based  on 
sequence data, these strains have been implicated as the source of the FMDV that 
have caused both past (2010) and recent outbreaks in East Asia.  In PR China, in 
Xinjiang Autonomous region and eight other provinces both types O and A have 
been detected in both pigs and cattle and in Taiwan POC and Hong Kong SAR type 
O has also been found in pigs. These viruses belong to the SEA topotype (Mya-98 !
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lineage), which is currently circulating in SEA and was last seen in Russia in 2006. 
This  FMD  type  O  was  also  seen  in  Mongolia  affecting  cattle,  sheep,  goats  and 
gazelles. These two viruses were the same lineages that caused outbreaks in cattle 
and farmed deer in South Korea. In Japan, the April 2010 FMD outbreak, which 
involved mainly cattle, was also confirmed to be caused by type O. This virus was 
found to be closely related to viruses occurring recently in P.R. China, Hong Kong 
SAR, South Korea, Myanmar and Thailand (SEACFMD 2010). 
 
2.5 Pathogenesis  
The methods of infection by FMDV include direct contact by mechanical transfer of 
virus  from  infected  to  susceptible  animals  through  cuts  or  abrasions  on  skin  or 
mucosae  or  by  deposition  of  droplets  or  aerosols  in  the  respiratory  tract  of  the 
recipient animals (Alexandersen et al. 2003). It is also acknowledged that cattle may 
sometimes be infected by direct trans-epithelial penetration and by ingestion and this 
might  result  in  different  primary  replication  sites  and  distinct  pattern  of  viral 
dissemination  (Arzt  et  al.  2011).    Indirect  contact  with  infected  animals  through 
contaminated  vehicles,  fomites,  and  living  objects  are  also  important  sources  of 
FMDV infection (Alexandersen et al. 2003).  
 
The site of primary replication after infection by the respiratory route is the pharynx 
(Burrows  1968;  Burrows  et  al.  1981;  Mohanty  and  Cottral  1970).  Following 
replication  in  the  pharynx  and  associated  lymph  nodes,  FMD  virus  enters  the 
bloodstream. Viraemia! in  blood!in cattle lasts for 3-5 days (Cottral and Bachrach 
1968)  and  virus  then  spreads  throughout  the  organs  and  tissues  of  the  body  to 
establish sites of secondary infection. This early stage of infection prior to the onset 
of clinical signs is associated with high titres of virus in secretions, excretions and 
tissues (Burrows et al. 1981). Virus may be excreted in milk and semen for up to 4 
days  before  clinical  signs  of  disease  become  apparent  (Burrows  1968;  R  1972; 
Sellers  et  al.  1968).  Clinical  disease  may  develop  in  2-14  days  after  infection !
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depending on virus dose, strain and site of entry. Clinically, FMD is characterized by 
lameness, anorexia, pyrexia, salivation, reduced milk production in lactating animals 
and  weight  loss.  There  is  frequently  secondary  bacterial  infection  of  the  lesions 
resulting in further loss of condition. Mastitis may be a sequel. In uncomplicated 
cases, resolution of the infection is usually complete by 14 days after infection. FMD 
virus may localize in the heart of young animals, resulting in myocarditis, which is 
usually  fatal.  However,  FMD  virus  infection  only  rarely  causes  death  in  older 
animals. Cattle and other species generally recover within a short period of time, 
although some damage to the pancreas and other glandular tissues has been reported 
(Woodbury 1995).  
 
Convalescent  ruminants  may  harbour  the  FMD  virus  in  the  pharyngeal  region, 
despite high levels of circulating antibody (Woodbury 1995). Vaccinated animals 
exposed to virus may become persistently infected without showing clinical signs 
(Mackay et al. 1998).  
 
Pigs are less susceptible to FMDV infection by airborne route when compared to 
ruminants, but they excrete more airborne FMDV (Alexandersen et al. 2003; Sellers 
and Parker 1969). Consequently, a common pattern of airborne FMD spread is from 
pigs to cattle, sheep and goats (Alexandersen and Donaldson 2002; Alexandersen et 
al. 2002) Pigs are important “amplifiers” of FMDV because of the abundance of 
infectious material excreted in their breath (Sellers et al. 1977). 
 
2.6 Clinical and pathological findings  
The clinical severity of FMD varies with the strain of virus, as well as the infecting 
dose, the species and individual susceptibility of the host (Kitching et al. 2005). FMD !
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is  characterised  by  an  acute  febrile  reaction  and  the  formation  of  vesicles  in  and 
around the mouth and on the feet. Clinical signs are usually severe in pigs, and early 
signs  include  acute  lameness,  reluctance  to  stand,  adoption  of  dog-sitting  posture, 
depression, loss of appetite and fever. In cattle, clinical signs include the drooling of 
saliva and mouth lesions that are often typical and rather severe and usually lesions of 
the  feet,  loss  of  appetite,  weight  loss,  severe  lameness  especially  among  draught 
power animals and a severe and prolonged impact or drop in milk production on dairy 
animals. In sheep and goats, signs maybe severe but are generally much more subtle 
than in pigs and cattle (Alexandersen et al. 2003). 
 
Other ruminant species, including wildlife, are capable of being infected with FMD, 
however in most cases they have mild infections and apart from African buffalo, wild 
ungulates  have  not,  so  far,  been  shown  to  be  able  to  maintain  FMD  viruses 
independently for more than a few months (OIE 2010).  
 
In  African  Cape  buffalo  infection  is  often  asymptomatic  (Rowlands  2008).  In 
Pakistan, outbreaks due to type O caused clinical lesions both in cattle and in water 
buffaloes (Klein et al. 2008). In Myanmar, vesicular lesions similar to that in cattle 
are also seen in some ASB during FMD outbreaks (Oo 2011).    
 
Although FMDV rarely kills adult animals, it can cause high mortality, particularly in 
lambs, piglets, and young goats, because of its predilection for the developing cells of 
the myocardium. Death occurs from heart failure before any vesicular lesions develop 
(Clavijo A 2003). Macroscopic examination of the heart in these cases often reveals a 
soft, flaccid heart with white or greyish stripes (the so-called “tiger heart”) or spots, !
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seen  mainly  in  the  left  ventricle  and  interventricular  septum  (Alexandersen  et  al. 
2003).  
 
2.7 Epidemiology and transmission 
In  regions  endemic  for  FMD,  the  virus  is  most  likely  maintained  in  persistently 
infected animals (Rowlands 2008). In some areas the wild animal population like the 
Cape buffalo in Africa may act as a reservoir for infection (Vosloo et al. 2007). In non 
endemic areas, infection may be introduced from a variety of sources such as the 
importation  of  infected  livestock,  contaminated  animal  products  or  contaminated 
materials (Sellers 1971). Long distance, airborne spread of some strains of FMDV is 
of  epidemiological  significance  in  temperate  climates  and  in  conditions  of  high 
relative  humidity  (RH)  (McVicar  and  Eisner  1983).  In  tropical  climates,  aerosols 
generated  by  infected  animals  like  cattle  and  buffalo  are  likely  to  be  rapidly 
inactivated  by  the  high  environmental  temperatures  and  intense  sunlight  (Forman 
1991), which probably limits the spread of virus from infected animals in the village 
production system (Cleland et al. 1995).  
 
Survival of the virus in the environment will depend on the nature of the material (e.g. 
desquamated epithelium, secretions, and excretions), the initial concentration of the 
virus in the material, the strain of the virus, the humidity, the pH and the temperature, 
and will therefore be highly variable under field conditions.  
 
Risk factors for an FMD virus introduction to specific regions or countries vary. In 
FMD free countries, risks may arise from deliberate, illegal importation of animals or 
animal products on a large scale and also the transport, wittingly or unwittingly, of 
small  amounts  of  infected  animal  products  by  travellers  (Barnett  et  al.  2002).  In !
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endemic areas, factors such as; livestock movement, mixing with other herds where 
they  drink,  buying  animals  from  markets  increases  the  risk  of  the  FMD  virus 
transmission (Bronsvoort et al. 2004). In SEA, the rule of supply and demand dictates 
the  price  of  livestock  and  thus  determines  the  pattern  of  livestock  movement 
(Wongsathapornchai  et  al.  2008).  The  legal  and  illegal  livestock  movement  and 
trading in SEA is considered as probably the most common means of FMD spread in 
the region (SEACFMD 2010).   
 
2.7.1 ASB and African buffalo - possible role in the FMD epidemiology  
To date no studies specific to ASB have yet been conducted to determine whether 
they have a role in the maintenance and transmission of FMD in mainland SEA, thus 
the reason for this study.    
 
The role of African Cape buffalo in the transmission and maintenance of SAT type 
viruses has been described by various authors (see 2.2.1). The African cape buffalo is 
a wildlife species, in high density and interacts mostly with other wildlife species 
like impala and it is thought that either SAT-serotype infection is maintained within 
local  impala  populations  for  prolonged  periods  or  that  re-infection  of  impala  by 
buffalo occurs repetitively, sometimes at frequent intervals (Vosloo et al. 2009).   
 
 2.8 Persistent Infection and the Carrier State of FMDV: 
Progressive research in the field of Virology both in human and animals enabled us 
to  realise  and  understand  one  of  its  significant  developments,  the  existence  of 
persistent infection. Therefore, understanding the principles of persistence e.g. origin 
and its reservoir, the effects of the continued replication in a host over its life in 
terms of causing the disease present important areas for further research (Oldstone !
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2006). In human viral infections such as retroviral infections, hepatitis B and C, 
measles and many others, significant research have been done but understanding of 
the mechanisms involved remains incomplete (Oldstone 2006).  
 
In  animal  virology,  FMD  viral  persistence  has  been  studied  extensively  in 
comparison to many other animal viruses that cause persistent infections.  Since van 
Bekkum and his colleagues described persistence of FMDV in cattle, carrier animals 
have been recognized as a potential reservoir of this virus (Gebauer et al. 1988). Yet, 
despite the above studies and the recognized importance of carrier animals in the 
epidemiology of FMD, the mechanism/s of viral persistence within the host animal 
has  yet  to  be  elucidated  (Woodbury  1995).  So,  like  other  important  human  and 
animal  virus  diseases  the  understanding  of  viral  persistence  in  FMD  remains 
incomplete.  
 
However, considerable progress in understanding FMDV persistence was achieved 
when Bekkum et al. (Van Bekkum JG 1959) showed the presence of infectious virus 
in the oesophageal-pharyngeal (OP) fluid from convalescent cattle for many weeks 
after  infection  and  this  led  to  the  hypothesis  that  FMDV  could  cause  persistent 
infection  (i.e.  carrier  animals)  which  was  supported  by  observations  from  FMD 
outbreaks in the field (Alexandersen et al. 2002).  
 
The prevalence rate of FMDV carriers in a population depends on the species, the 
incidence of infection and the immune status of the population (Alexandersen et al. 
2002).   Investigations of FMDV carriers over prolonged time intervals resulted in a 
number of publications reporting the duration of the carrier state in different FMD 
susceptible animals. In cattle, the maximum duration of the carrier state is 3.5 years; !
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in sheep, 9 months; in goats, 4 months; in African Cape buffalo, 5 years; and in 
water buffalo, it is unknown (Alexandersen et al. 2002)  . However, earlier studies 
showed limited periods of persistence of infection or carrier state in water buffalo 
(Mousa 1979) and this is examined further in 2.8.1.  
 
Animals are considered to be carriers of FMDV if the virus or viral genome can still 
be isolated from the oesophageal-pharyngeal fluid more than 28 days after infection 
(Salt 1994; Van Bekkum JG 1959). The mechanisms of persistent FMDV infection 
are  unknown;  however,  viral  mutation  leading  to  antigenic  variation  has  been 
suggested as one of the key factors (Diez et al. 1990; Gebauer et al. 1988). This 
usually lytic virus must have a mechanism for preventing cell death and evading the 
immune system (Kitching 2002a). The mechanisms for viral persistence within a 
host may be mediated by changes in the virus including the production of defective 
interfering (DI) particles, temperature sensitive mutants, recombination, integration 
and  the  infection  and  alteration  of  function  of  cells  of  the  immune  system  (Salt 
1993). Finally persistence could be mediated by immune mechanisms which may 
include  antibody  induced  antigenic  modulation  in  the  virus,  immune  selection, 
blocking factors and the generation of interferon (Woodbury 1995).  
Viruses  from  a  number  of  families  such  as  Adenoviridae,  Herpesviridae, 
Retroviridae, Picornaviridae and Poxviridae frequently persist in recovered animals 
(Timoney et al. 1988). However, the pathogenesis of the persistent infection in the 
oropharynx in the FMDV carrier state is not understood at this time. 
 
Several  epidemiological  investigations  have  shown  that  apparently  persistent 
infections by FMDV are common in areas where the disease is enzootic (Auge de 
Mello et al. 1970; Burrows 1966; Hedger 1968). FMD carriers are defined as those !
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ruminants in which FMDV persists (or is detected) in the pharyngeal region for more 
than 28 days after infection (Salt 1993; Sutmoller et al. 2003; Zhang and Kitching 
2001). However, the proportion of animals which become carriers varies with the 
severity of the virus challenge, but not the age or sex of the animal (cattle) involved 
(Hedger 1970). In endemic regions, up to 50% of the infected animals were found to 
be carriers, which may trigger outbreaks under suitable conditions (Sutmoller 1965). 
In the Kruger National Park in South Africa, rates of persistent infection of African 
Cape buffalo are as high as 60% (Hedger 1972; Hedger 1976).  In the early 1960s, 
before the start of the systematic vaccination programmes in Brazil, virus-positive 
probang samples by virus isolation (VI) were commonly recovered from over 50% of 
the cattle (Sutmoller 1965). Two decades later in 1983 and in 1984 when vaccination 
programmes  were  intensified,  probang  sampling  of  several  hundreds  of  cattle  in 
endemic areas of Brazil resulted in only a very small number of positive samples 
(Obdeijn da Silva, personal communication) (Sutmoller and Casas 2002).   
 
 Among wildlife, few become persistently infected (carriers) post infection. Llamas 
(Llama glama) do not become FMD carriers. Those that become affected only show 
the  presence  of  virus  in  the  pharyngeal  mucosae  for  up  to  14  days.  Recovered 
animals do not transmit the virus to other susceptible species (Lubroth et al. 1990). 
Viral  persistence  in  antelope  has  only  been  reported  in  kudu  (Tragelaphus 
strepticeros)  in  which,  after  artificial  infection,  virus  was  detected  for  almost  5 
months (Hedger 1972). Wildebeest (Connochaetus taurinus) carried SAT 1 virus for 
45 days after infection. But this was not confirmed in a subsequent study (Anderson 
et al. 1975).  FMD persistence was also found in sable antelope (Hippotragus niger) 
(Ferris et al. 1989) but in impala (Aepyceros melampus) experimental studies have 
failed to provide evidence of viral persistence (Hedger 1972). In red deer (Cervus !
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elaphus) and roe deer (Capreolus capreolus) FMDV was seldom recovered from the 
oro-pharynx beyond 14 days post exposure. Fallow deer (Dama dama) carried the 
virus for a minimum of 5 weeks (Forman et al. 1974). With these varied results on 
the studies of FMD persistence among wild animals, it is considered that, wildlife are 
more likely to spread FMDV in the clinical and sub-clinical state than as carriers 
(Sutmoller and Casas 2002).  
 
2.8.1 Duration and resolution of the FMDV carrier state 
The duration of the FMDV carrier state varies, and is probably host species and virus 
strain  dependent  (Woodbury  1995).  Virus  recovery  in  cattle  has  been  shown  2.5 
years after infection (Hedger 1970), but in sheep and goats no isolation was shown 
more  than  9  months  after  infection  (Burrows  1968;  McVicar  JW  1969).  Virus 
isolation  from  pigs  has  not  been  achieved  more  than  1  month  after  infection 
(Bekkum 1973). Pigs are considered to clear virus rapidly and not to become carriers 
(Alexandersen et al. 2002). Recent studies showed RNA copies, but no live virus, 
was detected beyond 28 days from the pharyngeal and soft palate tissues of a small 
number of vaccinated and infected pigs beyond the acute stage of the infection. Sub-
clinical infections can occur in vaccinated pigs but they are not carriers (Parida et al. 
2007). Two previous publications reported that virus was recoverable from pigs for 
as long as 21 to 28 days after infection (Mezencio et al. 1999; Yadin H 1994). 
However, infection was not present after 28 days, which by definition indicates pigs 
are not carriers. 
 
Individual African Cape buffalo have been shown to excrete virus for at least 5 years 
(Condy et al. 1985; Hedger RS 1971). They may also be persistently infected with 
more  than  one  type  of  FMDV  in  the  pharyngeal  region  (Hedger  1972).  Isolated !
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groups of African Cape buffalo may be able to maintain the virus circulating in the 
herds for many years (Condy et al. 1985; Thomson et al. 1992). In southern Africa, 
the  epidemiology  of  the  disease  appears  to  be  unique  because  circumstantial 
evidence indicates that outbreaks of FMD in livestock may be derived from free-
living African Cape buffalo (Condy 1979; Thomson 1995).  
 
In contrast to African Cape buffaloes, there are still limited studies on the carrier state 
among water buffaloes and ASB, and whether carrier water buffaloes and ASB cause 
or  can  cause  new  outbreaks  of  FMD.  The  limited  studies  on  the  duration  of 
persistence (carrier state) show varied results. In Egypt a study showed that duration 
of persistence in water buffaloes lasted up to 2 months (Moussa 1979). But according 
to Gomes et al, persistent infection in the water buffaloes during the first 35 days after 
infection  was  similar  to  that  in  the  cattle  (Gomes  et  al.  1997).  In  the  Philippines 
during the height of the 1995 to 2000 FMD outbreak due to serotype O pig adapted 
strain, a study on FMDV carrier status in ASB was conducted on six ASB post FMDV 
infection and carrier animals were not detected during the entire period of the study 
(Legaspi et al. 2003). According to Alexandersen et al. 2002, virus persistence among 
water  buffaloes  is  undetermined.    A  recent  study  under  experimental  conditions 
reported  persistent  infection  of  FMDV  in  water  buffaloes  for  more  than  one  year 
(Barros et al. 2007). This suggests that water buffaloes may act as viral reservoirs. 
This persistently infected host represent a potential source of viral variants, however 
long-term carriage of FMDV does not imply efficient transmission of disease (Barros 
et al. 2007).  
 
Over time among persistently infected (carrier) animals there is a gradual decline in 
the titre and frequency of virus recovery throughout the carrier period (Rossi et al. 
1988). Eventually the animal does eliminate the virus. The amounts recovered in !
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probang samples are usually at a level below that required for transmission of FMD 
virus to other susceptible animals by natural routes (Donaldson and Kitching 1989). 
But  these  results  are  mainly  from  studies  under  experimental  or  controlled 
conditions. It is possible that as yet unidentified “trigger factors” may result in higher 
levels of excretion under field conditions (Woodbury 1995). Most experimentally 
infected  cattle  carrier  animals  stop  excreting  virus  spontaneously  between  4-10 
months after infection, but some have continued up to 14-15 months (Burrows 1966; 
Van Bekkum JG 1959). Field evidence suggests that transmission within African 
Cape buffalo herds readily occurs from carrier African Cape buffalo to African Cape 
buffalo calves (Bengis et al. 1986). There are also two reports of transmission from 
African Cape buffalo to cattle under controlled conditions (Dawe et al. 1994; Hedger 
and  Condy  1985).  The  virus  persists  in  the  basal  layer  cells  of  the  pharyngeal 
epithelium, particularly of the dorsal palate (Zhang and Kitching 2001). The virus 
may persist in the oesophageal-pharyngeal (OP) region of cattle and other ruminants 
(Sutmoller 1965; 1968; Van Bekkum JG 1959), for up to several years (Condy et al. 
1985).  In  FMD  “carrier”  animals  long-term  viral  replication  is  restricted  to  the 
oropharynx (Burrows 1966).  
         
2.8.2 Persistent Mixed Infections 
Mixed infections in individual animals also occur with different serotypes of FMD 
virus. Experimental dual infections have been established with serotypes O and A in 
calves (Vallee H 1928), SAT 1, 2 and 3 have also been isolated from carrier African 
buffalo (Hedger et al. 1972).  Hedger (Hedger 1972) showed the transfer of SAT 2 
from a carrier African Cape buffalo to an animal already infected with SAT 1. In all 
these  cases,  one  dominant  serotype  was  present,  and  the  second  virus  was  not 
eliminated but replicated within the host. The occurrence of dual infections in the field !
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involving strains of FMDV virus serotype Asia 1 alongside strains of serotype O in 
Saudi Arabia has been reported (Woodbury et al. 1994). Persistent mixed infections in 
sheep in the field involving FMD serotypes O and A have also been reported (Gurhan 
SI 1993).  Despite the recognized importance of carrier animals in the epidemiology 
of FMD, the mechanisms of viral persistence within the host animal has yet to be 
clarified. The need to understand the mechanisms of establishment and maintenance 
of the carrier state in FMD has become more important due to the greater risk which 
these animals represent, particularly when a country or region has ceased its routine 
vaccination programme making the livestock population more susceptible to FMD 
infection.  
     
2.8.3 Site of FMDV Persistence in carrier animals 
An important aspect of FMDV is its capacity to establish persistent infection in both 
vaccinated and non-vaccinated ruminants exposed to the virus (Auge de Mello et al. 
1970).  To  determine  the  sites  of  persistence  and  multiplication  of  virus  in  carrier 
animals, Burrows (1966) examined different organs for the presence of live virus at 
various times between 14 and 196 days post-infection in cattle challenged via tongue 
inoculation with 10
5.0 ID50 virulent virus.   
 
Results of the study showed that the chief sites of virus multiplication based on the 
frequency of virus recovery and infectivity titres, were the dorsal surface of the soft 
palate  and  the  pharynx  and  concluded  that,  in  FMDV  ‘carriers’  long-term  viral 
replication  is  restricted  to  the  oropharynx  (Burrows  1966).  This  finding  was 
confirmed in a similar study using plaquing techniques with bovine embryo kidney 
cells suspended in agar, which during that time, proved to be more satisfactory and 
sensitive than other methods, and Van Bekkum et al (1966), as referred to by (Singh !
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1969), thought that the pharynx appeared to be the main site of virus production. After 
almost  four  decades  these  findings  have  been  supported  by  studies  using  in-situ 
hybridization  in  combination  with  tyramide  signal  amplification  (TSA).  These 
provided the first direct evidence that FMDV RNA is localised within the epithelial 
cells  of  the  soft  palate  and  pharynx  during  persistent  infection  (Zhang  and 
Alexandersen  2004;  Zhang  and  Kitching  2001).  However,  the  significance  of 
continued detection of viral RNA has not been clear since FMDV proteins have not 
been detected by sensitive immunohistochemistry methods in studies of these tissues, 
following the resolution of the vesicular lesions (Juleff et al. 2008).  
 
However, a recent study did not detect viral RNA in the epithelial compartments of all 
the tissues examined (dorsal soft palate, pharyngeal tonsils, palatine tonsils, lateral 
retropharyngeal  lymph  nodes  and  mandibular  lymph  node)  either  by  laser 
microdissection (LCM) and quantitative rRT-PCR, or in situ hybridization, although 
the study routinely detected viral RNA and capsid in Germinal Centres (GC) of these 
tissues (Juleff et al. 2008).  
 
2.8.4 FMDV Carriers causing outbreaks 
The importance of the carrier animal in the epidemiology of FMD has been a topic of 
debate. There is field evidence available both to support and refute the importance of 
the role of carriers. In countries, which are free zones or engaged in international 
trade, any animal with FMD virus antibody is considered a potential carrier. For 
more than 100 years, cattle that recovered from FMD were thought to be able to 
initiate  outbreaks  of  the  disease  (Salt  1993;  Sutmoller  and  Cottral  1967).  This 
suspicion was raised because of outbreaks that occurred in countries or areas free of 
FMD after the introduction of healthy convalescent cattle from regions where the !
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disease had occurred (Sutmoller and Casas 2002). An interesting observation was 
made in the United Kingdom (UK) after the serious 1922 to 1924 FMD epizootic. 
Given  the  extent  of  the  epidemic,  the  traditional  slaughter  policy  was  partly 
abandoned  and  105  infected  farms  were  isolated,  without  slaughter.  From  these 
farms eight months later, a convalescent bull and a heifer were sold to a district 
where no disease had been observed. After introduction of these animals into the new 
herd, FMD occurred and was attributed to these animals (Sutmoller P. 1967).  In the 
late 1940’s imported Brazilian zebu cattle were probably the source of an outbreak in 
Mexico (Casas Olascoaga R. and N. 1999). In 1959 and 1975 studies, evidence of 
transmission  from  carrier  cattle  or  sheep  was  not  reproduced  experimentally  but 
when  OP  fluid  was  injected  into  cattle  and  pigs  under  experimental  conditions, 
infection was demonstrated unequivocally. Therefore, the risk of transmission cannot 
be  excluded  since  there  is  infectious  virus  in  the  OP  fluid  of  such  animals  (O. 
Kaaden 1975; Van Bekkum JG 1959).  
 
The carrier state in the African Cape buffalo (Syncerus caffer) has been studied and 
may be a mechanism for virus persistence in Africa. A study wherein susceptible 
cattle was kept in close association over a period of 2.5 years with African Cape 
buffalo carrying FMDV did not result in the transfer of infection from African Cape 
buffalo to cattle during this period, although transmission did take place between the 
African Cape buffalo (Condy and Hedger 1974). In field observations in Botswana, a 
high percentage of African Cape buffalo carried FMDV but there were no clinical 
signs  of  disease  in  either  African  Cape  buffalo  or  other  susceptible  species  with 
which they were in close contact and there was a complete absence of the disease in 
domestic stock over an eight year period (Hedger 1976).  
 !
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Molecular, epidemiological and circumstantial evidence suggests that the two recent 
outbreaks of FMD in cattle in South Africa were caused by African Cape buffalo that 
escaped from the Kruger National Park (Vosloo et al. 2002a). Based on this, the 
strategy against FMD in South Africa has, for many years involved separation of 
cattle from African Cape buffalo by using fencing and other measures (Sutmoller et 
al. 2000).   
 
Some  authors  suggest  that  the  epidemiological  significance  of  the  carrier  is 
ambiguous, although transmission of FMDV from persistently infected African Cape 
buffalo to susceptible African Cape buffalo (Bengis et al. 1986) and cattle (Hedger 
and Condy 1985) has been shown under controlled conditions. However there is little 
doubt that FMD ‘carriers’ may represent a reservoir of potential infection (Gebauer et 
al. 1988). Finally, there is evidence of involvement of (non-vaccinated) persistently 
infected  cattle  in  outbreaks  caused  by  SAT  2  strains  in  Zimbabwe  (Vosloo  et  al. 
1992).  Similarly  a  study  by  Thompson  (1994)  showed  evidence  that  there  was 
involvement of non vaccinated persistently infected cattle in outbreaks caused by SAT 
2 strains in Zimbabwe. These may be special cases related to SAT type viruses and 
their relevance for types O, A, Asia 1 and C is unknown.  
 
The circumstantial evidence indicates that although such transmission is inefficient, it 
can occasionally occur from infected African Cape buffalos in the field (Vosloo et al. 
1996). However, Thomson pointed out that carrier transmission could simply be an 
infrequent  stochastic  phenomenon  (Thomson  1996)  or  carriers  may  transmit  the 
infection poorly to cohorts and to other susceptible species, only after prolonged and 
intimate contact (Thomson et al. 1992). 
  !
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2.9 FMD Diagnosis  
FMD  cannot  be  clinically  differentiated  from  other  vesicular  diseases,  including 
vesicular  stomatitis  virus  (VSV),  vesicular  exanthema  virus  (VEV)  and  swine 
vesicular disease (SVD). Clinical signs vary significantly and they may be, mild, 
subclinical or be so called ‘carrier animals’. Laboratory diagnosis of any suspected 
FMD case is a matter of urgency due to the speed of transmission and the potential 
serious impacts.  
 
The confirmation of diagnosis of foot and mouth disease is done by both direct and 
indirect methods which can include a) antigen/RNA/virus detection (direct) methods 
such as the following laboratory tests; virus isolation (VI) to isolate live virus (the 
gold standard), the antigen ELISA which detects the viral antigen and polymerase 
chain reaction (PCR) to detect the viral genome and b) antibody detection (indirect) 
methods which includes the following tests; the Virus Neutralization test (VNT), 
Liquid Phase Blocking ELISA (LPBE), competition ELISA for structural antibody 
detection and the Non Structural Protein ELISA (NSPE) for non-structural protein 
antibody detection (Crowther 2005). 
 
 2.9.1 Identification of the Agent:  
The  demonstration  of  serotype  specific  viral  antigen  by  FMDV  antigen  detection 
ELISA is usually sufficient for a positive diagnosis. Lesion material or tissue culture 
medium from cell cultures showing cytopathic effect (CPE), harvested and clarified 
are assayed for the presence of FMDV antigen in an indirect ELISA (Roeder and Le 
Blanc  Smith  1987).    However,  VI,  the  gold  standard  test,  is  still  necessary  for 
isolation  of  the  live  virus  to  fully  characterise  the  virus.  Probang  samples  are 
examined for the presence of live FMD virus by cell culture inoculation using primary !
33!
!
bovine  thyroid  (BTY)  cells.  Five  (5)  primary  BTY  cell  tubes  are  used  for  each 
probang sample. Each tube is inoculated with 200ul of the probang sample, which was 
thawed and equilibrated at room temperature before the inoculation. The inoculated 
BTY cells were observed for three days for cytopathic effects (CPE) of cells (OIE 
2004).  
 
FMD is one of the types of viruses which produce CPE in cell cultures, which in the 
case  of  FMDV  is  a  degenerative  change  in  tissue  culture  cells  consisting  of  cell 
rounding and death with disruption of cell monolayers (Figure 2.7) (Amer 2008).  
 
When the culture is positive for CPE, the fluid can then be used in FMDV antigen 
detection  ELISA,  which  is  serotype  specific,  for  the  detection  of  the  FMD  viral 
antigen and serotype. The tissue culture fluid or the original epithelial suspension, 
which was inoculated in the tissue culture, can also be directly used for FMD nucleic 
acid detection test using RT-PCR for detection of the complete VP1 gene. 
 
Armer,H., Moffat,K., Wileman,T., Belsham,G.J., Jackson,T., Duprex,W.P., Ryan,M.D. & 
Monaghan, P. (2008). Foot-and-Mouth Disease Virus, but Not Bovine Enterovirus, Targets 
the Host Cell Cytoskeleton via the Nonstructural Protein 3Cpro. J. Virol. 82, 10556–10566.
Cytopathic Effect in FMDV-infected Cells
0 hrs 1.25 hrs 2.5 hrs
 
Figure 2.7 Cytopathic Effect (CPE) in FMD-infected cells. 
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2.9.2 Serological Tests 
 
2.9.2.1 Detection of antibody to FMDV structural proteins 
In mild cases and where epithelial tissues/fluid is no longer available for collection, 
the demonstration of specific antibodies against FMDV in blood serum samples from 
non-vaccinated animals where there has been vesicular disease condition is sufficient 
for a confirmation of a positive diagnosis of FMD. Serum antibodies are induced 
against the outer capsid structural proteins following both vaccination against and 
infection with FMDV. The virus neutralisation test and antibody ELISAs like the 
liquid phase blocking ELISA (LPBE) and the Competition ELISA (C-ELISA) (similar 
to the ELISA for antigen detection) are serotype-specific tests and are OIE standard 
accepted tests for the detection of antibodies against the structural protein of FMDV 
in serum samples from FMD suspect animals. FMDV, like other RNA viruses e.g. 
influenza viruses, several hepatitis viruses and the human immunodeficiency viruses, 
are highly variable (Domingo et al. 1997; Rodriguez et al. 1992).  Studies of FMDV 
types O, A and C in the Philippines and type A in Turkey, showed that the VP1 gene 
changes by approximately 1% per year (Knowles and Samuel 2003).  
 
The  seven  different  serotypes  of  FMDV  are  differentiated  by  their  clustering  into 
distinct  genetic  lineages  with  approximately  30-50%  difference  in  the  VP1  gene 
(Knowles and Samuel 2003). The different serotypes are detected by using specific-
serotype antibody and antigen in both antigen detection and serology tests. However, 
with the variability within some serotypes some strain specific reagents need to be 
used for full antigenic characterisation.  
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2.9.2.2 Detection of antibody to FMDV non- structural proteins 
The  test,  which  differentiates  antibodies  due  to  infection  from  that  due  to 
vaccination, is called the Non Structural Protein (NSP) ELISA. The detection of 
antibodies  against  the  NSP  (highly  conserved)  of  FMD  has  now  been  used 
extensively  in  both  FMD  endemic  and  free  countries.  Currently  there  are  four 
commercially  available  (Priocheck,  Bommeli,  UBI,  Brescia)  and  some  in  -house 
NSP ELISA based tests against one or more of the FMD non-structural proteins like, 
3ABC, 3D, 2B, 2C and 3AB, that can be used to detect post FMD infection whether 
in  vaccinating  or  non-vaccinating  livestock  population.  (Brocchi  et  al.  2006; 
Bronsvoort et al. 2006) The OIE index method is a test system that combines the 
3ABC indirect ELISA for screening, supported by a confirmatory immunoblot test 
for antibodies against the 3A, 3B, 2C, 3D and 3ABC NSPs (Anonymous 2004). 
 
At present, of the NSP ELISAs, the 3ABC ELISA has proven to be more effective 
and most reliable among the others (Brocchi et al. 2006). Evaluations conducted in 
FMD control programmes in 1996 when the 3ABC ELISA was used to define the 
limits  of  the  FMD  outbreak  in  the  Balkans,  showed  that  antibody  to  the  3ABC 
polyprotein was considered the single most reliable indicator of infection (Mackay et 
al. 1998). All diagnosis of FMD whether direct and indirect methods must be carried 
out in a specialised laboratory (Alexandersen et al. 2003). 
 
2.9.3 Identification of and tests for persistently infected “carrier” animals 
 
2.9.3.1 Probang sample with FMD virus isolation   
The  identification  of  carrier  animals  requires  recovery  of  live  FMDV  from  those 
animals  (Kitching  2002b).  The  predilection  of  the  virus  for  the  epithelium  of  the !
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pharynx makes this tissue the most suitable to sample, a procedure which can be 
carried out using a probang sampling cup (Donaldson 1987). The quantity of virus 
present in the pharynx of carrier animals can vary considerably over time and the 
successful  recovery  of  virus  will  depend  on  this  and  other  factors,  such  as  the 
subsequent handling of the sample and the skill of the operator (Kitching 2002b). The 
probang (OP) fluid can be tested for the presence of FMDV by VI (gold standard) 
using primary BTY cells. But authors like Archetti et al and Zhang et al state that the 
probang  test  is  not  sufficiently  sensitive  and  is  labour  and  laboratory  intensive 
(Archetti et al. 1995; Zhang and Alexandersen 2003). With the use of RT-PCR which 
identifies small quantities of viral genome present in the sample, the sensitivity of the 
test can be improved (Kitching 2002b).  
 
2.9.3.2 NSP antibody and salivary IgA antibody to FMDV in carriers  
Carrier animals generally have antibodies to FMDV. These can be detected in the 
serum (OIE 2001) using either the NSP ELISA test which detects previous infection 
in both carrier and non carrier animals (Parida 2009) and also in the saliva and nasal 
samples. FMDV serotype specific immunoglobulin A (IgA) is present in saliva and 
nasal secretions of recovered or vaccinated cattle and is elevated in the carrier animal, 
probably  because  of  the  constant  low  levels  of  virus  maintaining  the  antigenic 
stimulus to the mucosal immune system (Kitching 2002b). A specific ELISA has been 
developed to detect and quantify this elevated level of FMDV specific IgA in saliva 
and nasal secretions (Kitching 2002b; Parida et al. 2006).   Animals  that  have 
recovered from FMD infection will have antibodies to the NSPs, because as the virus 
replicates in the tissues of the animals, these proteins will be expressed and stimulate 
the production of specific antibodies by the host. The detection of these antibodies can !
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therefore be used to identify those animals that have been infected with FMD and 
which may still be carrying live virus (Kitching 2002b).  
 
These alternative tests for antibodies to NSPs in serum or FMD specific IgA in saliva 
are not 100% sensitive or specific for detection of carriers. However, these newer tests 
do provide increased biosecurity by reducing the likelihood of trading carrier animals 
and can be used to help define the limits of an outbreak (Mackay 1998).  
 
2.9.3.3 Detection of FMDV carriers in livestock trade 
Initial diagnosis of FMD relies heavily on the recognition of clinical signs in affected 
animals.  However,  the  pan-Asian  topotype  of  FMDV  type  O,  which  caused  the 
outbreaks in the United Kingdom, was identified when it first entered Taipei China 
following isolation from probang samples from local Chinese yellow cattle which 
were being routinely tested prior to movement (Huang et al. 2001). Prior to this FMD 
had  not  been  present  in  cattle  in  Taipei  China  since  1928  and  these  cattle  had 
reportedly shown no evidence of disease.  
 
In sheep and goats, subclinical disease is common. PCR testing can identify small 
quantities of viral genome present in a lesion or an oropharyngeal sample but it can 
also  give  false  negative  results  due  to  the  presence  of  non-specific  inhibitors.  A 
comparative  study  using  both  tissue  culture  and  PCR  on  probang  samples 
demonstrated that some samples could give positive results using one method and 
negative results using the other and that both tests should ideally be used together 
(Kitching 2002b). While a positive PCR is highly suggestive of previous infection, 
there is still the unresolved question of the significance of positive PCR result because 
PCR identifies only part of the viral genome, and possibly the animal from which the !
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sample  was  collected  may  no  longer  be  carrying  infectious  virus  and  no  longer 
represent  any  risk  of  causing  a  further  outbreak.    Isolation  of  virus  from  blood 
samples is restricted to only a three day viraemic period and is not relevant for carrier 
detection (Kitching 2002b).  
 
A variety of tests have been developed to detect NSP antibodies in carriers, including 
ELISA and the enzyme-linked immune-transfer blot (EITB). The 2C antibodies may 
be  detectable  for  up  to  12  months,  while  the  3ABC  antibodies  persist  for  longer 
periods (Kitching 2002b). The possibility of carrier animals creating fresh outbreaks is 
probably  extremely  small  and  this  risk  can  be  further  reduced  by  probang  and 
serological  testing  (Kitching  2002b).  However  no  matter  how  small  the  risk  is, 
importing  countries  will  usually  choose  to  import  their  live  animals  and  animal 
products from areas where there is no FMD vaccination and no possibility of the 
presence of carrier animals (Kitching 2002b).  
 
After  an  FMD  field  outbreak,  some  animals  will  be  positive  for  FMDV  specific 
mucosal antibody (IgA), which suggests they have been infected and may possibly 
become a carrier animal. If mucosal samples from a statistically significant sample of 
animals tested in a herd are antibody-negative, the carrier state is extremely unlikely. 
Conversely,  a  persistent  mucosal  antibody  response  (beyond  3  to  4  months)  is 
strongly indicative of a carrier state (McVicar and Sutmoller 1974).   
 
2.10 Prevention and control of FMD 
Prevention  and  control  strategies  for  FMD  requires  a  good  understanding  of  the 
epidemiology of the disease in the region/country, the production system and its 
level of productivity, the dynamics of the populations being targeted, and the social !
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and  cultural  aspects  of  the  region/country  (Perry  and  Rich  2007;  Thurmond  and 
Perez  2006).  Approaches  to  control  and  eradicate  FMD  where  the  disease  is 
prevalent are generally based on a combination of rapid detection and early response 
to  an  outbreak,  high  level  of  vaccine  coverage,  quarantine,  control  of  animal 
movement,  slaughter  of  infected  animals  or  herds  and  contacts  (Bergmann  et  al. 
2005).   
 
2.10.1 Surveillance and early detection 
During  outbreak  situations  intensive  surveillance  on  the  outbreak  area  must  be 
carried out. Identifying animals that have been infected and the rapid diagnosis of 
FMD is of great importance in the prevention and control of the disease (Clavijo A 
2003). However, people carrying out clinical inspections, especially of the mouth, 
and collecting blood samples present a high-risk of spreading the disease. Therefore 
rules for biosecurity should be applied with the greatest care, even if clinical signs of 
FMD were not detected (Sutmoller et al. 2003).   
 
2.10.2 Quarantine and movement control 
Enforcement of farm isolation and biosecurity must be adequate to efficiently control 
the disease (Sutmoller et al. 2003). Movement of infected animals, products and 
people is the most important mechanism by which FMD may spread between farms 
and regions, and these can be controlled by the effective quarantine and movement 
restrictions that animal health authorities apply to affected regions (Hess E. 2008).   
 
2.10.3 Depopulation and decontamination 
FMDV  is  moderately  stable  but  can  readily  be  inactivated  by  appropriate 
disinfectants and heat. In general most strains are stable within a pH range 7.0-8.5, !
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especially at lower temperatures, but the virus is increasingly labile at pH values 
outside that range (Bachrach 1968; Bachrach et al. 1957).  Proper disinfection is 
important  part  of  the  disease  control.  Personnel  handling  infected  animal  may 
become contaminated on hands, clothes or in nasal passages with live FMD virus and 
mechanically  carry  the  virus  to  susceptible  animals  by  close  contact.  Veterinary 
surgical  instruments  or  artificial  insemination  equipment  may  likewise  become 
contaminated and transmit the infection with improper cleansing and sterilisation. 
This has occurred in Denmark (1982) and Italy (1993), respectively (Kitching 1998). 
Milk tankers were similarly implicated in the spread of disease during the 2001 UK 
FMD epidemic (Gibbens et al. 2001).  
 
Stamping out or slaughter is often used as the first step in FMD free zones without 
vaccination.  Increasingly  vaccination  is  used  if  the  outbreak  is  widespread  and 
particularly if there is no reason, e.g. trade to regain free zone status quickly. In 
countries that do not have FMD free zone status, such as developing countries or 
regions like SEA, vaccination is the preferred FMD control option as a ‘slaughter 
out’ policy is not currently socially desirable or economically feasible (Rast et al. 
2010).   
 
2.10.4 Vaccination for FMD control:   
The vaccines currently available are inactivated and contain whole virus in a semi-
purified state which may include one or several of the serotypes but the strain used 
should match the field strains that are causing the disease (Davies 2002).  
 
FMD  vaccines  use  adjuvants  to  enhance  their  immunogenicity.  The  approved 
adjuvants used are of two types: aluminium hydroxide gel (Al(OH)3) supplemented !
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with saponin is usually used for cattle and sheep (Doel 1999); and oil adjuvants 
which are used in pigs and are also used in cattle as a double oil emulsion (DOE), 
which is now widely used in SEA and is claimed to be more effective than the 
(Al(OH)3)/saponin vaccines in cattle (Doel 1999). The current generation of FMD 
vaccines protect animals for periods up to 12 months (Cox et al. 1999; Davies 2002). 
Vaccines can be employed to protect a population against a future challenge, or in 
emergency,  to  deal  with  a  current  epidemic  and  livestock  populations  can  be 
protected against major epidemics of FMD if 50% or more of the susceptible animals 
are vaccinated (Davies 2002).  
 
The  speed  at  which  vaccination  induces  protective  immunity  and  prevents 
transmission depends on the potency of the vaccine against the outbreak strain and 
the level of viral exposure, but may be as short as four days (Doel et al. 1994; Salt 
1994). Among FMD serotypes, serotype A vaccines generally are more effective 
than other serotypes (Doel et al. 1994). But among FMD serotypes, type A have 
more antigenic variation, so the vaccine needs to contain the specific representative 
subtype (Brehm et al. 2008; Cox and Barnett 2009).     
 
Routine vaccination reduces the incidence of carrier establishment in endemic areas 
in the field. This is the consequence of an indirect effect, as a reduced number of 
cases of FMD results in a lesser challenge to susceptible animals (Woodbury 1995). 
For example in Kenya a vaccinated area had a carrier prevalence of 0.49% compared 
with  carrier  prevalence  in  an  unvaccinated  area  of  3.34%  in  similar  livestock 
populations (Anderson et al. 1974). Transmission from carrier to susceptible animals 
is probably a rare event and will be more likely when the ratio of susceptible to 
carrier animals is high, for example in a non- vaccinated population.  !
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There  are  two  disadvantages  associated  with  vaccination.  Firstly,  all  vaccinated 
animals  will  be  seropositive  for  FMD  and  cannot  be  readily  distinguished  from 
infected animals, which have recovered, by VNT or LPBE tests. Secondly, FMD is 
able to persist as a ‘carrier state’ in cattle regardless of whether or not they were 
vaccinated prior to infection. The use of vaccine to help control an outbreak of FMD 
in a previously free country still has significant consequences on trade in susceptible 
animals and their products while in endemic countries that vaccinate against FMD, 
the possibility is high that clinical disease will be masked in those animals which 
have only partial immunity and which are exposed to live virus. Also, vaccinated 
animals during an outbreak of FMD will pass through a period of partial immunity 
before  the  vaccine  becomes  fully  effective,  during  which  clinical  signs  will  be 
reduced or prevented, but infection and virus transmission can still occur (Donaldson 
and Kitching 1989).  
 
For some countries in SEA, vaccinations are widely used to control FMD. But for 
other countries in SEA, vaccination is not used widely as one of the control measures 
because  of  the  expense.  In  the  Philippines,  mass  vaccination  was  used  by  the 
commercial pig sector as one of their control measures and supported the eventual 
eradication of FMD (Gleeson 2002). Some of the poorer countries, which produce 
FMD vaccines, have very limited vaccine production capacity. Thailand produces 
approximately 20 million doses of trivalent FMD vaccine (O, A and Asia 1), and 
both  commercial  and  government  produced  vaccines  are  used.  In  Myanmar  the 
government produces approximately 100,000 doses per year of monovalent vaccine 
(O and Asia 1). Malaysia uses only tetravalent imported vaccine to vaccinate cattle 
and  buffaloes  in  high  risk  areas.  In  Lao  PDR  little  vaccination  is  used  and  it  is !
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usually  restricted  to  vaccines  supplied  for  funded  field  research  projects.  In 
Cambodia,  there  was  almost  no  vaccine  used  except  for  very  small  amounts  of 
imported vaccine for use in animals being exported.  In Vietnam large commercial 
pig producers use vaccine and the provincial governments provide about two million 
doses of monovalent type O vaccine a year for cattle, buffalo and pigs (Edwards 
2004).  
 
The  2010  vaccination  programme  reports  from  different  SEACFMD  member 
countries  that  have  endemic  FMD  indicate  some  improvements  in  terms  of 
vaccination coverage. In Cambodia, ring vaccination is practiced around the outbreak 
villages and 15,000 doses of FMD vaccine were provided by the SEACFMD that 
was used for their ring vaccination programme; in Malaysia strategic vaccination 
among cattle and buffaloes in high risk areas is practiced and only uses commercial 
FMD vaccine; in Myanmar vaccination was conducted in high risk areas and they 
were able to produce around 200,000 monovalent type O vaccine doses in 2010 and 
they have an ongoing project with the International Atomic Energy Agency (IAEA) 
on the strengthening of the national capacity for the production of FMD vaccine; in 
Thailand there is an on-going national FMD vaccination booster campaign in cattle 
and this requires all FMD free farms to be vaccinated twice per year; in Vietnam, 
vaccination is still considered as the key intervention on their FMD programme and 
in 2010 the government purchased around 7.1 million doses of FMD vaccine but 
they still have low vaccination coverage and the immediate future plan is to increase 
vaccination coverage (SEACFMD 2010).      
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2.10.5 Other aspects of prevention and control  
A good understanding of the characteristics of the virus strain involved in an FMD 
outbreak is necessary to provide reliable prevention and control strategies. In the 
event of an incursion of FMD, provision for laboratory studies on the virus will be an 
essential component of the disease response and should be factored into contingency 
plans  (Hess  E.  2008).  Especially  in  areas  where  the  animal  production  system 
includes traditional, nomadic husbandry and in which FMD is endemic and animal 
movement is uncontrolled, a regular sampling from outbreaks will be necessary for 
genetic characterisation of the field virus strain/s. The systematic analysis of spatial 
and temporal occurrence and distribution of FMD strains in the infected area will 
help to understand the epidemiology and to determine if available vaccine strains are 
likely to be protective (Rweyemamu et al. 2008).  
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Chapter 3: Materials and Methods 
 
This chapter describes the study area, the collection, processing, storage and analysis 
of samples and the different laboratory procedures. 
 
3.1 Study Area 
Two countries in South East Asia (SEA) were selected for the study area, the Lao 
PDR and Myanmar (Burma) and these are approximately 720 Km apart (Fig. 3.1). In 
Lao PDR, seven villages from Vientiane province were chosen as the study area. 
Vientiane Province is located 120 Km north from Vientiane city which is located in a 
separate prefecture. In Myanmar, eight villages from three divisions were included in 
the  study;  the  Ayeyarwaddy  division  which  occupies  the  delta  region  of  the 
Ayeyarwaddy river and is located 120 Km from Yangon city; Yangon division 70 
Km north of Yangon city; and Magway division which is 403 Km north of Yangon 
city. The basis for the selection of the study areas was based on the most recent FMD 
recorded  and  confirmed  outbreaks  reported  by  the  farmers  to  the  Veterinary 
authorities at the time of the first sampling collection period.  
 
In  Lao  PDR  the  most  recent  confirmed  FMD  outbreak  occurred  eight  months 
previously. In Myanmar FMD outbreaks were more frequent than the usual due to 
disruption following the 2008 Cyclone Nargis, thus the first sample collections were 
done  four  and  eight  months  after  the  outbreaks  were  reported  to  the  Veterinary 
authorities.  In  the  Magway  Division,  Myanmar  only  ASB  were  reported  to  be 
involved in the FMD outbreaks.  
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Figure 3.1 Sample collection sites  
 
3.2 Sample Collection  
A cross sectional study of ASB four to eight months post-outbreak in Lao PDR and 
Myanmar  was  conducted  in  September,  2008  and  in  Magway  division,  the  third 
sampling  site  in  Myanmar  in  October  2009.  The  study  was  done  to  assess  the 
prevalence of FMDV infection in ASB in post-outbreak herds in SEA.  These were 
followed by a longitudinal study in these populations in both countries with two 
additional  samplings  six  months  apart  to  determine  the  percentage  positive,  the 
duration of persistence of FMDV in previously infected ASB in the herd and to 
determine the possibility of transmission of FMDV from persistently infected ASB 
to naïve ASB.    
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The  collections  of  samples  were  deliberately  focused  on  farmer  owners  in  the 
villages that have previously had outbreaks of FMD in ASB. All ASB regardless of 
the number and FMD status from the identified farmer owner were sampled. This 
was done for cultural reasons, so that the farmer owner would not think that there 
was discrimination against his animals and would not feel threatened. This facilitated 
ongoing  sampling  of  his/her  animals  for  the  two  additional  follow  up  sampling 
periods that was part of the approved sampling design of the study. During the first 
sampling period, all sampled animals were properly identified by listing the name of 
the farmer owners, number of ASB per farmer owner, animal sex, age, colour, any 
other unique identification that maybe used like cut horn, a missing ear, and other 
anatomical defects which allowed the study team to identify individual animals. This 
was done because for cultural and economic reasons, commercial identification like 
ear  tagging  is  not  practiced  in  both  countries.  Lao  PDR  and  Myanmar  farmers 
believed that any animal that is ear tagged is not healthy and has a low value.  
 
In  Myanmar  a  total  of  322  ASB  were  sampled  from  the  three  Divisions.  In 
Ayeyarwaddy Division, 100 ASB were sampled from 38 farmers in four different 
villages,  121  ASB  from  35  farmers  in  three  villages  in  Yangon  Division  and  in 
Magway Division, 101 ASB from 23 farmers were sampled from one village only. In 
Lao  PDR,  a  total  of  178  ASB  from  31  farmers  in  seven  villages  from  only  one 
Province were sampled. The author collected all samples from both countries in all 
three different collections. 
 
Examination for active or resolved clinical lesions and laboratory tests e.g. antigen 
detection  ELISA  and  NSPELISA  were  used  to  investigate  those  ASB  that  were 
known to have come from FMD outbreak farms.  !
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Saliva, probang fluid, and blood samples were collected from 500 ASB in herds from 
Lao  PDR  and  Myanmar  for  the  cross  sectional  study.  Detailed  histories  were 
recorded.  A  sampling  strategy  within  a  five  to  10  km  radius  from  the  recently 
reported FMD outbreaks in both countries which was confirmed by the results of the 
FMD antigen detection ELISA and serosurveillance test using NSP and LPB ELISAs 
was conducted to determine the prevalence of FMD in previously infected ASB post 
outbreak and the percentage positive for FMDV persistence until 20 months PI.!The 
distance between study areas (villages) within Province or Division had an average 
of only 3 miles. Movement of animals from one Province to another Province in Lao 
PDR and from one Division to another Division in Myanmar are temporarily stopped 
during FMD outbreaks. 
 
Samples collected were processed and stored in sterile containers at the appropriate 
temperature in each country and these were subsequently sent frozen on dry ice to 
the Institute for Animal Health (IAH), Pirbright Laboratory, England for testing. Six 
hundred and twenty (620) water buffalo serum samples from Italy collected by local 
animal  health  staff  from  animals  that  had  never  been  exposed  to  FMDV  were  
appropriately stored (-20°C) and subsequently transported to IAH where they were 
used as negative controls for the FMD non structural protein antibody tests.  
 
Table 3.1 Sample collection periods for cross sectional and longitudinal studies.  
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3.3 Collection of samples, processing and storage  
The Asian swamp buffalos were domesticated and usually had a snout ring with a 
rope for easy handling by the owner. Collection of samples only required the owner 
or an experienced animal health worker to hold the animal using the rope tied to the 
snout ring. 
 
3.3.1 Collection of saliva   
Saliva  samples  were  collected  using  using  salivette  kit  (Sarstedt  Ltd.,  UK)  and 
tampax tampon (regular tampon cut into 6 equal pieces). Saliva samples were eluted 
by adding 0.5ml Phosphate Buffered Saline (PBS) to the salivette kit and tampax 
tampon and directly placed in individual sterile plastic containers. Using a 14cm long 
curved Kelly forceps to grab one end of the salivette kit and/or tampax tampon, the 
swab  was  kept  underneath  the  tongue  and  vestibule  for  at  least  2  minutes  and 
returned directly back to the individual sterile plastic containers. The Kelly forceps 
used were sterilised using between collections from each animal. Kelly forceps were 
rinsed  and  then  disinfected  in  a  bucket  with  clean  water  containing  4%  sodium 
carbonate (Na2CO3). After disinfection, the Kelly forceps were thoroughly rinsed in 
three separate buckets of clean water in series. All collected saliva samples in the 
field were placed in a transport sample box with ice to maintain the temperature 
required  (4-6°C)  until  they  reached  the  laboratory.  Following  temporary  storage, 
saliva samples were centrifuged at 1500 x g (at 4°C) for 10 minutes to remove the 
debris and the supernatant was stored in a sterile cryovial, labelled accordingly and 
kept at -20ºC until samples were shipped to the Institute for Animal Health (IAH), 
Pirbright laboratory, England.  
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3.3.2 Collection of blood 
Blood samples were collected using sterile vacutainers via the jugular vein of the 
ASB. The site of collection was first disinfected using cotton with 70% alcohol to 
ensure  clean  and  sterile  blood  sample.  After  collection,  the  blood  sample  in  the 
vacutainer was allowed to stand for about one hour at room temperature to allow the 
blood  to  clot.  Following  temporary  storage  in  a  transport  icebox  (4-6°C),  blood 
samples were centrifuged at 1500 x g for 10 minutes to separate serum from the clot. 
Serum samples were stored in a sterile cryovial, labelled and kept at -20ºC until 
samples were shipped to IAH for FMD antibody detection and other laboratory tests 
required by the study. 
 
3.3.3 Collection of probang fluid 
Probang fluid samples were collected (Sutmoller 1965), using a specialized probang 
cup instrument (Fig 3.2). The probang cup is made of stainless steel. Briefly, the cup 
is around 3cm in diameter with a fixed 91 cm length handle attached to allow the 
sample  collector  to  manipulate  the  probang  in  the  oropharynx.  With  the  ASB 
properly restrained, the mouth was opened and the probang cup was passed over the 
root of the tongue. By placing one hand over the pharyngeal area, the probang cup 
was  continuously  introduced  until  it  was  palpated  in  the  upper  part  of  the 
oesophagus. The probang cup is passed backwards and forwards for at least 5 times 
each time pushing far enough forward to push the cup into the cranial oesophagus as 
evidenced by slight resistance to forward movement.  Then the probang cup was 
gently withdrawn, keeping it upright to ensure that the oropharyngeal fluid remained 
inside, and was visually inspected to make sure that the material contained some 
visible cellular material (AVIS 2002) and then directly poured into a sterile cryovial. 
In Lao PDR the probang fluid sample vials were directly stored in a field transport !
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storage box with dry ice, and the probang fluid sample vials collected in Myanmar 
were directly stored in liquid nitrogen tank while in the field. Between collections 
from each animal, probang cups were rinsed and then disinfected in a bucket with 
clean  water  containing  4%  sodium  carbonate  (Na2CO3).  After  disinfection,  the 
probang cup was thoroughly rinsed in three separate buckets of clean water in series 
(Fig 3.3). From the dry ice and liquid nitrogen temporary storage, probang fluid 
sample vials were directly transferred to a -70ºC freezer upon reaching the national 
FMD laboratories and were kept at that temperature until shipment to IAH for virus 
isolation and other laboratory tests. Transport by air to the IAH was on dry ice. 
 
 
Fig 3.2 Probang cups (Picture from FMD AVIS, 2002) 
 
 !
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Fig 3.3 Field collection site showing the cleaning process for the probangs with the 
disinfectant bucket (green) and then three separate buckets (black) of clean water in 
series. 
 
3.4 Analysis of Samples  
 
3.4.1 Virus Isolation (VI) 
Virus isolation at the IAH World Reference laboratory (WRL) for Foot-and-Mouth 
Disease (FMD) was conducted using the procedures described in Standard Operating 
Procedure method/protocol sheet AEXP MET 0031 (OIE 2004). Probang samples 
were examined for the presence of live FMD virus by cell culture inoculation using 
primary bovine thyroid (BTY) cells. The primary BTY cells were prepared by WRL 
staff from aseptically collected thyroid glands of young (six months old) calves using 
the procedure described by Snowdon (Snowdon 1966) and cultivated as monolayers 
in WRL Hepes medium. The WRL Hepes medium is made up of 2x Modified Eagles 
medium, Fungizone, 2ug/ml; penicillin, 200U/ml; PBS; L-glutamine, one tablet of 
NaOH, filtered deionised water and make up to 500 mls. with pH to 7.2. The cell 
monolayer was seeded at 2x10
5 cells/ml. and grown at 37ºC.  Five (5) primary BTY 
cell tubes were used for each probang sample. Each tube was inoculated with 200ul 
of  the  probang  sample,  which  was  thawed  and  equilibrated  at  room  temperature !
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before  the  inoculation.  The  inoculated  BTY  cells  were  incubated  at  37°C  and 
observed for 3 days for evidence of cytopathic effects (CPE) in the cell monolayers. 
(VI Procedure, see appendix1)! 
 
3.4.2 FMD Virus typing using indirect ELISA 
The tissue culture medium from all tubes showing CPE was harvested, clarified and 
assayed for the presence of FMDV antigen in an indirect ELISA (Roeder and Le 
Blanc Smith 1987). (ELISA Procedure see appendix 2)!
 
3.4.3 RNA Extraction  
A 0.2ml aliquot of the Probang sample of was added to 0.3ml lysis /binding buffer 
(Roche) and was stored at -70ºC before use. The extraction of total nucleic acid from 
probang samples was conducted in a 32-well sample cartridge using the MagNa Pure 
LC  isolation  kits  (Roche)  using  an  automated  nucleic  acid  robotic  work  station 
(Roche)  as  described  in  IAH-P  E  PD-VD-WRL025  version  5  standard  operating 
procedure (SOP).  (RNA Extraction see appendix 3). 
 
3.4.4 Real-time RT-PCR  
The quantity of viral RNA in probang samples was quantified by real-time RT-PCR 
based on IAH-PE-PD-VD-WRL026 version 5 standard operating procedure (Real-
time RT-PCR Procedure, See appendix 4). A TaqMan® probe, SAmulti2-P-IR-292-
269R of 24 nucleotides (sequence: 5_-CCT CGG GGT ACC TGA AGG GCA TCC-
3_) was designed using Primer Express Software (Applied Biosystems, UK) from 
internal  ribosomal  entry  site  (IRES)  sequences  (within  the  FMD  virus  RNA  5_-
untranslated  region)  available  from  public  databases.  The  sequence  is  totally 
conserved  in  and  specific  to  FMD  viruses;  making  this  genomic  region  highly !
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suitable for the detection of all seven serotypes of FMD virus. However, there is 
some homology with certain other cellular genes which likely stem from the function 
of this region but the maximum identity between the probe sequence region and 
cellular sequences was a single stretch of 18 nucleotides or, in one case, 19 out of 20 
nucleotides. At the temperature chosen for the PCR amplification, this degree of 
homology is not sufficient to give a background signal. Redundant primers SA-IR-
219-246F (sequence: 5_-CACYTY AAG RTG ACA YTG RTA CTG GTAC-3_) 
and SA-IR-315-293R (sequence: 5_-CAG ATY CCR AGT GWC ICI TGT TA-3_) 
on  each  side  of  the  conserved  probe  were  designed  using  the  Primer  Express 
Software and aligned sequences from public databases to enable the assay to detect 
all seven serotypes of FMD virus. Amplicon size was short (c120 nucleotides) which 
enhanced the PCR efficiency and lessened the risk of any RNA degradation affecting 
successful amplification. Use of the primers/probe set is in accordance with our UK 
patent proposal submitted July 2001 (UK application no. 011577.5). 
 
 
3.4.5 Liquid Phase Blocking ELISA (LPBE) 
Serum antibodies are induced against the outer capsid structural proteins following 
both vaccination against and infection with foot and mouth disease virus (FMDV). 
The LPBE is competition ELISA that can be used for the detection of antibodies 
against the structural protein of FMDV in serum samples from any cloven hoofed 
animals. This assay was based on the WRL for FMD standard operating procedure 
IAH-P EPI-VDG-SAU-005-version12 protocol (LPBE Procedure, see Appendix 5). 
 
3.4.6 Non Structural Protein ELISA Assay 
 !
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3.4.6.1 Ceditest (Prionics) FMDV-NS 
The Ceditest FMDV-NS detects antibodies directed against the non-structural 3ABC 
protein  of  FMDV.  The  Ceditest  FMDV-NS  is  a  blocking  ELISA  and  is  species 
independent.  The  ELISA  detects  FMDV  infected  animals  independent  of  the 
serotype  that  causes  the  infection  and  independent  of  the  fact  that  the  animal  is 
vaccinated or not. (Ceditest FMDV-NS Test Procedure, see Appendix 6). This test is 
subsequently referred to in the thesis as Priocheck FMDV-NS after the company 
changed name to Prionics.  
 
3.4.6.2 Chekit FMD-3ABC Bo-Ov 
The Chekit FMD 3ABC Bo-Ov ELISA test kit provides a rapid, simple and specific 
indirect  ELISA  method  for  detecting  non-structural  antibodies  against  foot-and-
mouth disease (FMD) in serum or plasma samples of bovine and ovine origin. This 
assay was based on the kit manufacturer standard protocol as described in Appendix 
7. 
 
3.4.6.3 FMDV 3ABC-Trapping ELISA 
The test is an indirect ELISA for the detection of antibodies to the non-structural 
polypeptide 3ABC of FMD virus in serum or plasma samples of large and small 
ruminants. The test can be applied to detect post infected animals regardless of their 
vaccination status and the FMD serotype that caused the infection. This assay was 
based on the kit manufacturer standard protocol as described in Appendix 8. 
 
3.4.6.4 UBI FMDV Non-structural Protein ELISA (Cattle) Direction Insert 
The test is an indirect solid-phase immunoassay, which employs a synthetic peptide 
as the solid-phase immunosorbent for detection of antibodies to the specific portion !
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of non-structural protein 3B of FMDV. This assay was based on the kit manufacturer 
standard protocol as described in Appendix 9.  
 
3.4.7 Detection of FMD serotype specific IgA by ELISA 
An  FMD  serotype-specific  IgA  ELISA  was  developed  to  detect  foot-and-mouth 
disease virus (FMDV) specific IgA antibody in the saliva and nasal secretions of post 
infected cattle (Parida et al. 2006; Salt et al. 1996). This assay was based on IAH 
protocol number: PSEP0058-1-010509 as described in Appendix 10.  
 
3.4.8 Statistical Analysis 
Estimates of FMD prevalence, percentage positive to the tests, and the proportion of 
FMDV persistence in previously infected ASB in the herd from all three different 
sampling periods from four until 20 months PI were calculated using the Epitools 
epidemiological  calculators  which  are  available  at:  http//epitools.ausvet.com.au 
(Sergeant 2009).  In this study, this epidemiological analysis was used in the cross 
sectional  study  wherein  a  good  representation  of  the  population  was  sampled  to 
determine the prevalence of FMD in the animals in a previously infected herd. In the 
two follow up sampling periods, the percent seropositivity in the animals resampled 
was  determined  in  a  previously  infected  herd  after  the  outbreaks.  This  was  to 
determine the duration of FMDV seropositivity and the proportion of the ASB that 
became or remained persistently FMDV antibody-positive until the end of the study 
period.  
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Chapter 4.  Diagnostic Tests for Foot and Mouth Disease (FMD) in 
Asian Swamp Buffalo (ASB) 
 
4.1. Introduction: 
Definitive diagnosis of FMD relies upon the identification and isolation of live FMD 
virus, a necessary requirement to confirm the start of an outbreak in a country or 
region  previously  free  of  disease  (Kitching  et  al.  2005).  Since  FMD  cannot  be 
clinically differentiated from other vesicular diseases including vesicular stomatitis 
virus (VSV), vesicular exanthema virus (VEV), and swine vesicular disease (SVD), 
laboratory diagnosis of any suspected FMD case is a matter of urgency. There are 
several diagnostic tests recommended for use in support of clinical diagnosis and in 
tracing the spread of disease. These are used to detect live virus, virus antigen or 
viral genome, or to detect serological evidence of the presence of the virus (OIE 
2001).  The  strategies  for  differentiating  infection  in  vaccinated  animals  (DIVA) 
(Uttenthal et al. 2010) and the perceived importance of the carrier animal and the 
difficulty of reliably detecting these animals, led to the development of improved 
tests to distinguish animals that were antibody-positive through vaccination, from 
those that were antibody-positive following infection (Kitching 2002b).  
 
This chapter will evaluate diagnostic- tests in ASB that have been validated and used 
extensively in other animals for detecting live virus, viral antigen and viral genome. 
It will also evaluate serological tests that will detect evidence of previous exposure to 
FMD and evidence of persistent FMD infection in ASB in SEA. 
 
4.2. Materials and Methods: 
The test evaluations were conducted on samples from ASB from the cross-sectional 
studies in three Divisions in Myanmar: Ayeyarwaddy, Yangon and Magway that !
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were four, four and eight months respectively after type O FMD outbreaks; and in 
Vientiane  Province  in  Lao  PDR  eight  months  after  a  type  O  FMD  outbreak.  In 
Magway division, only ASB were reported to be FMD infected. Samples also came 
from  longitudinal  studies  at  6  monthly  intervals  after  the  cross-sectional  surveys 
from these sites. The numbers of samples examined from these sites is shown in 
Table 4.1. The author examined all animals for any active clinical signs of FMD with 
the assistance from the local Veterinarians at the time of first sampling and all the 
proceeding sampling periods There were no active clinical cases of FMD in these 
herds at the time of sampling.  
 
4.2.1 Virus Detection:  
For  virus  isolation  (VI),  primary  bovine  thyroid  (BTY)  cells  were  used  for  the 
isolation of FMDV from oesophageal ‘probang’ (OP) fluid samples. For this, 200ul 
aliquots of OP fluid samples were inoculated into each of five BTY cell tubes per 
sample from the 956 OP fluid samples collected from all field collections (cross 
sectional and longitudinal studies). The inoculated BTY cell tubes were incubated at 
37ºC  and  observed  daily  for  the  presence  of  cytopathic  effect  (CPE)  in  the  cell 
monolayers. An OP fluid sample was positive when at least one inoculated tube 
showed CPE (Appendix 1). For detection of viral genome in OP fluid samples, real 
time RT-PCR was carried out as described previously (Reid et al. 2003) (Appendix 
4).  
 
4.2.2 Structural Protein Antibody Tests 
The  structural  protein  tests  are  FMDV  sero-type  specific  and  detect  antibodies 
elicited  by  vaccination  and  infection  (OIE  2001);  examples  are  the    virus 
neutralization (VN) test, solid-phase competition ELISA (SPCE) and  the liquid-!
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phase  blocking  ELISA  (LPBE).  They  are  the  prescribed  tests  for  trade  and  are 
appropriate for confirming previous or ongoing infection in non-vaccinated animals 
as well as for monitoring the immunity conferred by vaccination in the field (OIE 
2001).  In  this  study  the  LPBE  (Appendix  5)  was  used  to  detect  the  presence  of 
antibodies to FMD structural protein in ASB serum samples from both Lao PDR and 
Myanmar.  Testing for the FMD structural protein antibodies using LPBE was only 
done on samples from the first cross-sectional sampling at each study site. The LPBE 
was able to determine seropositivity to the specific FMD serotypes reported in recent 
outbreaks and the results could be compared to the results of the NSP ELISA tests, 
but a major reason for conducting the serotype specific LPBE was to compare with 
the FMD antibody serotype profile (for O, A and Asia 1 FMD serotypes) resulting 
from  the  saliva  IgA  test  on  persistently  FMD  infected  ASB.  However,  due  to 
logistical reasons, the LPBE was performed only against serotypes O, and A.  
 
4.2.3 Non-structural Protein (NSP) Antibody Tests 
All buffalo serum samples (N=956) from Lao PDR and Myanmar were tested for the 
presence of FMD NSP antibody using three commercially available NSP ELISA kits 
namely; Priocheck FMDV-NS (B.V. Lelystad, the Netherlands), Chekit-FMD-3ABC 
(Bommeli  Diagnostics,  Bern,  Switzerland),  UBI  FMD  NSP  ELISA  (United 
Biomedical Inc., NY, USA) and one in-house NSP assay that is a 3ABC trapping 
ELISA (IZLER, Brescia, Italy). (Appendices 6-9). 
 
Also, six hundred and twenty (620) water buffalo serum samples from Italy that had 
no previous history of FMD vaccination or infection were used to validate the test 
specificity  of  the  two  FMD  NSP  ELISA  tests  used  in  the  specificity  study 
(Appendices 6 and 8).  !
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4.2.4 Detection of IgA in Saliva 
Saliva samples (N=956) collected from all buffalos in the study were tested for the 
presence of FMDV serotype specific IgA antibody using an indirect ELISA which 
was recently developed at the IAH, Pirbright laboratory, to detect FMDV serotype 
specific  IgA  antibody  in  both  saliva  and  nasal  secretions  of  cattle  post-infection 
(Parida et al. 2006). (See appendix 10).  
 
4.2.5 Analysis of Data 
With reference to the previous validation of FMDV serological tests (Uttenthal et al. 
2010), the estimated test Sn and Sp of the LPBE and four different NSPE tests for 
measurement  of  the  respective  antibodies  in  ASB  samples  at  four,  eight  and  20 
months  PI  were  determined  and  calculated  using  the  Epitools  epidemiological 
calculators which are available at: http//epitools. ausvet.com.au (Sergeant 2009). To 
estimate FMD test Se and Sp in population/s of unknown prevalence, two types of 
estimation  were  used:  the  Expectation  Maximisation  and  the  Newton-Raphson 
estimations.  This  epidemiological  analysis  was  used  to  estimate  FMD  sero-
prevalence in these previously infected herds using tests with known test Se and Sp 
from Uttenthal et al.(2010). Bayesian analysis was used to evaluate the overall test 
performances and compare tests in the absence of a gold standard test in ASB from 
these  previously  FMDV  infected  herds  with  TAGS:  Evaluation  of  Tests  in  the 
Absence  of  a  Gold  Standard  (TAGS  V.2.0  R.Pouillot,  AFSSA,  France.  Email: 
r.pouillot@afssa.fr)  and  using  both  Expectation  Maximisation  and  the  Newton-
Raphson  estimations  of  Se  and  Sp.  To  evaluate  the  real  time  RT-PCR  test 
performance on ASB samples from previously infected herds, the test was evaluated 
against the gold standard, which is the virus isolation (VI).  !
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4.3. Results  
4.3.1 FMD Virus Isolation 
OP fluid samples were tested using VI in BTY cells for the isolation of FMD live 
virus and real time RT-PCR for viral genome detection and the results are in Table 
4.1. 
 
Table 4.1 Summary of OP fluid samples tested by VI and real time RT-PCR 
 
 
In Lao PDR: 178 ASB came from 7 villages from Vientiane Province, with the first collection 8 
months post-outbreak; in Myanmar: 1
st Division refers to 100 ASB from 4 villages in Ayeyarwaddy 
Division with first collection at 4 months post-outbreak; 2
nd Division refers to refers to 121 ASB from 
3 villages in Yangon Division with first collection at 4 months post-outbreak; 3
rd Division refers to 
101 ASB from one village with first collection 8 months post-outbreak. 
 
From the three separate sampling collections there were three FMDV positive OP 
fluid  samples  from  Lao  PDR  and  13  FMDV  positive  OP  fluid  samples  from 
Myanmar detected by VI. The two (2.38%) positives from Lao PDR were isolated 
from the second collection, which was 14 months PI, and the viruses isolated were 
both FMDV serotype A. The third positive from Lao PDR was isolated from the !
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third collection period, and was also serotype A. The 13 (12.87%) positive OP fluid 
samples from Magway division, Myanmar were from the first collection at eight 
months PI, and the viruses isolated were all FMDV serotype O.   All remaining OP 
fluid  samples  in  all  three  separate  sampling  collections  from  both  Lao  PDR  and 
Myanmar were negative for FMD virus.  
 
4.3.2 FMDV Real-time RT-PCR  
Real-time RT-PCR was used to detect viral genome from selected OP fluid samples 
collected. The 101 OP fluid samples collected from one village which previously had 
a confirmed FMD outbreak in Magway Division, Myanmar, and where only ASB 
animals were reported to be infected, were tested to validate the real time RT-PCR 
on ASB OP fluid samples. The ASB were eight months PI and had a percentage 
seropositivity of 96% by LPBE. Results showed that out of 101 OP fluid samples 
collected 19 (18.81%) were positive for FMD viral genome based on real time RT-
PCR.   
 
The real time RT-PCR test Se and Sp (Table 4.2) were calculated against VI, the 
gold standard test. The calculation was based on 95% confidence limits (Sergeant 
2009) and results showed that the real time RT-PCR Se was only 30% with Sp of 
82%  when  used  to  detect  presence  of  FMD  viral  genome  at  eight  months  post 
infection on ASB under natural field conditions. The low Se and Sp results may be 
attributed to the sampling technique, which affects the quality of the samples, the 
period of collection post infection or the kind of samples. The two tests have never 
been validated using samples from naturally FMD infected ASB and this study was 
the first to use the two tests in ASB population in SEA. These factors need to further 
looked at, if the two tests will be considered for adaptation in SEA conditions.  !
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Table 4.2 Real time RT-PCR test evaluations against a gold standard at eight months 
PI in ASB OP fluid samples 
          
 
 
 
4.3.3 Antibody to structural protein by LPBE 
Only samples from the cross sectional study was tested for the presence of structural 
antibody  against  FMD  serotypes  O  and  A  using  the  LPBE  test  (Table  4.3).  For 
logistics reason LPBE was not performed against serotype Asia 1. In Lao PDR 38.8 
% of the total number of samples collected were positive for antibodies against FMD 
serotype O, 25.3% were positive against FMD serotype A and 13.5% were positive 
to both serotype O and A by LPBE. In Myanmar, 22% were positive against FMD 
serotype O, only 3% were positive against FMD serotype A and the same 3% were 
positive to both serotypes O and A in Ayeyarwaddy division. In Yangon Division 
there were 77.7% positive for antibody against FMD serotype O, only 2.5% against 
FMD  serotype  A  and  only  2.5%  were  positive  to  both  serotypes  O  and  A.  In 
Magway division, 89% were positive for antibody against FMD serotype O, 10.9% !
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positive against FMD serotype A and only 8.9% were positive to both serotypes O 
and A.  
 
 
 
Table 4.3 Percentage seropositive by LPBE for FMD serotypes O and A in the cross 
sectional study in ASB in Lao PDR and Myanmar.  
 
 
 
 
4.3.4 Evaluation of NSP antibody ELISA tests 
For this study 620 water buffalo serum samples from Italy were used to evaluate 
NSP ELISA and LPBE test Sp (Table 4.4). The Italian samples were collected from 
an  FMD  free  area  and  all  the  water  buffalo  that  were  sampled  had  no  previous 
history of FMD virus exposure and vaccination. For logistical reasons, the NSPE 
ELISA test Sp evaluation was only done using the two tests that have been found to 
have consistent high test Se and Sp (Brocchi et al. 2006; Paton et al. 2006), the 
Priocheck and the IZS (Italy 3ABC). Results of the test Sp of the NSP ELISAs from 
the  evaluation  using  the  620  serum  samples  from  FMD  free  water  buffalo  from 
Brescia, Italy showed a test Sp of 99.8% for Priocheck and 100% for IZS Italy. The 
LPBE  also  failed  to  detect  FMDV  structural  protein  antibodies  against  FMD 
serotypes O and A.   
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Table 4.4 NSP ELISA and LPBE test specificity (Sp) evaluation using water buffalo 
samples (WBS).  
 
 
 
 
The Expectation Maximisation and the Newton-Raphson estimations were used to 
calculate the test Se and Sp of the four different NSP ELISAs tests and LPBE on 
ASB samples from the first collections from both Lao PDR and Myanmar and results 
are shown in Tables 4.5 and 4.6. For logistical reasons the LPBE was only done to 
detect  antibodies  against  FMD  serotypes  O  and  A.  The  samples  collected  four 
months PI from Myanmar (Table 4.5) were grouped into two separate populations 
since the two divisions involved are 120 km apart from each other and have different 
disease prevalence based on the results using Test in the Absence of a Gold Standard 
(TAGS) analysis. In Lao PDR, the first sample collection was done at eight months 
PI and originated from one province only. Based on both Expectation Maximisation 
and  the  Newton-Raphson  estimations,  test  results  on  ASB  samples  from  both 
Myanmar and Lao PDR at 4-8 months post-outbreak showed that there was minimal 
difference in test Sp between the four NSP ELISA kits and the LPBE for FMD type 
O  which  was  involved  in  the  last  outbreaks.  This  applied  regardless  of  the 
population,  the  percentage  seropositivity  and  the  time  of  sample  collections  post 
infection. However, the Se of the four NSP ELISA tests and the LPBE varied with 
results from 100% to as low as 42%. !
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Table 4.5 Test Se and Sp of LPBE and 4 NSPE kits on 221 ASB serum samples four 
months post-FMD outbreaks in Ayeyarwaddy and Yangon Divisions in Myanmar  
 
(Legend: Est (Estimate); Clinf (Confidence level inferior); Clsup (Confidence level 
superior): Prev1 (Prevalence 1, Ayeyarwaddy division); Prev2 (Prevalence 2 Yangon 
division);  Sp  (Specificity);  Se  (Sensitivity).  Sp5  and  Se5  are  specificity  and 
sensitivity of LPBE for FMD type O respectively.   
 
 
 
 
 
 
Table 4.6 Test Se and Sp of LPBE and 4 NSPE kits on 178 ASB serum samples eight 
months post-FMD outbreak in Lao PDR  
 
(Legend: Est (Estimate); Clinf (Confidence level inferior); Clsup (Confidence level 
superior); pre1 (Prevalence 1); Sp (Specificity); Se (Sensitivity).  Sp5 and Se5 are 
specificity and sensitivity of LPBE for FMD type O respectively. 
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The calculations of the Se and Sp of four different NSP ELISA tests at the third 
sampling, the end of the study period (20 months PI) are shown in Table 4.7. At this 
time, the LPBE test was no longer included in the tests since the purpose of doing the 
LPBE was not to detect infection but to compare with the FMD antibody serotype 
profile resulting from the saliva IgA test on persistently FMD infected ASB. The 
calculations were made using samples from Lao PDR with an estimated herd level 
seropositive  rate  of  41%.  The  test  Sp  of  four  NSP  ELISA  tests  did  not  have  a 
significant  difference  from  those  samples  from  the  first  collection  except  for  the 
Priocheck in which the test Sp dropped significantly to as low as 52%. However, the 
test Se of the four different NSP ELISA tests varied at 20 months PI from 100% to as 
low as 19% in both types of estimations used.  
 
 
Table 4.7 Test Se and Sp of 4 NSPE kits on 77 ASB serum samples 20 months post-
FMD outbreak in Lao PDR  
 
(Legend: Est (Estimate); Clinf (Confidence level inferior); Clsup (Confidence level 
superior); Pre1 (Prevalence Lao PDR); Sp (Specificity); Se (Sensitivity).   
 
 
 
 
Among the four NSP ELISA tests evaluated, preference was given to the Priocheck 
test for the subsequent study on ASB that had been previously infected with FMD. 
From the above evaluations both Priocheck and IZS had overall similar Sp and Se !
68!
!
and both were better than the Chekit and UBI tests. For logistical reasons and market 
availability, Priocheck was chosen to compare test performance with salivary IgA 
ELISA.  Priocheck  is  commercially  available  while  IZS  is  an  in-house  test. 
Evaluation of the IgA test against Priocheck was also done using TAGS with both 
the Expectation Maximisation and the Newton-Raphson calculations. Samples from 
the first and third (last) collections, based on three different kinds of population with 
varied  estimated  seropositivity  rates,  were  used  to  evaluate  the  IgA  test  in 
comparison with the Priocheck NSPE and results are shown in Tables 4.8 and 4.9. At 
four to eight months PI with different estimated seropositive rates of 2% (Myanmar 
Ayeyarwaddy Division), 89% (Myanmar Yangon Division) and 74% (Lao PDR), the 
IgA test Sp was 99% with a Se of only 41%. However, after 20 months PI the IgA 
test  Sp  (92%)  decreased  slightly  in  contrast  to  the  test  Se  which  increased 
significantly from 41% to 99%. 
 
Table 4.8 Evaluation of the Se and Sp in the absence of a gold standard for NSPE 
(Priocheck) and IgA test on 399 serum and saliva samples respectively from three 
different populations (4-8 months PI). 
 
(Legend: Est (Estimate); Clinf (Confidence level inferior); Clsup (Confidence level 
superior); Pre1 (Ayeyarwaddy Division); Pre2 (Yangon Division); Pre3 (Lao PDR); 
Sp (Specificity); Se (Sensitivity).   
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Table 4.9: Evaluation of the Se and Sp in the absence of a gold standard for NSPE (Priocheck) 
and IgA test on 121 serum and saliva samples respectively from two different populations (16-20 
Months PI).  
 
(Legend: Est (Estimate); Clinf (Confidence level inferior); Clsup (Confidence level 
superior) pre2 (Prevalence in Yangon Division, Myanmar); Pre3 (Prevalence in Lao 
PDR); Sp (Specificity); Se (Sensitivity).   
 
 
 
 
 
 
4.4 Discussion 
The gold standard for FMD diagnosis is the VI using a tissue culture system. The 
primary  BTY  cell  is  the  most  sensitive  tissue  culture  system  available  for  the 
detection of FMD infectivity (Snowdon 1966). The majority of OP fluid samples 
were negative for live FMD virus by VI, which was not unexpected as the animals 
were sampled some 4 to 20 months after known FMD outbreaks and as such could 
be  expected  to  have  low  VI  rate.  This  method  of  identifying  persistently  FMD 
infected carriers has only 50% sensitivity (Kitching 1998). This sensitivity can be 
improved by repeated OP fluid sampling (Kitching 1998).   Also, the amount of virus 
in OP fluid samples, even those taken under optimal conditions, is generally low 
(Alexandersen et al. 2003). Although OP fluid sampling can identify carrier animals, !
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it cannot be used to exclude the possibility of carrier animals because a) the amounts 
of virus are low, often close to the limits of detection of cell culture assay systems 
and  decline  overtime  and  b)  the  excretion  of  virus  by  carriers  is  intermittent 
(Alexandersen et al. 2002).  
 
Recovery of live FMD virus and viral genome from carrier animals is intermittent 
and a study in 2004 on FMD carrier cattle under experimental conditions indicated 
that the real time RT-PCR was intermittently positive in OP fluid samples. In some 
cattle,  viral  RNA  was  detected  in  seven  sequential  samples  but  in  one  case  the 
interval between positive samples was 393 days. Also using the real time RT-PCR 
more samples were positive in the early phase after infection than with VI; whereas 
later after infection more samples were positive by VI than by using real time RT-
PCR  (Moonen  et  al.  2004).  Based  on  these  findings,  the  author  stated  that  the 
detection  of  FMDV  in  carriers  by  VI  and  real  time  RT-PCR  appears  to  be  a 
stochastic event, with a decreasing probability of a positive result (Moonen et al. 
2004).  
 
The  four  NSP  ELISA  tests  and  the  IgA  ELISA  used  in  this  study  have  been 
previously  validated  using  mostly  European  cattle  and  samples  mainly  from 
experimental studies (Uttenthal et al. 2010), but have not been validated under SEA 
conditions using samples from field infected animals. This is the first study, which 
evaluated  the  different  NSP  ELISAs  and  the  IgA  ELISA  on  ASB  from  FMD 
endemic areas in SEA.  
 
Previous findings indicate that the Se of the LPBE is close to 100% with a Sp of 95% 
(Alexandersen et al. 2003). In this study, the LPBE was also used on samples from !
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the  first  collection  period  in  order  to  compare  with  the  FMD  antibody  serotype 
profile for FMDV types O, and A resulting from the saliva IgA test on persistently 
FMD infected animals. The results of the LPBE for type O in the ASB populations 
showed  similar  results  to  NSPE  tests  with  test  Se  and  Sp  of  99%  and  94% 
respectively at four months PI irrespective of the herd level seropositivity (80% and 
14%  estimated  seropositive  rate  respectively)  from  two  separate  populations. 
However at eight months PI, the Se of the LPBE test decreased to as low as 68% in a 
population with an estimated seropositive rate of 62%, although the test Sp did not 
change significantly.  
 
Recent studies comparing several NSP ELISA tests including the Priocheck test have 
produced a range of estimates of Se and Sp in cattle. The Se ranged from 50.0 to 
100.0% depending on how long after infection animals were tested, while the Sp was 
much more precisely estimated and ranged from 97.2 to 99.0% (Brocchi et al. 2006; 
Paton et al. 2006). But these are of course, based largely on experimental studies (Se 
estimates)  and  in  cattle  and  may  in  fact  not  be  a  very  reliable  guide  to  their 
performance in buffalo (Bronsvoort et al. 2008).    
 
Other factors should also be considered for the variations in test Se and Sp between 
the  four  NSP  ELISA  tests.  One  is  the  different  format  of  the  test  and  different 
conjugates used. The Priocheck test uses anti-3AB monoclonal antibody conjugate in 
a  blocking  ELISA  and  3ABC  NSP  antigen;  CHEKIT  and  IZS,  Italy  use  anti-
ruminant IgG conjugates in an indirect ELISA with 3ABC NSP antigen and the UBI 
uses protein A/G conjugate in an indirect ELISA but using a different NSP antigen 
(3B). None of the four tests have been validated previously with ASB samples.  The 
FMDV  serotype  or  serotypes,  the  species  examined  the  severity  of  the  virus !
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challenge in the field and the time of sample collection post infection could also 
affect the test Se and Sp (Brocchi et al. 2006). 
 
One possible reason for a significant increase in the test Se observed for the IgA 
ELISA in ASB from the third collection in these studies could be due to a sampling 
effect with the decrease in the number of animals sampled towards the end of the 
study.  In these populations there was a higher proportion of ASB previously tested 
positive  compared  with  those  previously  tested  negative  and  with  the  sampling 
during the last collection period this probably contributed a bias that resulted in an 
apparent increase in test Se. Other examples where field evaluation studies have 
varied from the published validation studies have been reported. In one case, tests 
evaluated and considered suitable for samples from northern European cattle, did not 
give expected results when testing populations of cattle from Africa (Jacobson 1996).   
 
The performance of diagnostic tests can be evaluated in several ways. The traditional 
and accepted way is by using a gold standard wherein the Se of the test is calculated 
using truly diseased or infected animals and the test Sp is calculated using truly 
disease-free  and  infection-free  animals.  But  previously  similar  studies  have 
suggested that for NSP ELISAs, latent class models are a useful alternative to the 
traditional approach of evaluating diagnostic tests against a known ‘gold-standard’ 
test  as  imperfections  in  the  ‘gold-standard’  may  give  biased  test  characteristics 
(Bronsvoort et al. 2006).  Also, some of the new and existing tests currently used are 
still in the validation stage and don’t have a valid ‘gold standard’ test that can be 
used as reference or basis for the validation of such new tests.  
 
Although the isolation of FMD virus from the OP region of convalescent animals has 
been the most specific technique for identifying FMDV carrier animals, it suffers !
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from poor sensitivity and is labour intensive and expensive (Lubroth and Brown 
1995). In late 1990s, a significant step towards identifying the potentially persistently 
infected  animal  was  the  development  of  NSP  antibody  tests  (Mackay  1998). 
However these tests may not reliably identify the vaccinated animal which has had 
contact with live virus and become a carrier without sero-converting to the NSPs 
(Kitching 2002b).  
 
Levels of FMD virus-specific salivary IgA became elevated after infection and OP 
persistence of FMDV, regardless of vaccination status and the level of FMD specific 
IgA in saliva was directly correlated with persistence of virus or viral genome in OP 
fluid (Parida et al. 2006). With the development of a serotype specific ELISA which 
detects FMDV specific IgA antibody in the saliva of FMD animals post-infection, 
identification of persistently infected ‘carrier’ animals becomes less labour intensive 
and expensive. This FMD salivary IgA test was designed and validated mostly on 
cattle samples but this study has shown that it has suitable sensitivity and specificity 
for identifying ASB that are likely to be persistently FMD infected ‘carriers’. 
  
In  conclusion,  the  study  reported  in  this  chapter  has  evaluated  four  FMD  NSP 
ELISAs in ASB at four, eight and 20 months post FMDV infection and has measured 
the Se and Sp of these tests in naturally infected ASB under field conditions at this 
time  post-infection.  There  was  some  variation  in  these  parameters  between  the 
different FMD ELISAs in ASB and also some differences from estimates of these 
parameters from studies on other FMD susceptible species or from studies under 
experimental conditions.  The findings on Sp and Se for the tests from this study are 
further considered in estimating the herd level seropositivity rates at the different 
sampling  times  post-FMD  infection  and  also  in  defining  the  rates  of  apparently !
74!
!
persistently infected ‘carrier’ in ASB in the studies reported in subsequent chapters. 
The selection of tests that were used in the cross-sectional and longitudinal studies 
on  persistent  FMDV  in  ASB  reported  in  subsequent  chapters  was  based  on  the 
findings reported in this chapter.  
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Chapter 5 - Foot and Mouth Disease (FMD) in Asian Swamp Buffalo 
(ASB) 
 
5.1 Introduction  
Foot  and  Mouth  Disease  (FMD)  is  the  most  important  transboundary  livestock 
disease,  is  of  global  significance  and  it  is  endemic  in  Lao  PDR  with  outbreaks 
occurring regularly (Rast et al. 2010). In Myanmar, outbreaks of FMD have been  
reported in six to 12 Divisions/States during  the past five years (SEACFMD 2010).   
 
Lao PDR and Myanmar are part of the OIE South East Asia and China Foot and 
Mouth  Disease  Campaign  (SEACFMD  2010)  and  this  program  has  developed  a 
roadmap for disease freedom with vaccination in the region by 2020 (SEACFMD 
2010). 
 
Among  the  seven  FMD  serotypes,  only  serotypes  O,  A  and  Asia  1  have  been 
diagnosed in both Lao PDR and Myanmar. Type O is the dominant serotype and is 
endemic in the region, followed by type A which was last seen in Myanmar near the 
border with Bangladesh in September, 2010. Type Asia 1 was last seen in Vietnam in 
2007 and in China in 2009 (SEACFMD 2010).  Based on country reports, cattle are 
the most commonly infected among the FMD susceptible species in both Lao PDR 
and  Myanmar.  The  Asian  Swamp  buffalo  (ASB)  are  the  next  most  commonly 
reported  (SEACFMD  2010).  However,  a  study  in  Lao  PDR  showed  that  the 
seroprevalence in ASB was higher than in cattle (Blacksell et al. 2008).  
 
This chapter describes the occurrence and epidemiology of FMD in ASB in Lao 
PDR and Myanmar using data from SEACFMD records from country reports and 
field  country  studies.  The  aims  of  this  chapter  were  to  describe  aspects  of  the !
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occurrence and epidemiology of FMD in ASB in Lao PDR and Myanmar based on 
records of the SEACFMD and the results of a cross sectional study carried out in 
2008.  
 
5.2 Materials and Methods 
 
5.2.1 Herd level prevalence and outbreak data on FMD in ASB in Lao PDR and 
Myanmar (2005-2009) 
 
Data from Lao PDR and Myanmar were reviewed and analysed and this included 
FMD reports from the last five years, and results from previous studies on FMD 
occurrence  in  Lao  PDR  (Blacksell  et  al.  2008;  SEACFMD  2010).    This  was 
supplemented  with  information  obtained  from  veterinary  officers  from  both 
Myanmar and Lao PDR during actual disease outbreak investigations. Factors of 
interest  were  numbers  of  outbreaks,  spatial  and  temporal  distribution,  seasonal 
patterns,  potential  sources  of  outbreaks,  species  of  livestock  infected,  FMDV 
serotypes present and factors influencing the spread of the FMDV. FMD outbreak 
definition adopted in this study was based on the definition used by FMD Control 
programme in SEA, which states that “ one or more cases in two weeks in one 
Epidemiological unit (village or farm)” (SEACFMD 2010). 
 
 
5.2.2  Cross sectional study of FMDV persistence in ASB in previously infected 
herds in Lao PDR and Myanmar  
 
A cross sectional study that involved sampling 500 ASB was conducted to determine 
prevalence of FMDV persistence in a previously infected ASB in the herd.  Animals 
were sampled four and eight months post infection (PI) in Lao PDR and Myanmar.  
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5.2.2.1 Sampling sites  
The  sampling  sites  included  one  province  in  Lao  PDR  and  three  divisions 
(Ayeyarwaddy, Yangon and Magway) in Myanmar. These were primarily selected 
on the basis of having had recent FMD outbreaks with laboratory confirmed cases of 
ASB at the start of the study period (Figure 5.1). 
 
Figure 5.1 Lao PDR and Myanmar sampling sites 
 
5.2.2.2 Sample collection 
The study involved collection of blood, OP fluid, and saliva from 500 unvaccinated 
ASB from areas that had recent confirmed outbreaks of FMD in both Lao PDR and 
Myanmar (Figure 5.1). In Myanmar a total of 322 ASB in eight villages from 96 
farmers were sampled. In Lao PDR, 178 ASB were sampled in seven villages from 
31 farmers.!In Lao PDR and in Ayeyarwaddy and Yangon divisions in Myanmar, 
collections of samples were deliberately focused on livestock owners in the villages 
that  had  previously  been  affected  by  FMD.  All  ASB  from  the  identified  farmer 
owner were sampled regardless of the number and FMD status. This was done for !
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cultural reasons, and so that the owner would not think that there was discrimination 
among his animals and would not feel threatened. In Magway division in Myanmar, 
all ASB in the village (101) were targeted and sampled and all ASB that were known 
to have been infected were identified as previously described in Chapter 3 (section 
3.2).  Field  samples  in  Lao  PDR  and  in  Ayeyarwaddy  and  Yangon  divisions  of 
Myanmar were collected in September 2008 and in Magway division, Myanmar in 
October  2009.  All  samples  were  sent  to  the  Institute  for  Animal  Health  (IAH) 
Pirbright, United Kingdom for laboratory testing.  
 
5.2.2.3 Laboratory procedures 
As described in Chapter 4, evaluations were conducted on four (4) NSP ELISA tests 
(Priocheck,  IZS  Italy,  Chekit  and  United  Biomedical  Incorporated  (UBI))  in  the 
absence  of  a  “gold  standard  test”  to  estimate  their  sensitivity  and  specificity  in 
testing ASB populations. In this chapter these tests have been used to estimate the 
prevalence of FMDV persistence in previously infected ASB herds at four to eight 
months PI in both Lao PDR and Myanmar. In addition the other diagnostic tests 
evaluated for specificity and sensitivity in Chapter 4, the salivary FMD IgA antibody 
ELISA, the FMDV RT-PCR and the FMD VI tests, were also used to assess FMDV 
persistence in ASB in these previously FMDV infected herds.  
 
This will be the first study that has used this bank of tests to determine the FMD NSP 
antibody seroprevalence and estimate the prevalence of persistent FMDV infection in 
ASB  from  previously  FMDV  infected  herds  in  SEA.  Procedures  for  each  of  the 
laboratory tests used in the study and the methods used for the serological survey are 
described in Chapter 3.  
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All OP fluid samples that tested positive for CPE in BTY cell inoculation were tested 
for FMD serotypes by serotyping ELISA (Appendix 2). The Liquid Phase Blocking 
ELISA  (LPBE)  was  not  used  to  detect  infection  but  to  compare  with  the  FMD 
antibody  serotype  profile  resulting  from  the  saliva  IgA  test  on  FMD  persistently 
infected animals. For logistics reason the LPBE was only performed against FMD 
serotypes O and A. The results of the LPBE testing are presented in chapter 4.  
 
5.2.2.4 Statistical Analysis  
Estimates of the FMD NSP antibody seroprevalence and prevalence of persistent 
FMDV infection in ASB from previously infected herds at four to eight months PI in 
Lao  PDR  and  Myanmar  were  calculated  using  the  Epitools  epidemiological 
calculators which are available at: http//epitools.ausvet.com.au (Sergeant 2009).The 
specific epidemiological analysis used for this study is described in Chapters 3 and 4. 
 
5.3 Results 
 
5.3.1 Analysis of herd level outbreak data for FMD in Lao PDR and Myanmar 
over five years 
 
A  review  of  FMD  outbreaks  between  2005  and  2009  in  Lao  PDR  (176)! and 
Myanmar (92)!was based on OIE data (SEACFMD 2010) and information obtained 
from veterinary officers from both countries during disease outbreak investigations. 
This showed that during this period the temporal pattern of FMD occurrence was 
similar between the two countries (Figure 5.2). 
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Figure 5.2 Five year temporal pattern of FMD occurrence in Lao PDR and Myanmar 
 
 
FMD  outbreaks  in  Lao  PDR  and  Myanmar  are  more  common  during  the  rainy 
season (June to September) and most outbreaks last for a month or less depending on 
the level of field virus challenge and the number of animals infected. The common 
sources of outbreaks were considered to be movements, the introduction of infected 
cattle and ASB from livestock auction markets, and nearby villages that had cattle 
and ASB infected with FMD (SEACFMD 2010).  
 
FMD  outbreaks  had  occurred  in  both  Lao  PDR  and  Myanmar  with  the  highest 
number of reported cases in cattle followed by ASB (SEACFMD 2010). Between 
2005 and 2009, Lao PDR had reports of FMD from 11 provinces and the numbers of 
outbreaks ranged from two to 41 per year with the highest number in Vientiane 
capital in 2006. This was the sampling site used for the present FMD study on ASB 
in  Lao  PDR.  In  Myanmar,  FMD  was  reported  in  17  Division  or  States  with  an 
average of 18 outbreaks per year (Figure 5.3).  
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Figure 5.3 Number of Outbreaks (OB) and Provinces/Divisions Infected (PI) in Lao 
PDR and Myanmar 
 
 
Between 2005 and 2009, the number of FMD affected ASB reported in both Lao 
PDR and Myanmar varied from 20 animals to a few hundred (Table 5.1).  These 
numbers  are  low  considering  the  relatively  large  population  of  ASB,  their 
susceptibility to FMD, frequent movements, and the role they play in the farming 
system in both countries and in terms of their economic value to the farmers in both 
countries.  This was not unexpected because disease reports are known to under 
represent the true situation in countries with endemic FMD (Edwards, J personal 
communication). 
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Table 5.1 Number of ASB reported to be affected by FMD from 2005-2009 
                                           
                                                                                                
 
5.3.2  Results  of  cross–sectional  serological  studies  in  ASB  in  Lao  PDR  and 
Myanmar  
 
 
 
5.3.2.1  Percentage  seropositive  by  NSP  ELISA  and  salivary  IgA  ELISA  test 
positives in ASB 
 
Table 5.2 shows the different percentage seropositive by the four NSP ELISA tests 
and the salivary IgA ELISA results, which were used to detect, serotype specific IgA 
present in the saliva of previously FMD infected ASB at eight months PI in Lao 
PDR.   
 
 
Table 5.2 Estimates of percentage seropositive of 178 ASB serum samples by the 
four  NSP  ELISA  tests  and  percent  positive  of  178  ASB  saliva  samples  by  IgA 
ELISA at eight months PI in Lao PDR.  
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In Lao PDR, estimates of the percentage seropositive in a previously FMD infected 
herd  of  ASB  by  the  four  different  NSP  ELISAs  at  eight  months  PI  differed 
significantly from each other. The UBI gave the lowest estimate among the four NSP 
ELISAs. The Priocheck and the IZS Italy percentage were almost the same with 66% 
and 62% respectively. The Chekit had 47% percentage seropositive and the lowest 
percentage was from UBI at 20%. The percentage positive at eight months PI in Lao 
PDR  by  salivary  IgA  ELISA,  which  detects  specific  antibodies  from  FMD 
persistently infected animals, was at 41%.  
 
To  increase  test  sensitivity  as  has  been  proposed  for  studies  in  cattle  and  sheep 
(Parida  et  al.  2006;  Parida  et  al.  2008),  two  independent  tests  (in  this  study  the 
Priocheck and the salivary IgA ELISA) were combined and results were calculated 
and analysed. The results of the combined tests will also further refine the estimates 
of prevalence of persistent FMDV infection in ASB in previously infected herds.  
The preference for the Priocheck NSP ELISA was based on its high test sensitivity 
(Se)  in  evaluation  studies  conducted  in  Chapter  4  and  also  for  logistical  reasons 
(commercial  availability,  easy  to  use  in  the  laboratory  because  it  is  species 
independent). The results of combining the two tests for estimating the prevalence of 
persistently FMDV infected ASB from infected herds at eight months PI from Lao 
PDR is presented in Table 5.3  
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Table 5.3 Comparing the performance of two tests (Priocheck + IgA ELISA) in ASB 
at eight months PI from previously infected herds in the Lao PDR cross sectional 
study. 
 
 
 
 
The results of the combined two tests show that the percentage positive by Priocheck 
or IgA ELISA or both is 70.8% (126/178) compared to 62.9% by Priocheck alone 
and 42.1% by IgA ELISA alone. The percentage of ASB that were negative to both 
tests was at 29.2% (52/178).   
  
In Myanmar, three different sampling sites were selected for the cross sectional study 
and the percentage detection results differed significantly from division to division. 
The results of the cross sectional study in the Ayeyarwaddy Division, Myanmar is 
presented in Table 5.4 
 
 
Table 5.4 Estimates of percentage seropositive of 100 ASB serum samples for the 
four NSP ELISAs and percent positive of 100 ASB saliva samples by IgA ELISA at 
four months PI in Ayeyarwaddy Division, Myanmar. 
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In  the  Ayeyarwaddy  Division  at  four  months  PI,  the  estimated  percentage 
seropositivity in ASB from the NSP ELISA tests ranged from 21% to 10%. The 
Chekit  NSP  ELISA  had  the  highest  percentage  seropositive  estimate  at  21%, 
followed by IZS Italy at 17% percentage detection, the Priocheck at 16% and the 
UBI at 10%.  The percentage seropositivity in ASB in previously infected herds by 
salivary IgA ELISA was only at 2% four months PI.  
 
 Using the combined Priocheck and IgA ELISA tests for ASB in previously infected 
herds  the  percentage  positive  by  Priocheck  or  IgA  ELISA  or  both  was  19% 
compared  with  17%  with  Priocheck  alone  and  4%  with  IgA  ELISA  alone.  The 
percentage of ASB that were negative to both tests was at 81%. The results are 
presented in Table 5.5.   
 
Table  5.5  Comparing  the  performance  of  two  tests  (Priocheck  +  IgA  ELISA)  in 
Ayeyarwaddy, Myanmar cross sectional study 
 
 
 
The cross sectional study results at four months PI in Yangon Division, Myanmar are 
presented in Table 5.6. The estimated percentage seropositivity in ASB from the 
NSP ELISA tests ranged from 77% to 31%. The Priocheck NSP ELISA had the 
highest percentage seropositive at 77% followed by the IZS Italy at 72%, the Chekit 
at 49% and the UBI at 31%. The percentage positivity in ASB in previously infected 
herds by salivary IgA ELISA was only 11%.  
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Table 5.6 Estimates of FMD percentage seropositivity of 121 ASB serum samples 
for the four NSP ELISAs and percent positive of 121 ASB saliva samples by IgA 
ELISA at four months PI in Yangon Division, Myanmar.  
 
 
 
Using the combined Priocheck and IgA ELISA tests for ASB, at four months PI in 
previously infected herds in Yangon Division, the percentage positive by Priocheck 
or IgA ELISA or both was 49.5% compared with 44.6% with Priocheck alone and 
13.2% with IgA ELISA alone. The percentage of ASB that were negative to both 
tests was 50.4% (Table 5.7).  
 
Table  5.7  Comparing  the  performance  of  two  tests  (Priocheck  +  IgA  ELISA)  in 
Yangon, Myanmar cross sectional study 
 
 
 
 
The third sampling site in Myanmar, the Magway Division had an FMD outbreak in 
February 2009 that was reported to have only affected the ASB population.  A total 
of 101 ASB were sampled at 8 months PI and the test results are presented in Table 
5.8. The estimated percentage seropositivity differed significantly among the four 
NSP  ELISAs  with  a  range  from  86%  to  22%.  The  Priocheck  had  the  highest 
estimated percentage seropositive detection at 86%, followed by IZS Italy at 64%, !
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Chekit  at  41%  and  the  UBI  at  22%.  The  percentage  positivity  in  ASB  in  the 
previously infected herds by salivary IgA ELISA was 45%.  
 
 
 
Table 5.8 Estimates of FMD percentage seropositivity of 101 ASB serum samples 
for the four NSP ELISAs and percent positive of 101 ASB saliva samples by IgA 
ELISA at eight months PI in Magway Division, Myanmar.  
 
 
 
Using  the  combined  Priocheck  and  salivary  IgA  ELISA  tests  for  ASB,  at  eight 
months PI in previously infected herds in Magway division, the percentage positive 
by  Priocheck  or  IgA  ELISA  or  both  was  84.2%  compared  with  83.2%  with 
Priocheck alone and 38.6% with IgA ELISA alone. The percentage of ASB that were 
negative to both tests was 15.8% (Table 5.9)  
 
 
Table 5.9 Comparing the performance of the two tests (Priocheck + IgA ELISA) in 
Magway, Myanmar cross sectional study. 
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5.3.2.2 FMD herd level percentage positivity by VI and real time RT-PCR tests 
 
The percentage positivity by VI and real time RT-PCR tests in ASB from FMD 
infected herds at eight months PI, in Magway Division is shown in Table 5.10. The 
results showed that, 14% of the 101 ASB sampled were positive for live FMD virus 
and only 10% were positive by real time RT-PCR. The percentage test Se and Sp of 
both  VI  and  real  time  RT-PCR  were  based  on  Zhidang  Zhang  and  Soren 
Alexandersen, 2003 (Zhang and Alexandersen 2003). All animals that tested positive 
to  both,  and  or  VI  and  real  time  RT-PCR  were  also  positive  to  NSPELISA 
(Priocheck) and IgA ELISA.   
 
 
Table  5.10  Estimate  of  percentage  positivity  by  real  time  RT-PCR  and  by  virus 
isolation  
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5.4 Discussion 
 
 In SEA countries such as Lao PDR and Myanmar, FMD in ASB is reported less 
often  than  in  cattle  (SEACFMD  2010).  When  FMD  outbreaks  occur  during  the 
paddy  field  preparation  the  damaging  agricultural  impact  of  FMD  in  ASB  is 
appreciated more because farmers in SEA have a stronger dependence on ASB than 
on  cattle  to  plough  the  fields.  This  agricultural  role  of  ASB  may  be  one  of  the 
reasons why FMD viruses of serotypes O, A and Asia 1 are maintained in the rice 
farming  systems  along  the  Mekong  river  in  Vietnam,  Cambodia  and  Lao  PDR 
(Rweyemamu et al. 2008).  
 
Previous reports on FMD outbreaks in both Lao PDR and Myanmar mainly referred  
to cattle rather than ASB. However, recent findings from serological studies in Lao 
PDR showed a higher percentage of FMD in ASB than in cattle (Blacksell et al. 
2008).   Previous studies also showed that movements of ASB and cattle are the 
major sources of FMD spreads in the two countries and other parts of SEA (Cocks et 
al. 2009; Wongsathapornchai et al. 2008). Farmers in Lao PDR and Myanmar still 
use ASB for paddy preparation and in addition keep small numbers of cattle and 
swine for consumption and sale at peak times of demand (Rweyemamu et al. 2008). 
 
The  maintenance  of  FMD  in  ASB  and  cattle  in  Myanmar  and  Lao  PDR  has 
implications for the rest of the region. In recent times serotype O FMD viruses from 
Myanmar  (Myanmar  98)  have  spread  through  the  greater  Mekong  countries  to 
Vietnam and China and this has become the dominant strain in the region. Type A 
strains have been reported from Thailand, Lao PDR and Malaysia and appear to have !
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moved  with  livestock  from  Thailand  through  Lao  PDR  to  Vietnam,  China  and 
Malaysia. 
 
This  cross  sectional  study  found  a  high  percentage  of  FMD  NSP  antibody 
seropositivity in ASB from herds previously infected with FMDV in Lao PDR and 
this is consistent with the high seroprevalence of FMD in ASB in Lao PDR found by 
Blacksell et al (Blacksell et al. 2008). The study showed similar results in Myanmar, 
and from both countries it also was apparent that geographical location; severity of 
outbreak and period of time of sample collection post outbreak can influence the 
percentage of NSP antibody seropositivity and the proportion of ASB with persistent 
FMDV infection in herds that have been previously infected with FMDV. Those 
animals showing persistent FMDV infection for at least 28 days after infection are 
potential  FMDV  carriers  by  definition  (Alexandersen  et  al.  2003;  Salt  1993; 
Woodbury 1995). 
   
The percentage positivity using the gold standard test (VI) and the real time RT-PCR 
to detect FMDV persistence in ASB in previously infected herds in Lao PDR and 
Myanmar  were  significantly  lower  than  results  in  a  study  of  FMDV  persistence 
conducted in cattle in Cameroon which had gave an apparent prevalence of probang 
positive herds of 19.5% (de et al. 2006), but the exact date of infection in Cameroon 
study was not known and the cattle were only sampled once.  
 
Under experimental conditions, the real time RT-PCR is more sensitive than VI but 
they have similar test specificity (Zhang and Alexandersen 2003). However, both 
tests have been optimised and validated using samples from experimental studies in 
cattle and sheep, and the degree to which the reference animals represent all of the !
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host and environmental variables in the populations targeted by the assay has a major 
impact on the accuracy of the test result interpretation (Jacobson 1996). Another 
explanation for the low percentage detection by both VI and real time RT-PCR is 
that recovery of live virus in OP fluid samples is intermittent, of low quantity and 
sometimes below the detectable limits by tissue culture isolation (Alexandersen et al. 
2003; Zhang and Alexandersen 2003). During the 2008 FMD outbreaks in Lao PDR 
and Myanmar, most clinical cases that were seen and reported came from cattle and 
few  were  seen  in  ASB,  which  made  the  respective  Veterinary  Officers  in  each 
country believe that FMD in ASB is mostly subclinical. The ASB that had been 
infected  during  the  previous  outbreak  were  determined  through  reports  from  the 
farmer owner to the local Veterinary officers and confirmed by the national Foot and 
Mouth  Disease  laboratory  staff  using  diagnostic  tests  e.g.  antigen  detection  and 
NSPELISA. Some of these ASB still showed old healed scars consistent with on the 
dorsal  portion  of  the  tongue  during  the  first  (4  month  post-outbreak)  collection 
period of the study.  
!
Whether subclinical infection has a correlation with the low quantity of live virus 
present in the OP region of the persistently infected ASB needs to be investigated. 
Another difficulty is that these tests have never been validated on ASB samples from 
field infections in SEA. Therefore the tests may not give similar results from this 
particular population to those results from other populations that were used in the 
validation of the test.  
 
Although the isolation of FMD virus from the OP region of convalescent animals has 
been the most specific technique for identifying FMDV persistent ‘carrier’ animals, 
it suffers from poor sensitivity and is labour intensive and expensive (Lubroth and !
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Brown 1995). In late 1990s, a significant step towards identifying the potentially 
persistently infected animal was the development of NSP antibody tests (Mackay 
1998). However, antibody response to FMDV NSP will persist for a variable time 
period even after the infection is shut down and a percentage of animals that are NSP 
positives will no longer be infected with live FMDV.  
 
The salivary IgA ELISA is a new test that was developed to optimise detection of 
FMD persistence in previously FMD infected animals because the levels of FMD 
virus-specific salivary IgA became elevated after infection and OP persistence of 
FMDV, regardless of vaccination status and the level of IgA in saliva was correlated 
with persistence of virus or viral genome in OP fluid (Parida et al. 2006).  
 
Using salivary IgA ELISA to estimate the level of persistent FMDV infection in 
ASB in previously infected herds in both Lao PDR and Myanmar showed some 
contrasts  between  locations  and  time  post  herd  infection.  In  Lao  PDR  and  in 
Magway  division,  Myanmar  where  sampling  was  done  at  eight  month  PI,  the 
estimates of percentage positive of FMDV persistence by salivary IgA ELISA were 
41% and 45% respectively. In Ayeyarwaddy and Yangon divisions where sampling 
was done at four months PI, the estimates percentage positive were only 2% and 
11% respectively. However, in Lao PDR and in Magway division the NSP ELISA 
seropositivity (Priocheck) was 66% and 86% respectively, whereas in Ayeyarwaddy 
the NSP ELISA seropositivity was only 16%. In Yangon NSP ELISA seropositivity 
was at 77% but this may represent a large proportion of ASB that were more recently 
infected, that have NSP antibody but only a limited percentage having persistent 
FMDV infection with elevated salivary FMD specific IgA antibody.    
 !
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In this study, two independent tests (Priocheck and salivary IgA ELISA) were also 
compared for indirect detection of persistent FMDV infection in ASB four to eight 
months PI from previously FMD infected herds in Lao PDR and Myanmar. This has 
been proposed as a sensitive herd test procedure for detection of persistently or sub-
clinically FMDV infected sheep and cattle (Parida et al. 2006; Parida et al. 2008).   
 
This  study  using  the  combined  NSP  (Priocheck)  and  salivary  IgA  ELISA  tests 
showed that including animals positive to the NSP ELISA (Priocheck), IgA ELISA, 
or both gave an increased positivity rate compared with that for each test alone. The 
differences  between  the  combined  test  and  the  NSP  ELISA  alone  were  not 
significant  but  there  were  significant  and  substantial  increases  (1.7  to  4.8  times) 
between the combined test and the IgA ELISA alone. However, the NSP ELISA may 
not reliably identify ASB that are persistently infected because some animals that are 
positive for NSP antibodies may no longer be infected. Conversely, the definitive 
cut-off for the IgA ELISA test that will give optimum sensitivity and specificity in 
multiple species including ASB still needs to be established by further evaluation of 
a larger number of saliva samples from other FMD susceptible species infected with 
other FMD serotypes.  
 
Based on the results in this study, it is therefore proposed that for studying the role of 
ASB, especially with respect to persistent FMDV infection, in the epidemiology of 
FMD in SEA, that screening of ASB population exposed to FMD infection can be 
done using the NSP ELISA test (in this case the Priocheck) with the salivary IgA 
ELISA then used to increase the specificity for detection of animals with persistent 
serum  and  salivary  antibody  to  FMDV  that  is  associated  with  persistent  FMDV 
infection. The findings from this chapter would suggest this was more sensitive and !
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practical  than  using  the  gold  standard  (VI)  test.  In  situations  where  selection  of 
FMDV  free  animals,  or  designation  of  FMD  free  herds  is  required,  the  use  of 
combined NSP ELISA and IgA ELISA testing with negative results to both tests 
would give the greatest risk management to avoid persistently infected (“carrier”) 
animals.    
 
Although all assays used in this study have been validated using samples from other 
FMD susceptible species and particularly bovine samples under experimental and 
controlled conditions, they have never been fully examined using ASB samples or 
any  animal  samples  in  significant  numbers  from  SEA.  These  studies  reported  in 
Chapters 4 and 5 were the first to validate the test performance of these laboratory 
assays on significant numbers of ASB samples from herds at defined intervals after 
naturally occurring FMDV infections under field conditions in SEA.  
 
The results of this study on the performance of the different tests for FMD detection 
will contribute to the OIE requirements for validation and certification of diagnostic 
assays where ‘fitness for purpose’ has been established as the criterion for validation. 
The concept of ‘fitness for purpose’ indicates that the test will be useful for the 
designated  purpose, e.g. demonstrate freedom from infection in a defined population 
(country/zone/compartment/herd) (OIE 2009).  
  
By using other alternative tests which are less invasive, and less labour intensive, 
like  the  IgA  ELISA  based  test,  to  detect  FMDV  persistence  (carriers)  this  can 
increase the level of surveillance for FMD persistently infected animals. The IgA 
ELISA test also has the potential to be able to accurately detect and determine the 
prevalence of FMD persistence ‘carriers’ in both experimental studies and in natural !
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field conditions (Parida et al. 2006). The same test was also used in a study in India 
which showed that under experimental conditions, all five Indian water buffaloes that 
were inoculated with FMDV serotype Asia 1 were found to be persistently FMD 
virus infected beyond 28 days PI and were positive by IgA ELISA (Maddur et al. 
2009). Nonetheless, all the tests (VI, RT-PCR, NSP ELISA and IgA ELISA) used in 
this  cross  sectional  study  in  ASB  have  provided  evidence  for  the  presence  of 
persistently  FMDV  infected  ASB  (“carriers”)    at  four  and  eight  months  PI  in 
previously infected herds. The NSP antibody seroprevalence results have also shown 
that FMD is present at relatively high levels in ASB in Lao PDR and Myanmar and 
that this is not reflected in routine disease reporting. ASB are therefore likely to play 
an important role in the epidemiology of FMD in Lao PDR and Myanmar.   
 
Because of the severity and highly contagious nature of FMD and the potential for 
persistently infected FMD animals showing no clinical signs that can have major 
adverse consequences for the interregional and international trade in livestock and 
animal products (Alexandersen et al. 2003), sensitive and specific tests need to be 
available for detection of FMD carriers to facilitate trade. The results of this study 
will be able to help the ASEAN member countries to identify persistently FMDV 
infected (‘carrier’) animals in ASB and possibly other species. More importantly, 
understanding the role of persistently infected animals in the epidemiology of FMD 
in Southeast Asia should be one of the priorities for research coordination by the 
SEACFMD campaign.  
 !
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Chapter 6 - The Role of Asian Swamp Buffaloes (ASB) as Carriers 
of FMD 
 
6.1 Introduction 
Two  important  characteristics  of  FMDV  are  its  capacity  to  establish  persistent 
“carrier state” infection in both vaccinated and non-vaccinated ruminants exposed to 
the virus (Auge de Mello et al. 1970; Sutmoller 1965; Van Bekkum JG 1959) and the 
major impact of carriers on FMD control policies (Alexandersen et al. 2002). FMD 
persistence (so called ‘carrier’ status) is defined as the presence of detectable virus 
for at least 28 days after infection (Alexandersen et al. 2003; Salt 1993; Woodbury 
1995).    
 
In the SEA region, there have been limited studies on FMD persistence especially in 
ASB  populations.  The  prevalence  of  FMD  persistence  in  ASB,  the  duration  of 
infection, their role in the maintenance and transmission FMDV and their capacity to 
cause new outbreaks of FMD are still unknown. Previous studies on the long-term or 
persistent infection of FMDV in water buffalo suggests that besides acting as viral 
reservoirs, the persistently infected host may represent a potential source of viral 
variants, although long-term carriage of FMDV does not imply efficient transmission 
of disease (Barros et al. 2007). In India, studies on water buffalo showed that the 
covert nature of the disease in Indian water buffalo, coupled with the prolonged 
shedding  of  virus,  suggested  that  this  species  may  be  a  host  of  epidemiological 
importance (Maroudam et al. 2008). The above study also indicated that FMD could 
be transmitted from water buffalo to water buffalo and from water buffalo to cattle 
by direct contact (Maroudam et al. 2008). The study also showed that water buffalo 
may be infected whilst showing only minor clinical signs and they can then act as a !
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source of infection for healthy cattle and other water buffalo upon direct contact as 
reported in the field (Gomes et al. 1997).  
 
This  chapter  reports  on  the  results  of  four  (according  to  Table  3.1)  longitudinal 
studies with sampling at six months intervals conducted in ASB in both Lao PDR 
and Myanmar. These studies have used and evaluated different laboratory tests in  
their investigation of persistence of FMDV infection in ASB, its duration and the 
possible role of persistently infected ASB in the spread and maintenance of FMD in 
the two countries.  
 
This  chapter  aims  to  demonstrate  the  existence  of  persistently  FMDV  infected 
(‘carrier’) ASB in SEA, the duration of the persistent infection and the possible role 
of  ASB  in  the  spread  and  maintenance  of  the  FMD  virus  in  SEA  region  with 
emphasis in Lao PDR and Myanmar.  
 
 
6.2 Materials and Methods     
 
 
 
6.2.1 Sampling Sites 
 
One Province (Lao PDR) and three Divisions (Myanmar) were strategically selected 
as sampling sites from two of the most FMD endemic countries in SEA, Lao PDR 
and Myanmar. These were chosen because they have large ASB populations and 
confirmed FMD outbreaks had occurred most recently in those countries at the time 
when  the  research  study  started  in  September  2008.    Detailed  description  of  the 
sampling sites is provided in Chapter 3.  !
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Figure 6.1 Sampling sites in Myanmar and Lao PDR  
 
 
 
 
6.2.2 Sampling Strategy 
 
   
The study consisted of four (according to Table 3.1) longitudinal studies with field 
sample collections at six monthly intervals between September, 2008 and June, 2010. 
Five hundred (500) ASB were selected from one province in Lao PDR and three 
divisions in Myanmar that had recently experienced confirmed outbreaks of FMD. In 
Lao PDR, the ASB sampled were at least eight months PI and in Myanmar the ASB 
were four and eight months PI.  Blood, saliva and oesophageal-pharyngeal fluid (OP) 
samples were collected from 399 ASB during the first sampling period in September 
2008 and 101 ASB in October 2009 as described in Chapter 3 (section 3.2) and 
Chapter 5 (section 5.2.2.2). The detailed sampling procedures and laboratory tests !
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used for the different samples collected are described in Chapter 3 (subsections 3.2 to 
3.4.7 and Appendices 1 – 10). 
 
All samples collected were processed and labelled at the respective FMD national 
laboratory in each country and were sent to the Institute for Animal Health (IAH), 
Pirbright, United Kingdom for all laboratory tests. The same strategy for sampling, 
processing  and  laboratory  testing  of  all  samples  was  followed  for  all  three 
collections.  
 
From the 500 ASB present during the
 first sampling, the number of ASB sampled 
decreased at each further sampling. The decrease in the number of ASB available for 
the  succeeding  sampling  periods  was  influenced  mainly  by  economic  factors. 
Owners reported that some were sold; others were being rented out to friends in other 
villages for ploughing of rice fields and other animals had died from other diseases.  
 
6.2.3 Laboratory Tests 
6.2.3.1 Virus isolation (VI) 
Isolation of live FMDV from OP fluid samples was done using the primary bovine 
thyroid (BTY) cells according to the IAH Pirbright laboratory’s SOP protocol on VI 
(Appendix one, Chapter three). An OP fluid sample was considered positive when 
one or more BTY cell tubes showed cytopathic effect (CPE) from the first to the 
third day of the tissue culture isolation test (Cox et al. 2005; Snowdon 1966).  
 
6.2.3.2. Real time RT-PCR  
All OP fluid samples positive for VI and other selected OP fluid samples that were 
negative for the detection of live FMD virus in BTY cell inoculation were tested for !
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the detection of FMDV RNA using real time RT-PCR (Zhang and Alexandersen 
2003),  Chapter  three,  Appendix  four).  Results  were  expressed  in  CT  (threshold 
cycle) values when positive and with no CT values when negative. 
 
6.2.3.3 Antigen Detection by Indirect ELISA 
All OP fluid samples that tested positive for CPE in BTY cell inoculation were tested 
to determine the FMD serotypes involved by indirect antigen detection ELISA which 
detects FMD antigen of all seven FMD serotypes (Roeder and Le Blanc Smith 1987). 
Test results were expressed in optical density (OD) values and OD values of ≥0.1 
were regarded as positive (Chapter three).  
 
6.2.3.4 Non-Structural Protein (NSP) antibody detection  
Antibodies to FMD non-structural proteins (NSP) were detected using four different 
NSP ELISA kits (Brocchi et al. 2006). All serum samples were tested using the four 
NSP ELISA test kits in parallel to detect the antibodies against FMD NSP. Three of 
the kits are commercially available namely; Priocheck (Lelystad, the Netherlands), 
Chekit-FMD-3ABC (Bommeli Diagnostics, Bern, Switzerland) and the UBI FMD 
NSP (United Biomedical Inc., NY, USA). The
 fourth was an in-house test, the 3ABC 
trapping ELISA (IZSLER Brescia). Test results were expressed as either OD values 
or percentage inhibition (PI) depending on the NSP ELISA manufacturer instructions 
manual. Detailed NSP ELISA procedures are provided in Chapter 3 and Appendices 
6-9.  
 
6.2.3.5 IgA detection 
A mucosal IgA ELISA based test was used to detect IgA antibodies specific to the 
structural proteins of FMD serotypes O, A and Asia 1 in all saliva samples collected. 
Detection of FMD specific IgA antibody in all of the saliva samples were measured !
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using  an  in-house  indirect  ELISA  for  the  detection  of  IgA  antibodies  to  FMD 
structural proteins (Parida et al. 2006). Test results were interpreted and expressed as 
optical density (OD) values. The detailed procedure for the IgA ELISA is provided 
in Appendix 10. 
 
6.2.4 Data analysis  
The  FMDV  seroprevalence  in  ASB  from  previously  infected  populations  was 
determined  during  the  first  collection  period  (Chapter  5  -  cross  sectional  study) 
where  there  were  a  significant  number  of  samples  collected  randomly  from  a 
sampling frame representing previously infected herds. However, in the two follow 
up sampling periods, testing was done on previously tested animals and the numbers 
of ASB available had decreased for various reasons. Therefore the analysis of data 
was  complicated  and  was  based  on  calculating  the  best  estimate  for  percentage 
positive at the different locations and times PI for the various tests based on the test 
Se and Sp and the sample size using the Epitools epidemiological calculators which 
are available at: http//epitools. Ausvet.com.au (Sergeant 2009). Detailed description 
of the data analysis is described in Chapter 3 (section 3. 4.8) and Chapter 4 (section 
4.2.5).  
 
6.3 Results 
 
6.3.1 ELISA test comparisons on field sample collection 
The total number of samples collected (blood serum and saliva) and the percentage 
seropositive from each of the four different NSP ELISAs and the percentage positive 
by  IgA  ELISA  for  ASB  from  previously  infected  herds  in  both  Lao  PDR  and 
Myanmar from all three field collections are shown in Table 6.1.   !
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Table 6.1 The total numbers of samples collected and tested from the three samplings 
and  the  percentage  seropositive  by  four  different  NSP  ELISAs  and  percentage 
positive by IgA ELISA.  
 
 
 
 
 
6.3.2 Bayesian Analysis of ELISA test performance 
Based on the laboratory test results from all serum and saliva samples collected from 
the three sampling periods, comparison of the test performances of four NSP ELISAs 
and  the  IgA  ELISA  in  ASB  population  in  SEA  were  calculated  using  Bayesian 
analysis (Figure 6.2). The results of the Bayesian analysis showed that among the 
four NSP ELISAs, the Priocheck and the IZS (3ABC Italy) had the highest test Se 
and Sp. But the IZS is an in house test and Priocheck is commercially available, thus 
Priocheck  was  selected  as  the  NSP  ELISA  for  this  study  and  could  serve  as  a 
reference test for future similar studies and for the FMD control programme in SEA.  
 
The NSP ELISA detects antibodies due to infection in animals that may or may no 
longer be carrying live virus. The salivary IgA ELISA cut-off is set at a level that 
detects FMDV serotype-specific IgA responses present in cattle and ASB that are 
persistently  FMDV  positive  and  are  potentially  FMDV  carrier  animals.  The  IgA 
ELISA  can  be  used  to  differentiate  carrier  from  non-carrier  animals.  Based  on  
analysis shown in Figure 6.2, the test Se for both Priocheck and salivary IgA ELISA !
103!
!
were almost the same at around 80%. However, the test Sp for both individual tests 
were  high  at  99%,  which  was  the  same  with  the  Sp  when  the  two  tests  were 
combined.  
 
In order to maximise the sensitivity of detection of persistent FMDV infection in 
ASB from herds that had previously FMD outbreaks, the combined test results of the 
Priocheck  and  the  salivary  IgA  ELISA  tests  were  used  to  measure  percentage 
detection.  The combination of the two independent tests in previously infected ASB 
herds in both Lao PDR and Myanmar was used for all three sampling collection 
periods.   
Se#[95%#BPI] Sp[95%#BPI] PPV#[95%#BPI] NPV#[95%#BPI] LR+#[95%#BPI] LR2[95%#BPI]
PrioCHECK 0.803%[0.797)0.818] 0.995%[0.987)1] 99.65%%[99.18%)100%] 72.64%%[71.32%)74.28%] 9175.5%[63.68)3988] 0.1981%[0.1833)0.1997]
3ABC#Italy 0.811[0.798)0.839] 0.994%[0.987)1] 99.61%%[99.19%)99.99%] 72.95%%[70.11%)76.48%] 747.4%[63.21)2889] 0.1907[0.1610.2039]
UBI 0.674[0.673)679] 0.997%[0.990)1] 99.67%%[99.13%)100%] 62.01%%[61.52%)62.41%] 2047%[60.72)8660] 0.3266%[0.322)0.330]
Chekit 0.608%[0.524)0.716] 0.979[0.960)0.999] 98.91%%[97.39%)99.95%] 44.43%%[27.80%)64.02%] 160.5%[14.34)574.6] 0.4001%[0.2882)0.4879]
IgA 0.800[0.797)0.806] 0.996%[0.988)1] 99.74%%[99.22%)100%] 72.57%[71.98%)73.27%] 5344%[68.21)6970] 0.2011%[0.1945)0.2044]
PrioCHECK +#IgA# 0.983%[0.894)0.999] 0.993[0.987)0.999] 99.68%%[99.36%)99.99%] 96.33%%[76.13%)99.99%] 1707%[76.32)2953] 0.017%[0)0.1072]
Characterisation%of%test%performances%by%Bayesian
framework%in%buffalo%population%in%SEA
 
 
Figure 6.2 Test performances by Bayesian analysis of four different NSP ELISAs 
and  IgA  ELISA  in  ASB  in  SEA.  (Se  sensitivity;  Sp  specificity;  PPV  positive 
predictive value; NPV negative predictive value; LR+ likelihood ratio for positive 
tests; LR- likelihood ratio for negative tests) !
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6.3.3 Estimated level of FMDV persistence by NSP ELISA and by salivary IgA 
ELISA in ASB from herds that had previously FMD outbreaks for the three 
different sampling periods in Lao PDR 
 
The estimates of persistent FMDV infection from all animals available for sampling 
in all three collections by NSP ELISA (Priocheck) and salivary IgA ELISA testing in 
previously infected ASB in the herds in Lao PDR at eight months, 14 months and 20 
months PI is presented in Table 6.2. At eight months PI, the percentage of FMDV 
antibody reactors  in ASB from previous outbreak herds was at 62.9 %, by NSP 
ELISA, 54% by salivary IgA ELISA and 70% by NSP and/or IgA ELISA tests. 
However, the estimate of level of persistent FMDV infection based on positivity to  
both tests, the Priocheck +ve /IgA +ve (animals that tested positive to both Priocheck 
and salivary IgA), was 33% and positive by salivary IgA ELISA but negative NSP 
ELISA was only 7.3% at eight months PI.   
 
The results during the second sampling period showed an increase in both tests used 
and  also  the  combined  test  results.  The  increase  percentage  detection  during  the 
second sampling period was at 13.3% for the NSP ELISA, 13% increase by the 
salivary  IgA  ELISA,  10%  increase  for  the  results  of  the  combined  tests,  13% 
increase to both tests but had slight decrease of .2% by salivary IgA only. The results 
of the third sampling period however showed a decrease in all percentage detection 
by the tests used. From 76.2% percentage positive it went down to 68%, a decrease 
of 8.2% by NSP ELISA. From 67% to 35%, a significant decrease of 32% for the 
salivary IgA ELISA and the results of the combined tests decreased from 80% to 
77% a difference of 3%. From 46% that tested positive to both tests it went down to 
26% which is a significant decrease of 20% and from 7.1% down to 6.5% for the 
salivary IgA test only which is a slight decrease of 0.6% only.  !
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Table 6.2 Summary estimates of percentage detection of FMDV persistence by NSP 
ELISA and by salivary IgA ELISA in previously infected ASB in the herd in all 
three sampling periods in Lao PDR (1st sampling - 178 samples 8 months post-
outbreak; 2
nd sampling – 84 samples 14 months post-outbreak; 3
rd sampling – 77 
samples 20 months post-outbreak).  
 
 
 
 
6.3.4 Investigation of FMD carriers in ASB using virus isolation in Lao PDR  
The usual gold standard test for the detection of FMDV persistence ‘carriers’ is the 
virus isolation (VI) using tissue culture system (Alexandersen et al. 2003). However, 
in all OP fluid samples collected from Lao PDR in all the three collection periods 
only three samples were positive by VI for FMD virus serotype A. Two positive 
samples  were  isolated  from  the  OP  fluid  samples  collected  during  the  second 
sampling period, which was 14 months post-outbreak. The third positive sample was 
isolated during the third sampling period, which was 20 months post-outbreak. The 
three  virus  isolates  from  ASB  carrier  animals  were  characterized  genetically  and 
based on the genetic characterization shown in the phylogenetic tree in Figure 6.3, 
were 94% similar to Lao 2006 FMD type A and 92% similar to Malaysia 2002 FMD 
type A (Figure 6.3).  
 
FMDV serotype A was not isolated during the previous FMD outbreaks in Lao PDR 
caused by FMDV type O and the isolation of three FMDV type A viruses (A Lao 61 
2009, A Lao 64 2009 and A Lao 155) in the second and third sampling periods 14 !
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and 20 months post-outbreak was unexpected. The three ASB positive for these Lao 
FMDV type A viruses were both NSP and salivary FMDV type O and A IgA ELISA 
positives. However, the salivary IgA ELISA test results from the first and second 
collection periods showed a higher proportion of ASB were antibody positive to 
serotype A than serotype O (Figure 6.4).  
 
 !
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Figure  6.3  Phylogenetic  tree  based  on  capsid  sequences  of  FMDV  showing 
relationships  between  Lao  PDR  serotype  A  FMDV  isolates  and  other  type  A 
representatives  in  the  world.  The  blue  circles  highlight  viruses  from  the  FMD 
carriers in ASB.   
 
 !
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6.3.5 FMD serotypes detected by salivary IgA ELISA tests in ASB in Lao PDR. 
 
The summary of the specific FMD serotype antibodies detected in all saliva samples 
from  ASB  in  three  collections  from  Lao  PDR  is  presented  in  Figure  6.4.  The 
majority of the positive samples were due to serotype A and this was followed by 
serotype O and with some few samples that were positive for serotype Asia 1.  The 
detection of serotype A by IgA ELISA was consistent with the VI results where 
serotype A live virus was isolated and characterized by genetic sequencing.   
 
 
 
 
Figure 6.4 FMDV serotypes detected and the percent of samples positive to each 
FMD serotype by IgA ELISA in Lao PDR three sampling periods.  
 
(1
st  sampling  –September,  2008;  2
nd  sampling  –March,  2009;  3
rd  sampling  –
September, 2009).  
 
 
 
6.3.6 Results of the longitudinal study in Lao PDR 
 
The number of ASB that tested positive to Priocheck and salivary IgA and to both 
tests and the change over time in the longitudinal study is presented in Tables 6.3 for !
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comparisons between two test periods and in Table 6.4 as a summary of results from 
the three sampling periods.  
 
Table 6.3 Summary of ASB test results for sequential sampling periods for Priocheck 
NSP ELISA and salivary IgA ELISA in the Lao PDR longitudinal study shown as 
number of ASB giving results in this category. (1st sampling - 178 samples 8 months 
post-outbreak; 2
nd sampling – 84 samples 14 months post-outbreak; 3
rd sampling – 
77 samples 20 months post-outbreak) 
 
 
 
(++ indicates positive in both; +- indicates positive in the initial test and negative in 
the next; -+ indicates negative in the initial test and positive in the next; -- indicates 
negative in both tests). 
 
 
 
Table  6.4  Summary  of  ASB  test  results  for  3  sequential  sampling  periods  for 
Priocheck NSP ELISA and salivary IgA ELISA from Lao PDR longitudinal study 
shown as number of ASB giving results in this category. (1st sampling - 178 samples 
8 months post-outbreak; 2
nd sampling – 84 samples 14 months post-outbreak; 3
rd 
sampling – 77 samples 20 months post-outbreak) 
 
. 
 
 
(+++ indicates positive in three collections; ++- indicates positive in the first two 
tests and negative in the third collection next; +-- indicates positive in the first test 
and negative in both second and third tests; --- indicates negative in all three tests; -
++ indicates negative in first test and positive in both second and third tests; --+ 
indicates negative in both first and second tests and positive in third test). 
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Overall, from the 178 ASB collected during the first sampling period, 112 (62.9%) 
tested positive to the Priocheck and 70 (39.3%) tested positive to the salivary IgA 
and 59 (33.15%) tested positive to both tests at eight months PI. During the second 
sampling period only 84 ASB were available for resampling. From those 84 ASB 
sampled, 54 remained positive by Priocheck, 26 by salivary IgA and 19 to both tests. 
For the third sampling period, which was 20 months PI, only 77 ASB were recovered 
for the third sampling period. From the 77 ASB during the third sampling period, 
only 22 remained positive by Priocheck to all the three sampling periods, five by 
salivary IgA and only four ASB remained positive to both tests in all three sampling 
periods.  From  first  to  second  sampling  periods,  14  ASB  remained  negative  by 
Priocheck, 25 by salivary IgA but only four remained negative by Priocheck and 16 
by salivary IgA during the entire 20 months study period.  
 
The  decrease  in  numbers  giving  results  to  the  different  sampling  periods  were 
sometimes due to insufficient volume of samples collected for many repeats done on 
the different tests.  Others were due to other tests combinations like +-+, -+-, etc. 
which is not included in the table.  Based on the above results, in Lao PDR, the 
estimated  percentage  of  persistently  FMDV  infected  ASB  in  previously  infected 
herds steadily decreased over time up to the end of the study period.  
 
 
6.3.7 Estimated level of FMDV persistence by NSP ELISA and by salivary IgA 
ELISA in ASB from herds that had previously FMD outbreaks for the three 
different sampling periods in Myanmar 
 
The estimates of persistent FMDV infection by NSP ELISA (Priocheck) and salivary 
IgA ELISA in previously infected ASB in herds in three Divisions in Myanmar over 
the  three  sampling  periods  is  presented  in  Table  6.5.    The  overall  percentage 
detection of FMDV persistence in Myanmar during the first sampling period was at !
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72.8% by NSP ELISA, 26% by the salivary IgA ELISA, the combined two tests at 
61.7%, to both tests at 44.6% and by salivary IgA only at 2.1% only. The second 
sampling test results saw a decrease in the percentage detection for the NSP ELISA 
(Priocheck) and for the combined tests. However, the salivary IgA test showed an 
increase from 26% to 51%, also an increase of 6.4% (44.6% to 51%) for both tests 
and 6.7% (2.1% to 8.8%) increase to salivary IgA only. During the last sampling 
period, there was an increase in the percentage positivity to Priocheck (14.6%) and 
the combined tests (11.2%), but had dramatic decrease in salivary IgA at 34.7%, in 
both tests at 42% and for salivary IgA only, a decrease of 6.5%.  
 
 
Table 6.5 Summary estimates of percentage detection of FMDV persistence by NSP 
ELISA and by salivary IgA ELISA in previously infected ASB in the herd in the 
three sampling periods in Myanmar. (1st sampling - 322 samples 4 or 8 months post-
outbreak; 2
nd sampling – 251 samples 10 or 16 months post-outbreak; 3
rd sampling – 
44 samples 16 months post-outbreak).  
  
 
 
 
 
Myanmar had three sampling sites that were selected for the whole study. Based on 
the  previous  FMD  status  report  before  the  study  started,  the  level  of  field  virus 
challenge differed among the three sampling sites. This was based on the number of 
animals affected, the number of species affected and the reported duration of the 
disease  outbreak.  To  verify  and  support  the  clinical  observations,  the  percentage 
positivity in NSP and salivary IgA ELISA tests of ASB from previously infected !
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herds  were  separately  summarised  and  analysed  for  each  sampling  site.  The 
summary for the Ayeyarwaddy division is presented in Table 6.6.  
The  Ayeyarwaddy  division  had  only  two  sampling  collection  periods  due  to 
inaccessibility of the area during the last collection period of the study. The results of 
the NSP ELISA showed 17% detection, 5% by salivary IgA. The combined tests 
showed  a  total  of  20%  detection  rate,  but  only  2%  detection  by  both  tests  in 
Ayeyarwaddy division at four months post-outbreak. During the second sampling 
period, the NSP ELISA results showed a decrease of 3.1%, while the IgA ELISA test 
result had an increase of 17% with almost similar results for the combined tests and 
an increase of 3.8% (2% to 5.8%) by both tests.  
 
 
Table 6.6 Estimates of percentage detection of FMDV persistence by NSP ELISA 
and by salivary IgA ELISA in ASB from previously infected herds in two sampling 
periods in Ayeyarwaddy division, Myanmar. (1st sampling - 100 samples 4 months 
post-outbreak; 2
nd sampling – 86 samples 10 months post-outbreak)  
 
 
 
The estimates of percentage detection of FMDV persistence in ASB from previously 
infected herds in Yangon division are presented in Table 6.7. The Yangon Division 
had three collection periods starting from four months PI up to the end of the study 
period. The Yangon Division had 73.5% percentage positivity by Priocheck, 14% by 
the salivary IgA, 64.5% by the combined tests, and only 9% by both tests at four 
months post-outbreak. During the second sampling period IgA ELISA result had a 
significant  increase  from  14%  to  64%,  the  combined  tests  increased  percentage 
positivity from 64.5% to 76.2%, both tests increase significantly from 9% to 41.6% !
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but the Priocheck decreased from 73.5% to 66%.  The third sampling period test 
results showed similar percentage detection rate by the NSP ELISA from the second 
sampling period, but the IgA ELISA result showed a significant decrease from 64% 
to 11%. However, the result of the combined tests slightly decreased from 76.2% to 
68.9% but the results of both tests significantly decreased from 41.6 to only 9% 
detection rate during the last sampling period   
 
 
Table 6.7 Estimates of percentage detection of FMDV persistence by NSP ELISA 
and by salivary IgA ELISA in previously infected ASB in the herd in three sampling 
periods in Yangon Division, Myanmar. (1st sampling - 121 samples 4 months post-
outbreak; 2
nd sampling – 84 samples 10 months post-outbreak; 3
rd sampling – 44 
samples 16 months post-outbreak). 
 
 
 
The result of the estimates for the percentage detection of FMDV persistence in ASB 
from  previously  infected  herds  in  Magway  Division  in  Myanmar  is  presented  in 
Table  6.8.  The  Magway  Division  had  only  two  collection  periods.  The  first 
collection period was conducted in October 2009, which was exactly eight months 
post-outbreak. The second sampling period was conducted in June, 2010 which was 
eight months after the first collection period and was exactly 16 months PI.  The 
Magway Division sampling site was reported to have had an FMD outbreak that 
affected only ASB at eight months before the first collection period. The test results 
showed a high percentage seropositivity of 81.2% by NSP ELISA and percentage 
positivity of 34.7% by salivary IgA ELISA, 82.2% positivity by the combined tests 
and  32.7%  by  both  tests.  The  results  of  the  second  collection  period  showed  a !
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significant increase for salivary IgA ELISA (28.4%), the combined tests (9.2%), both 
tests (26.3%) but with only 2.8% increase for the NSP ELISA test result. In this 
particular sampling site more than 50% of the ASB that were sampled were reported 
to have been previously diagnosed with clinical lesions and the majority of those 
animals had only mild lesions. The 13 ASB that were positive on VI and 19 positive 
by real time RT-PCR at eight months post-infection (first sampling) in Myanmar 
were all from this sampling site.      
 
 
Table 6.8 Estimates of percentage detection of FMDV persistence by NSP ELISA 
and  by  salivary  IgA  ELISA  in  ASB  from  previously  infected  herds  over  two 
sampling  periods  in  Magway  Division,  Myanmar  (1st  sampling  -  101  samples  8 
months post-outbreak; 2
nd sampling – 81 samples 16 months post-outbreak)  
 
 
 
6.3.8 FMD serotypes detected by salivary IgA ELISA tests in ASB in Myanmar 
The  data  on  the  number  of  ASB  saliva  samples  tested  and  specific  serotype/s 
detected by the salivary IgA ELISA is summarised in Figure 6.5. FMD serotypes 
seen in Myanmar were the same in all three sampling sites. But for purposes of 
presenting what specific serotype/s were present in the country, only the summary 
results from Yangon Division that had three collections are presented in Figure 6.5. 
The previous history indicated that the latest confirmed FMD outbreak in the study 
sites in Myanmar at the start of the sampling period was due to FMDV serotype O.  
Based on the IgA ELISA test results, some ASB saliva samples were positive to one, 
two or the three serotypes of FMD historically present in Myanmar.  !
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Figure 6.5 FMDV serotypes detected and the percent of samples positive to each 
FMD serotype by IgA ELISA in Yangon Division, Myanmar for three sampling 
periods.  
  
 
(1
st  sampling  –  September,  2008,  2
nd  sampling  –  April,  2009,  3
rd  sampling  –
September, 2009). 
 
 
 
 
6.3.9 Investigation of FMD carriers in ASB using virus isolation and real time 
RT-PCR in Myanmar 
 
A total of 616 OP fluid samples collected in three different samplings in Myanmar 
were tested for the presence of infectious FMD virus using the tissue culture system, 
only 13 of the samples were positive for live FMD virus type O and 19 were positive 
for FMDV type O nucleic acid by real time RT-PCR. All 13 FMD live virus positive 
samples and 19 samples positive by real time RT-PCR came from the first sampling 
period from Magway Division only (8 months post-FMD type O outbreak).      
 
The genetic characterisation of the serotype O isolated in FMD carriers in ASB from 
Myanmar is presented in Figure 6.6. Viruses from the persistently FMDV infected !
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ASB are highlighted inside the green circle and the figure shows their relationship 
with other serotype O representatives worldwide. 
 
The FMD viruses isolated from FMDV carrier ASB were 97% similar to Myanmar 
2008 FMDV type O. These VI and genetic sequencing results are consistent with 
findings in the reported 2008 outbreaks which were caused by serotype O. Using VI 
(the  gold  standard)  to  detect  persistent  FMDV  ‘carrier’  ASB,  the  results  from 
Magway Division gave the estimated percentage prevalence of persistently FMDV 
infected ASB from previously infected herds at 14.1% by VI and 10.7% by real time 
RT-PCR at eight months PI. As discussed in Chapter 5 and shown in Table 5.10 the 
above VI and real time RT-PCR percentage prevalences were based on 91% test Se 
with 100% test Sp for VI and 100% test Se and 91% test Sp for the real time RT-
PCR (Zhang and Alexandersen 2003)  
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Figure  6.6  Phylogenetic  tree  based  on  capsid  sequences  of  FMDV  showing 
relationships  between  Myanmar  serotype  O  FMDV  isolates  and  other  type  O 
representatives worldwide. Viruses from the FMD carrier in ASB are highlighted 
inside the green circle.  
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6.3.10 Results of the longitudinal study in Myanmar 
In Myanmar the longitudinal studies were analysed separately for each of the three 
Divisions studied. The number of ASB that tested positive to Priocheck, salivary IgA 
and  to  both  tests  and  the  change  over  time  is  presented  by  each  Division  in 
Myanmar.  
 
In Ayeyarwaddy Division (Table 6.9), which was the first collection site, only two 
collections were made due to inaccessibility of the area during the last collection 
period. From 100 ASB that were sampled during the first collection period, only 
20% ASB tested positive by the combined tests after four months post-outbreak. 
From the 20 ASB positive, 12 of those remained positive by Priocheck with only two 
positive by salivary IgA and zero for both tests after ten months post-outbreak. In the 
Ayeyarwaddy  Division,  74  of  the  ASB  sampled  were  consistently  negative  for 
Priocheck and 84 by salivary IgA in both sampling periods.  
 
 
Table 6.9 Summary of ASB test results for sequential sampling periods for Priocheck 
NSP  ELISA  and  salivary  IgA  ELISA  in  the  Ayeyarwaddy  Division,  Myanmar  
longitudinal study shown as number of ASB giving results in this category. (1st 
sampling  -  100  samples  4  months  post-outbreak;  2
nd  sampling  –  86  samples  10 
months post-outbreak) 
 
 
 
(++  Indicates  positive  in  both  tests;  +-  indicates  positive  in  the  initial  test  and 
negative in the next test; -+ indicates negative in the initial test and positive in the 
next test; -- indicates negative in both tests)  
 
 !
119!
!
The number of ASB that tested positive to Priocheck, salivary IgA and to both tests 
and the change over time in the longitudinal study in Yangon Division are presented 
in Tables 6.10 and 6.11.  From the original 121 samples during the first sampling 
period, 89 ASB tested positive in Priocheck and 14 in salivary IgA. From those 89 
positive only 50 ASB remained positive by Priocheck, and only seven out of 14 by 
salivary  IgA  but  with  only  four  ASB  remained  positive  to  both  tests  during  the 
second  sampling  period.  From  first  to  second  sampling  period,  17  remained 
consistently negative by Priocheck and 18 by salivary IgA. Test results from the third 
sampling periods, showed 28 ASB were consistently positive by Priocheck, only one 
ASB for salivary IgA and again only one ASB to both tests in all three sampling 
periods. Only five and 18 ASB remained consistently negative by Priocheck and by 
salivary IgA respectively in all three sampling periods.  
 
As for Lao PDR, the decrease in numbers giving positive results in the different 
sampling periods were sometimes due to insufficient volume of samples collected for 
many repeats done on the different tests.  Others were due to other test combinations 
like +-+, -+-, etc. which are not included in the table.  Based on the above results, in 
Lao  PDR,  the  estimated  percentage  of  persistently  FMDV  infected  ASB  in 
previously infected herds steadily decreased over time up to the end of the study 
period.  
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120!
!
Table  6.10  Summary  of  of  ASB  test  results  for  sequential  sampling  periods  for 
Priocheck NSP ELISA and salivary IgA ELISA in the Yangon Division, Myanmar 
longitudinal  study  shown  as  number  of  ASB  giving  results  in  this  category  (1st 
sampling  -  121  samples  4  months  post-outbreak;  2
nd  sampling  –  84  samples  10 
months post-outbreak; 3
rd sampling – 44 samples 16 months post-outbreak) 
 
 
 
(++  indicates  positive  in  both  tests;  +-  indicates  positive  in  the  initial  test  and 
negative in the next test; -+ indicates negative in the initial test and positive in the 
next test; -- indicates negative in both tests).  
 
 
 
 
Table  6.11  Summary  of  ASB  test  results  for  3  sequential  sampling  periods  for 
Priocheck NSP ELISA and salivary IgA ELISA from Yangon Division, Myanmar 
longitudinal study shown as number of ASB giving results in this category. (1st 
sampling  -  121  samples  4  months  post-outbreak;  2
nd  sampling  –  84  samples  10 
months post-outbreak; 3
rd sampling – 44 samples 16 months post-outbreak)  
 
 
 
(+++ indicates positive in three collections; ++- indicates positive in the first two 
tests and negative in the third collection next; +-- indicates positive in the first test 
and negative in both second and third tests; --- indicates negative in all three tests; -
++ indicates negative in first test and positive in both second and third tests; --+ 
indicates negative in both first and second tests and positive in third test). 
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The third sampling site in Myanmar was the Magway Division and the test results 
are  presented  in  table  6.12.    As  in  Ayeyarwaddy  Division  only  two  sample 
collections were done starting at eight months PI and again at 16 months PI.  Of the 
101  ASB  collected  during  the  first  collection  period  82  ASB  tested  positive  to 
Priocheck, 35 by salivary IgA and 33 for both tests. During the second sampling 
period, only 64 ASB remained positive by Priocheck from first to second sampling 
period. Only 22 were positive by salivary IgA and also 22 were positive to both tests. 
Nine and 18 ASB remained consistently negative for Priocheck and salivary IgA 
respectively after 16 months PI.  
 
 
Table  6.12  Summary  of  ASB  test  results  for  sequential  sampling  periods  for 
Priocheck NSP ELISA and salivary IgA ELISA in the Magway Division, Myanmar 
longitudinal  study  shown  as  number  of  ASB  giving  results  in  this  category  (1st 
sampling  -  101  samples  8  months  post-outbreak;  2
nd  sampling  –  81  samples  16 
months post-outbreak) 
 
 
 (++  indicates  positive  in  both  tests;  +-  indicates  positive  in  the  initial  test  and 
negative in the next test; -+ indicates negative in the initial test and positive in the 
next test; -- indicates negative in both tests).  
 
 
 
6.3.11  Percentage  of  ASB  from  previously  infected  herds  that  remained 
persistently positive in ELISA tests; that becomes negative over time; and the 
percentage of negatives that became positive in both Lao PDR and Myanmar 
 
Based on the results of the combined Priocheck and IgA ELISA, the percentage of 
persistently FMDV NSP and IgA ELISA positive ASB over time in both Lao PDR 
and Myanmar is presented in Figure 6.7.  
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In  Lao  PDR,  5.2%  of  ASB  remained  persistently  FMDV  NSP  and  IgA  ELISA 
positive over three sampling periods; 7.3% of the ASB that were persistently FMDV 
FMDV NSP and IgA ELISA positive in the first and second sampling periods tested 
negative in the third sampling period; and 2.4% of ASB that were FMDV NSP and 
IgA ELISA positive in the first sampling period (eight months post-outbreak) tested 
negative in both the second and third sampling periods. However, 2.8% of the ASB 
sampled that tested negative during the first sampling period tested positive to both 
tests in the second and third sampling periods. Also 2.8% of ASB that were negative 
in both first and second sampling periods tested positive to both tests in the third 
sampling period.  
 
In  Myanmar,  2.3%  of  ASB  remained  persistently  FMDV  NSP  and  IgA  ELISA 
positive over three sampling periods; only 2.5% of the ASB that were persistently 
FMDV  FMDV  NSP  and  IgA  ELISA  positive  in  the  first  and  second  sampling 
periods tested negative in the third sampling period; and 1.7% of ASB that were 
FMDV NSP and IgA ELISA positive in the first sampling period tested negative in 
both second and third sampling periods. However, 2.5% of the ASB sampled that 
tested negative during the first sampling period tested positive to both tests in the 
second and third sampling periods. Also 0.8% of ASB that were negative in both first 
and  second  sampling  periods  tested  positive  to  both  tests  in  the  third  sampling 
period. 
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Figure 6.7 Percentage positives by combined Priocheck and IgA ELISA tests over 
time in previously FMDV infected herds in Lao PDR and Myanmar. In Lao PDR 
178 ASB were tested in the 1
st sampling at 8 months post-outbreak, 84 in the 2
nd 
sampling at 14 months post-outbreak and 77 in the 3
rd sampling at 20 months post-
outbreak. In Myanmar only Yangon Division had 3 samplings with 121 ASB tested 
in the 1
st sampling at 4 months post-outbreak, 84 in the 2
nd sampling at 10 months 
post-outbreak and 44 in the 3
rd sampling at 16 months post-outbreak. Percentages are 
based on the number of animals that were present for the 3rd sampling and had 3 
sequential results.  
 
(+++ indicates persistently positive over the three collections; ++- indicates positive 
in the first two tests and negative in the third collection test; +-- indicates positive in 
the first test and negative in both second and third tests; -++ indicates negative in 
first test and positive in both second and third tests; --+ indicates negative in both 
first and second tests and positive in third test). 
 
 
 
 
6.4 Discussion  
 
Animals in which FMD virus persists in the pharyngeal region for more than four 
weeks after the infection (persistently infected animals) are called ‘carriers’ (Salt 
1993; Sutmoller 1968). This study showed that ASB under SEA conditions can be 
persistently infected with FMDV for at least eight months PI by both VI and real 
time RT-PCR tests. In Magway Division, Myanmar the percentage of persistently 
FMDV infected ASB from herds infected eight months previously was 14.1% by VI 
and 10.7% by real time RT-PCR. However, both tests are relatively insensitive and !
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are too complex for widespread monitoring of persistent FMDV infection especially 
in endemic areas.  
 
Different routine and new tests were analysed and evaluated on ASB samples to 
determine whether their test Se and Sp will give suitable estimates on the percentage 
prevalence  of  persistently  FMDV  infected  ASB  in  previously  infected  herds  and 
whether these tests can be adopted and used to investigate persistent FMDV infection 
in ASB under SEA conditions. Previous studies in cattle indicated that the induction 
of  NSP  antibodies  correlates  with  the  extent  and  duration  of  virus  replication 
(Armstrong et al. 2005; Cox et al. 2005; Parida et al. 2005). However, other studies 
also indicate that the NSP ELISA detects past infection (sero-conversion) as well as 
persistently  FMDV  infected  (‘carrier’)  cattle  (Biswal  et  al.  2008).  With  the 
development and validation of the salivary IgA ELISA in cattle it showed that the 
IgA saliva test, can either be use as a front-line method of detecting FMDV carriers 
or as a method of confirming the specificity of reactors demonstrated using NSP 
screening tests (Parida et al. 2006). The combined NSP (Priocheck) and IgA ELISAs 
in this study detected persistently FMDV NSP and IgA antibody positive ASB for at 
least 20 months post-outbreak without field evidence of further FMDV incursions 
and this is consistent with persistent FMDV infection and potential FMD “carrier” 
state. The results of the longitudinal studies by NSP ELISA and IgA ELISA in both 
Lao PDR and Myanmar also showed that the ASB may have a role in the spread and 
maintenance of the FMD virus in SEA region especially in Lao PDR and Myanmar.  
This study also showed that the technology for the different tests can be successfully 
used under SEA conditions and indicated a test combination that would be quite 
feasible for investigation of FMDV carriers in ASB in SEA.  
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The sero-type specific ELISA detects FMDV specific IgA antibody in the saliva of 
previously  infected  ruminants  and  is  less  labour  intensive  and  expensive  for  the 
identification of persistently ‘carrier’ animals than VI or real time RT-PCR testing 
(Parida et al. 2006). This test detected FMD serotype specific IgA antibodies in ASB 
saliva samples for at least up to 20 months PI. This test would need to be replicated 
for all FMDV serotypes likely to be present in a region so it is still more complex 
than the NSP ELISA, which can detect antibody to NSP in all serotypes of FMDV 
circulating in a single test. Therefore the NSP ELISA could be used as an initial 
screening  test  followed  by  serotype  specific  salivary  IgA  ELISA  to  identify 
persistently FMDV infected animals.   
 
Using the results of both NSP (Priocheck) and IgA ELISA to improve detection of 
FMD persistence (Parida et al. 2006; Parida et al. 2005) in ASB, this study showed 
that the percentage of persistent FMDV NSP and IgA antibody positive ASB differs 
with  geographical  location,  severity  of  field  challenge  and  possibly  the  FMD 
epidemiology  of  the  areas  affected.  In  Ayeyarwaddy  Division,  Myanmar,  the 
prevalence of these ASB reactors in previously infected herds was only 2% at four 
months  post-outbreak.  In  both  Lao  PDR  and  Magway  Division,  Myanmar,  the 
percentage of FMDV NSP and IgA antibody positive ASB in previously infected 
herds at eight months post-outbreak were similar at 33% and 32.7% respectively.  
However, at 20 months post-outbreak in Lao PDR, the percentage of FMDV NSP 
and  IgA  antibody  positive  ASB  positive  was  reduced  to  26%  and  in  Magway 
Division in Myanmar at 16 months post-outbreak the percentage of FMDV NSP and 
IgA antibody positive ASB was reduced to 27%. At 16 months post outbreak in 
Yangon Division the percentage of FMDV NSP and IgA antibody positive ASB was 
reduced to 2.3%.  !
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These  results  in  ASB  were  slightly  lower  than  the  seroprevalence  of  FMDV  in 
African buffaloes described as very high (50-70%) under free living conditions in 
Botswana  at  18  months  PI  (Condy  et  al.  1985;  Hedger  1972).  However,  in  the 
outbreak in Magway Division, Myanmar where only ASB were reported to have 
been infected, the prevalence of FMDV NSP and IgA antibody positive ASB at eight 
months post-outbreak was 32.7%. However, after 16 months PI, the prevalence of 
FMDV NSP and IgA antibody positive ASB in Magway Division was 27%. Magway 
Division was also the area that had 13/101 ASB positive by VI at eight months post-
outbreak. The prevalence of FMDV persistence in Magway Division was lower than 
that  of  a  previous  study  in  cattle  conducted  under  experimental  and  controlled 
conditions (Salt et al. 1996). That study in cattle, showed that between 77% and 78% 
might be FMD positive by VI at five weeks after challenge.  
 
The previous 2008 FMD outbreaks in Lao PDR were thought to have been due to 
FMD  serotype  O.  However,  using  the  VI  and  real  time  RT-PCR  to  determine 
prevalence of FMDV persistence in ASB in previously infected herds, live FMD 
virus type A was isolated from the OP fluid in two ASB in Lao PDR at 14 months 
after the type O FMD outbreak. The reasons for this could possibly be that there was 
mixed infection during the 2008 outbreak as has been observed from other studies on 
different species (Hedger et al. 1972; Vallee H 1928); and that serotype O was more 
dominant (Hedger et al. 1972) than serotype A during the 2008 outbreak; or that 
another inapparent incursion of FMD serotype A had occurred and that virus was 
being maintained in carrier ASB, similar to what occurs in African Cape buffalo 
(Vosloo et al. 2009).  
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In Lao PDR, there was a significant increase in the percentage positivity by both the 
Priocheck  and  salivary  IgA  ELISA  in  ASB  from  the  previously  infected  herds 
between the first and second sampling periods, which may have been related to the 
isolation of 2 FMD viruses at the time of the second sampling. Then for the third 
collection period, there was a significant decrease in percentage positive by both 
tests despite another FMD virus being isolated at the time of the third sampling. 
There were no new outbreaks of FMD reported during the entire study period.  
 
The longitudinal studies also clearly showed (Figure 6.7) that in both regions there 
were a proportion of ASB in the previously infected herds that were negative initially 
and became positive and remained positive to both the NSP ELISA and salivary IgA 
ELISA tests. In the absence of new incursions and FMD outbreaks this indicates that 
FMDV  circulation  was  occurring  in  these  herds.  The  unapparent  FMDV 
transmission  from  persistently  FMDV  infected  ASB  to  naïve  animals  during  the 
study period may have remained undetected due to the absence of regular and active 
disease surveillance being in place. Similar findings have occurred in other areas 
where  it  was  considered  that  the  virus  was  continuously  circulating  in  the  area 
resulting in the possibility of a transmission from persistently FMD infected buffalo 
to naïve animals (Sutmoller et al. 2003; Vosloo et al. 1992). The observations in this 
study are supported by the genetic sequencing results which indicated that the type A 
viruses isolated in Lao PDR from the persistently FMDV infected ASB were 94% 
similar to Lao 2006 FMD type A and the type O viruses in Myanmar were 97% 
similar  to  Myanmar  2008  FMDV  O.  However,  considering  the  relatively  low 
percentage of ELISA seroconversions in the ASB herds and although the estimated 
specificity of the tests was shown to be quite good (Chapter 4) one must also be !
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careful that these are not non-specific reactions rather than because the animals were 
newly infected (Bruderer et al. 2004)  
 
This study showed that the NSP ELISA gave relatively high percentage positives in 
ASB from previously outbreak herds in SEA. As has been observed in cattle the 
positives represent animals that have undergone past infection but may no longer be 
infected  (sero-conversion)  as  well  as  those  that  are  persistently  FMDV  infected 
(‘carrier’) animals (J. K Biswal 2008).  The IgA ELISA based test can be used as a 
direct screening test in ASB to identify FMDV persistence or it can be used as a 
confirmatory test on NSP ELISA positive animals to confirm persistently FMDV 
infected ‘carrier’ status as the salivary IgA ELISA has been shown to only detect 
sub-clinical infections and carrier animals (Archetti et al. 1995; J. K Biswal 2008; 
Parida et al. 2006). The VI, which is the gold standard for the detection of FMDV 
persistence ‘carrier’ animals, has relatively low sensitivity. It is also a complex test 
with strict technical and biosecurity requirements. This means that the application 
and routine use of VI in countries like Lao PDR and Myanmar, which do not have 
the access to the required facilities and equipment to use VI as a routine test will not 
be viable.  
 
In this study, and even with the absence of VI, those samples that were positive in 
both NSP (Priocheck) and salivary IgA ELISA tests are likely to be truly persistently 
infected ASB. Thus NSP ELISA and salivary IgA ELISA based testing will enhance 
studies on the prevalence of FMDV persistence in ASB in the region and in other 
FMD susceptible species. The use of the two tests will greatly assist the regional 
campaign for FMD control.  
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Further research is needed to understand the mechanisms and the epidemiological 
significance of persistent infections with FMDV (carriers) in the maintenance and 
transmission of FMD in SEA. This will require more studies both under field and 
experimental conditions to clarify the mechanism for the establishment of FMDV 
persistence,  the  factors  influencing  transmission  and  to  demonstrate  the  rates  of 
transmission from persistently FMDV infected ASB. 
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Chapter 7 - General Discussion 
  
   
This study has demonstrated that the Asian Swamp Buffalo (ASB) in South East 
Asia (SEA) can be persistently infected with Foot and Mouth Disease (FMD) for up 
to 20 months (PI) or possibly longer. This result differs from previous findings of an 
initial study in the Philippines where previously infected ASB were found not to be 
persistently infected with FMD at the time of the study (Legaspi et al. 2003). The 
different tests used in this study to determine herd level percentage of persistent 
FMDV  infection  in  ASB  in  SEA  conditions  were  evaluated  and  the  study  has 
identified a combination of tests of suitable sensitivity, specificity and practicality for 
use in investigations of FMDV persistence and transmission in SEA.  The results of 
the longitudinal studies also showed that the ASB might have a role in the spread and 
maintenance of FMD virus (FMDV) in SEA especially in Lao PDR and Myanmar. 
The aims of the study, which were outlined in Chapter 1, were addressed and are 
discussed below. The results of this study have shown that ASB can be important in 
the  epidemiology  of  FMD  in  SEA  and  that  ASB  need  to  be  considered  when 
formulating FMD control programs in the region. 
 
The evaluation and comparison of the diagnostic tests for FMD in ASB are reported 
and discussed in Chapter 4. In unvaccinated populations, evidence of previous FMD 
infection for livestock trade can be obtained by serological testing for antibody to 
FMD structural proteins (SP). The existing serological tests to detect SP antibodies 
of FMDV are the Virus Neutralization test (VNT) and Liquid Phase Blocking (LPB) 
Enzyme Linked Immunosorbent Assay (ELISA) (LPBE) or the modified version of 
this, the Solid Phase Competition ELISA (SPCE). The VNT was not used in this 
particular study due to limited time and resources, which are required for handling of !
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live FMD virus. In populations with endemic FMD, the LPBE and SPCE have the 
limitation that they will detect antibodies from animals that have been vaccinated but 
not infected as well as animals that have been infected. In this study the LPBE was 
only used on samples from the first collection since the purpose was not to detect 
infection but to compare with and confirm the serotype specificity detected by the 
salivary IgA ELISA.  
 
The  ELISA  test  for  antibodies  to  non-structural  proteins  (NSPs)  is  a  significant 
advance in the detection of animals that have been infected with FMDV irrespective 
of whether they have been vaccinated or not. Persistently FMDV infected animals 
also remain NSP antibody positive for prolonged periods so the tests can provide an 
indication of persistently FMDV infected animals (‘carriers’). However, the test has 
limitations,  in  that  a  proportion  of  NSP  antibody  positive  animals  will  not  be 
persistently  infected,  thus  there  is  a  need  to  use  other  tests  in  identifying  such 
animals  e.g.  virological  or  RT-PCR  testing  on  probang  samples  and/or  other 
serological testing (Kitching 2002b). In this study, four different NSP ELISAs were 
used and evaluated to determine the FMDV seroprevalence in ASB from previously 
infected herds at four months, eight months, 14 months, 16 months and 20 months 
PI. The estimates of percentage positivity given by the different NSP ELISA tests 
varied significantly from each other. The United Biomedical Incorporated (UBI) had 
the  lowest  percentage  detection  in  all  sampling  periods.  The  Priocheck  and  IZS 
(3ABC Italy) had very similar test sensitivity (Se) and specificity (Sp) and this was 
higher than for Chekit. In this study, preference was given to the Priocheck test 
because of its commercial availability; it is species independent and is the most user- 
friendly among the four NSP ELISA tests available for evaluation. !
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A salivary IgA ELISA based test (Parida et al. 2006) to detect FMD carrier animals 
has been developed and validated in cattle and sheep at the Institute for Animal 
Health (IAH), Pirbright Laboratory. It is used to detect IgA antibodies to specific 
FMD structural proteins in saliva of animals that have been previously infected with 
FMDV. Previous observational studies after FMD outbreaks, indicated that mucosal 
antibody  positive  animals  were  associated  with  previously  infected  cases  but  if 
samples  are  antibody  negative,  the  persistent  infection  is  extremely  unlikely  and 
conversely,  a  persistent  mucosal  antibody  response  (beyond  3  to  4  months)  is 
strongly  indicative  of  a  persistent  infection  (Archetti  et  al.  1995;  McVicar  and 
Sutmoller  1974).  In  the  present  study  both  in  Lao  PDR  and  Myanmar  mucosal 
antibody responses were detected by the use of salivary IgA ELISA in ASB. The 
results  showed  that  at  20  months  post-outbreak  the  percentage  test  positivity 
(Priocheck + ve / IgA + ve) in ASB from previously infected herds in Lao PDR was 
26% and at 16 months post-outbreak in Magway Division, Myanmar the percentage 
test  positivity  (Priocheck  +  ve  /  IgA  +  ve)  was  27%  but  for  Yangon  Division, 
Myanmar it was 2.3% positive. This indicates the presence of persistently FMDV 
infected  ASB  (‘carriers’)  in  previously  infected  herds  at  16  to  20  months  post-
outbreak in Myanmar and Lao PDR.  
 
Previous  studies  showed  that  when  used  together  with  other  laboratory  tests  to 
determine prevalence of persistently FMDV infected animals, the NSP ELISA is still 
currently the most sensitive method to detect carriers especially in a vaccinated cattle 
population (Moonen et al. 2004).  In the same study Moonen et al. (2004) showed 
that the prevalence by NSP ELISA could be as high as 100% soon after infection, 
declined slowly beyond 34 days PI, but nevertheless at 609 days after inoculation, 
60% of the experimental cattle were still seropositive by NSP ELISA (Moonen et al. !
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2004).  The  antibody  ELISA  tests  are  indirect  tests  for  virus  persistence  and  are 
subject to non-specific results, especially for the NSP ELISA (Bruderer et al. 2004). 
However, in this study the strategy of combining tests to maximise detection (Parida 
et al. 2006; Parida et al. 2008) and only considering dual NSP ELISA and salivary 
IgA  ELISA  positive  animals  (Priocheck  +ve  /  IgA  +ve)  as  persistently  FMDV 
infected has addressed the specificity issue. Also, the positive results of serotype A 
from  the  salivary  IgA  ELISA  in  Lao  PDR  were  confirmed  by  VI  and  genetic 
sequencing data.  
 
Currently, virus isolation (VI) from oesophageal-pharyngeal (OP) (probang) fluid is 
the recommended method to detect persistently infected animals, although detection 
of  viral  sequences  in  other  tissues  and  fluids  has  been  reported  during  FMDV 
persistence in cattle (Bergmann et al. 1996). However, the excretion of FMD virus 
by FMD persistently ‘carriers’ animals is intermittent and the amount of virus is low 
and declines over time (Alexandersen et al. 2002). This could be one of the reasons 
why there were few positives for FMD virus isolation from samples collected in both 
Lao PDR and Myanmar in all three collections periods. In one Division in Myanmar 
(Magway),  only  14.1%  of  the  animals  were  positive  for  virus  isolation  at  eight 
months PI, while only 10.7% of the animals were positive by real time RT-PCR.  
Ideally, testing to identify and subsequently eliminate FMD persistent infection in 
animals from the population could be done by surveillance using tests for antibodies 
to  the  non-structural  (NS)  proteins  of  FMDV  combined  with  probang  sampling. 
However,  both  of  these  methods  have  their  practical  and  statistical  limitations 
(Hedger  1971;  Mackay  1998).  Probang  samples  collected  from  carriers  generally 
contain a low load of FMDV, as a result the sensitivity of the assay is low (Zhang 
and Alexandersen 2003). Under SEA conditions the routine use of VI and real time !
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RT-PCR for the detection of persistently infected animals is not feasible due to the 
logistics of sample collection, expense of the tests and limitations of suitable virus 
culture and PCR laboratory facilities. Based on the results of the evaluation of tests 
in this study, the NSP ELISA together with the salivary IgA ELISA will be the most 
practical tests to use in the SEA region.  
 
In this present study, the test Sn and Sp of the different tests to detect prevalence of 
persistently infected ASB and percentage seropositive post infection were analysed 
and compared.   Using the VI and the real time RT-PCR to detect prevalence of 
persistently infected ASB in a herd, the results showed that at eight months PI, only 
14.1% of the 101 ASB in Magway Division were persistently FMD infected and 
only 10.7% by real time RT-PCR. To maximise detection of the persistently FMD 
infected ASB, the tests results of the combined Priocheck and IgA ELISA (Priocheck 
and/or IgA +ve) were evaluated and analysed. However in this study, only those 
samples that tested positive to both tests (Priocheck +ve / IgA +ve) were considered 
as persistently FMD infected ASB in order to address the test specificity issue. 
 
 
Based  on  samples  collected  at  eight  months  PI  in  both  Lao  PDR  and  Myanmar 
(Magway  Division)  the  percentage  seropositive  by  Priocheck  were  at  62.9%  and 
81.2% respectively. Results of the salivary IgA ELISA showed that 54% (Lao PDR) 
and 34.65% (Magway Division) of the ASB sampled were persistently infected eight 
months PI. Using the results of the combined Priocheck and IgA ELISA (Priocheck 
and/or IgA +ve) to maximise detection of persistently FMD infected ASB in a herd, 
results showed an increase from 54% to 71.8% in Lao PDR and in Magway Division 
an increase from 34.65% to 82.2%.  
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The results of the combined Priocheck and IgA ELISA are the maximum percentage 
detection of those ASB that are seropositive and or persistently FMD infected ASB 
in a herd PI. However, they may not be the true prevalence of persistently FMD 
infected  because  some  NSP  positive  animal  may  no  longer  be  persistently  FMD 
infected as stated in previous studies. In this study only those animals that tested 
positive to both Priocheck and salivary IgA ELISA (Priocheck +ve / IgA +ve) were 
considered as those truly persistently FMD infected animals.  This strategy was made 
in order to address the specificity issue in detecting persistently FMD infected ASB 
in a herd in the absence of a specific tests like VI and real time RT-PCR.  
 
Based on the above strategy, the prevalence of the persistently FMD infected ASB in 
Lao PDR and Magway Division, Myanmar were almost the same (33% and 32.7% 
respectively)  eight  months  PI.  The  results  of  this  strategy  showed  higher  test 
sensitivity in detecting persistently FMD infected ASB when compared to that of VI 
and real time RT-PCR (from 14.1% and 10.7% to 32.7%). Using the same strategy, 
results showed that in Lao PDR 26% of the ASB sampled were still persistently 
FMDV  infected  at  20  months  post-outbreak  and  in  Magway  Division,  Myanmar  
27% of the ASB were still persistently FMDV infected at 16 months post-outbreak 
although in Yangon Division, Myanmar only 2.3% of ASB were persistently infected 
at 16 months post-outbreak.   
 
The increase in percentage positive results of both tests to detect FMD persistence in 
previously  infected  ASB  agrees  with  the  experimental  findings  on  cattle  where 
Priocheck and IgA ELISA had good correlation when used to detect persistently 
infected cattle (Parida et al. 2006). Using both NSP (Priocheck) and salivary IgA 
ELISAs (Priocheck +ve / IgA +ve) to detect persistence of FMDV in ASB, this study !
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showed that persistent virus infection can still be detected 20 month PI. The different 
estimates generated by the present study maybe be attributed to differences in the 
species tested, FMD virus strain and that NSP ELISA is serotype independent while 
salivary IgA ELISA is serotype specific.  
 
The status of FMD in ASB in SEA was reviewed using information from past studies 
and animal health status reports from government livestock services from both Lao 
PDR  and  Myanmar  and  this  was  presented  in  Chapter  5.  The  information 
complemented the results of the cross-sectional study, which determined the FMDV 
antibody prevalence in ASB from previously FMDV infected herds in Lao PDR and 
Myanmar. FMD outbreaks for the five years before the start of the study were mostly 
in cattle with FMD serotype O as the dominant serotype, and the prevalence in ASB 
was second to that of cattle based on the animal health status annual reports from 
both Lao PDR and Myanmar. Recent findings from studies in Lao PDR showed that 
the seroprevalence of FMD in ASB was higher than that in cattle (Blacksell et al. 
2008).  Also,  the  findings  from  the  present  studies  showed  that  the  persistently 
FMDV infected ASB could be as high as 26%, 20 months PI.  This is consistent with 
the findings of Blacksell et al (2008) but is lower and differs from those earlier 
studies in endemic regions where up to 50% of infected animals where found to be 
carriers and these could eventually trigger outbreaks under suitable conditions (Salt 
et al. 1996; Sutmoller 1965).   
 
The results of the cross-sectional study showed high FMDV antibody prevalence in 
ASB from herds previously affected by FMD in both Lao PDR and Myanmar. This 
study was based on the 2008 FMD outbreaks in both countries, which were reported, 
and confirmed to be due to FMD serotype O. But the results of the cross-sectional !
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study in Lao PDR confirmed higher percentage positivity to FMD serotype A than 
serotype O by the salivary IgA ELISA in ASB from herds previously affected by 
FMD. Possible reasons for this include occurrence of mixed infections with both 
serotypes (Vallee H 1928)  or the FMD serotype A virus was being maintained in 
ASB that are persistently infected with FMD serotype A virus (Hedger 1972).  
 
Vaccination  against  FMD  has  been  limited  in  both  countries.  In  Myanmar  ring 
vaccination is applied only during outbreaks to control spread of FMD infection. In 
Lao PDR vaccination is rarely implemented even during outbreaks of FMD and this 
is due to the inability to pay for vaccines.  Because of the limited vaccination and 
surveillance activities in both countries, the percentage positive to FMD in ASB 
from previously infected herds can provide a useful estimate of the FMDV antibody 
prevalence in endemic ASB herds in both countries. The results generated by the 
cross-sectional study on ASB herds provided useful information on the epidemiology 
of FMD in both Lao PDR and Myanmar and will be of help in the formulating and 
updating the on-going national FMD control program of each country. 
 
The  rates  of  persistent  FMDV  infection  and  the  duration  of  persistent  FMDV 
infection in ASB under experimental and natural conditions have not been studied 
before. Published studies on the FMDV persistence (‘carriers’) in buffalos have been 
mostly confined to African Cape buffalo and some limited studies on water buffalo 
from India and South American countries. Views on the classification of the water 
buffalo  vary.    Some  authorities  list  a  single  species,  Bubalus  bubalis  with  three 
subspecies,  the  river  buffalo  (B.  bubalis  bubalis)  of  South  Asia,  the  carabao  or 
swamp buffalo (B. bubalis carabanesis) of the Philippines and Southeast Asia, and 
the  arni  or  wild  water  buffalo  (B.  bubalis  arnee)  (Roth  2004).  In  this  study  the !
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duration, rate of persistence of FMD infection in ASB and its possible role in the 
spread and maintenance of FMD in SEA region was investigated and the results were 
reported and discussed in Chapter 6.   
 
The prevalence of persistently FMDV infected ‘carriers’ in a population depends on 
the  species,  the  incidence  of  infection  and  the  immune  status  of  the  population 
(Alexandersen  et  al.  2002).  The  present  study  indicated  that  the  ASB  can  be 
persistently FMDV infected for at least 20 months PI. This finding is consistent with 
that of cattle which has a maximum duration of the carrier state for 3.5 years and in 
African Cape buffalo for up to 5 years (Alexandersen et al. 2002)  . 
 
Although the study did not focus on the duration of persistence in individual animals, 
based  on  the  longitudinal  studies  it  was  found  that  a  proportion  of  ASB  from 
previously infected herds are persistently infected with FMD virus and over time the 
rates of prevalence can still be as high as 26% at 20 months PI.   
 
The role of ASB, as FMDV ‘carriers’ under field conditions, in the maintenance and 
spread of FMD in SEA has not been investigated before. Previous studies on water 
buffalos with serotype O FMDV showed recovery of the virus over a one-year period 
and  although  considered  as  FMD  ‘carriers’  they  only  indicated  that  they  were 
reservoirs of the virus and therefore had importance in the FMD epidemiology with a 
potential  role  in  the  spread  the  FMD  virus  but  without  actually  demonstrating 
transmission of FMDV (Barros et al. 2007; Maddur et al. 2009; Maroudam et al. 
2008). In African buffaloes, there is field evidence to indicate that carrier animal can 
precipitate new outbreaks of disease, and more anecdotal evidence also implicates !
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carrier  cattle  and  sheep  in  disease  recrudescence  or  in  starting  new  outbreaks 
(Alexandersen et al. 2002; Alexandersen et al. 2003).   
 
In this longitudinal study in SEA, there was substantial variation in the percentage of 
persistently FMDV infected ASB, as determined by NSP ELISA and salivary IgA 
ELISA positive results in these previously infected herds. The geographical location 
of herds and probably the epidemiology of FMD at each sampling site may have also 
contributed  to  the  significant  difference  in  the  percentage  of  persistently  FMD 
infected ASB in these herds. After the initial sampling of the sites, the numbers of 
ASB that were able to be tested in the longitudinal sampling decreased in some cases 
substantially  and  some  sites  were  not  able  to  be  tested  on  three  occasions.  This 
probably  introduced  some  sampling  bias  and  helps  to  explain  the  fluctuations  of 
percentage  of  persistently  FMDV  infected  ASB  over  time  in  previously  infected 
herds.  The prevalence of carrier African Cape buffalo has been described to be very 
high (50% - 70%) under free-living conditions in Botswana (Condy et al. 1985; 
Hedger 1972), but this study was only done as single time-point surveillance. An 
earlier study in Brazil also showed similar prevalence of carrier animals in cattle 
(Sutmoller 1965). 
 
In the present study on FMD in ASB, the viruses that caused the 2008 outbreaks in 
Lao PDR and Myanmar were FMD serotype O viruses (Rast et al. 2010; SEACFMD 
2010).  However, during this study, sequentially testing of ASB from affected herds 
from the 2008 FMD outbreaks in both countries, FMD serotype A was isolated in 
ASB OP fluid samples at 14 months PI in Lao PDR, and FMD serotype O of the 
outbreak  strain  was  isolated  in  ASB  OP  fluid  samples  at  eight  months  PI  in 
Myanmar. The last confirmed FMD serotype A outbreak in Lao PDR prior to the !
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start of this study was in 2006. By sequence analysis the FMD serotype A isolated 
from ASB in this study was closely related to the serotype A viruses isolated in 2006 
Lao PDR and also to FMD serotype A virus from the Malaysian outbreaks in 2002.  
The results of the NSP ELISA and salivary IgA ELISA testing has identified some 
ASB in both countries that were negative in the first collection and tested positive in 
the second and last collections. Other ASB that were tested negative in the first and 
second  collections  then  tested  positive  during  the  last  collection.  Based  on  this 
sequential  serology  (NSP  ELISA  and  IgA  ELISA)  results  and  confirmed  by  the 
genetic sequence data it appears that either the FMD serotype A virus was being 
maintained in ASB ‘carriers’ in Lao PDR or there was undetected recirculation of 
subclinical serotype A in the area in cattle or ASB or both over a prolonged period. 
Based  on  the  salivary  IgA  ELISA  results  and  genetic  sequencing  that  confirmed 
presence  of  serotype  A  being  maintained  in  ASB  ‘carriers’,  it  is  probable  that 
transmission of FMD serotype A to naïve ASB within these populations is occurring 
but is undetected because of the absence of regular FMDV surveillance in Lao PDR. 
However, evidence based on previous studies also indicates that transmission from 
carrier animals is considered to be infrequent. Although the infectivity levels which 
can be recovered from carriers are low, virus continues to be present (Alexandersen 
et al. 2002). Likewise, the risk of transmission from carrier animals appears to be 
very  low  and  requires  certain,  as  yet  undefined,  trigger  factors,  but  it  cannot  be 
totally excluded (Alexandersen et al. 2002) and may have a significant impact on 
control strategies.  
 
For disease control programs and in livestock trade the possibility of FMD ‘carrier’ 
animals  creating  fresh  outbreaks  is  probably  small  but  this  risk  can  be  further 
reduced by virological testing of OP fluid samples and serological testing to detect !
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‘carrier’ animals (Kitching 2002b). In SEA countries especially in Lao PDR and 
Myanmar,  where  regular  FMD  monitoring  is  not  in  place,  persistently  FMDV 
infected ASB could transmit the virus to cause new infections or outbreaks but this 
would go undetected. This is likely to have occurred, at least with FMDV serotype A 
in Lao PDR during this study period. In situations like this, and in the absence of the 
gold standard test which is the VI, the combined Priocheck and salivary IgA ELISA 
will be useful, easy to use and will help in maximising detection of the persistently 
FMD infected animals in SEA. 
 
Vaccination for prevention of clinical disease may not prevent the development of 
the ‘carrier’ state in cattle (Hedger 1970; Sutmoller 1968). This was given as one of 
the reasons that vaccination was not used in the United Kingdom in 2001 outbreak 
(Barnett et al. 2004) This potential risk is considered sufficient to have major impact 
on control measures taken in international trade and on the decision whether or not to 
vaccinate to assist in the control of an FMD outbreak (Moonen et al. 2004). In SEA 
and especially in Lao PDR and Myanmar where regular vaccination against FMD is 
not practiced, animals that have tested positive in approved serological tests, like 
NSP  ELISA,  LPBE,  SPCE  or  VNT,  can  be  considered  to  have  had  evidence  of 
exposure to FMDV infection. Furthermore, if confirmed by tests like the salivary 
IgA ELISA they have a high probability of being persistently FMDV infected and 
may have a risk of transmitting FMDV to other FMD susceptible animals.!
 
In Lao PDR and Myanmar, where ASB play an integral part in their owner’s food 
and  agricultural  production  systems,  the  unique  livestock  production  system 
(common grazing and drinking grounds and caretaker) can be one of the major risk 
factors in the transmission and maintenance of FMD in the region. This unique type !
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of livestock production system together with the evidence from this study that ASB 
populations have a relatively high proportion of FMDV ‘carriers’ by VI, real time 
RT-PCR  and  NSP  and  salivary  IgA  ELISA  testing;  and  that  persistently  FMDV 
infected ASB in previously infected herds can persist for 20 months PI and possibly 
longer periods provides important information about the epidemiology of FMD in 
ASB  in  the  region.  Therefore  it  is  recommended  that  further  development  and 
enhancement of control programs for FMD in the region should include targeted 
surveillance  of  ASB  populations  to  detect  and  quantify  FMDV  infection  and 
persistence, virus excretion and to demonstrate the rates of transmission from carrier 
ASB.  The results of this present study on the duration of persistence and the level of 
persistently  FMDV  infected  ASB  from  previously  infected  herds’  shows  that 
consideration needs to be given to the role of persistently FMD infected ASB in the 
overall  FMD  control  programme  in  SEA.      The  findings  from  Lao  PDR  and 
Myanmar have relevance to the other countries involved in the SEACFMD campaign 
and  should  lead  to  formulation  of  recommendations  to  member  countries  on 
strategies for animal movement management and the control of FMD in ASB in 
SEA.  
 
Further  research  is  also  recommended  to  understand  the  mechanisms  for 
establishment  of  FMDV  ‘carriers’  in  ASB  populations,  the  factors  influencing 
FMDV  shedding  from  ‘carriers’  and  the  rate  of  transmission  to  naïve  animals. 
Further  research  and  development  of  tests  of  even  greater  accuracy  in  the 
identification  of  individual  ASB  ‘carrier’  animals  should  also  be  undertaken. 
Enhancing the understanding and detection of FMD ‘carriers’ will contribute greatly 
towards controlling FMD which is still the number one animal disease in the region !
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and  has  major  social  and  economic  impacts  on  trade  and  food  security  in  SEA 
nations especially in Lao PDR and Myanmar.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 !
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Appendices 
 
Appendix 1 - Virus Isolation (VI) Procedure 
The primary BTY cells were prepared from aseptically collected thyroid glands of 
young (six months old) calves using the procedure described by Snowdon (Snowdon 
1966)  and  cultivated  as  monolayers  in  WRL  Hepes  medium.  The  WRL  Hepes 
medium is made up of 2x Modified Eagles medium, Fungizone, 2ug/ml; penicillin, 
200U/ml; PBS; L-glutamine, I tablet of NaOH, filtered deionised water and make up 
to 500 mls. with pH to 7.2. The cell monolayer should was seeded at 2x10
5 cells/ml. 
and grown at 37ºC.  Five (5) primary BTY cell tubes were used for each probang 
sample.  Each  tube  was  inoculated  with  200ul  of  the  probang  sample  which  was 
thawed and equilibrated at room temperature before the inoculation. The inoculated 
BTY cells were incubated at 37°C and observed for 3 days for evidence of cytophatic 
effects (CPE) in the cell monolayers. 
 
1. Switch on the biological cabinet class II and clear cabinet of all unnecessary materials. 
2. Wash the cell monolayer(s) to be infected including the negative control tubes with 
sterile PBS three times, pre-warmed to 37ºC.  
3. Inoculate the cell culture(s) with the required amount of sample (normally 0.2ml. of 
probang sample per 2.0ml Leighton tube), taking care not to disrupt the monolayer. 
4. Rinse the outside of tube(s) in disinfecting solution. 
5. Incubate at 37ºC, for 30 to 60 minutes. The inoculated tube(s) should be incubated 
stationary, cell monolayer(s) at bottom. 
6. Wash the cell monolayer(s) three times with sterile pre-warmed PBS. 
7. Add  the  required  amount  of  maintenance  medium  to  infected  cell  monolayer(s), 
usually 2 ml per Leighton tube. !
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8. Rinse the outside of tube(s) in disinfecting solution. 
9. Incubate at 37ºC, in a rotating drum, for 3 days. 
10. The inoculated culture(s) should be read daily for the presence of cytopathic effect. 
11. A probang sample is positive (+) when at least one inoculated tube shows cytopathic 
effect. 
 
 
Appendix 2 - FMD Virus typing using indirect ELISA Procedure 
 
1. ELISA plates (maxisorp) are coated with 50ul/well FMD serotypes O, A, Asia1, C, 
SAT 1,SAT2, SAT 3 and SVD rabbit antiviral sera diluted at 1/5000 in 0.05 M 
carbonate/bicarbonate buffer, pH 9.6. Rows A to H receive, respectively, antisera to 
serotypes O, A, and Asia 1, C, SAT 1, SAT 2, SAT 3 and SVD. 
2. Leave overnight at 4ºC in a stationary position or place in an orbital shaker set at 100-
120 revolutions per minute in a 37ºC incubator for 1 hour. 
3. Thaw and prepare test sample suspension (undiluted clarified cell culture supernatant 
fluid). 
4. The ELISA plates are washed five times in PBS. 
5. On each plate, load wells of columns 4, 8 and 12 with 50ul PBST. Additionally, add 
50ul of PBST to wells 1, 2 and 3 of rows A to H on plate 1. To well 1 of row A of 
plate 1 add 12.5ul of control antigen type O, to well 1 of row B add 12.5 ul of control 
antigen A; continue in this manner for control antigen of types C, SAT 1, SAT 2, 
SAT 3, Asia 1 and SVDV in order to well 1, rows C to H. Mix diluents in well 1 of 
rows A to H and transfer 12.5ul from well 1 to 2 (rows A to H), mix and transfer 
12.5ul from well 2 to 3, mix and discard 12.5ul from well 3 (rows A to H) (this gives 
a five-fold dilution series of each control antigen). It is only necessary to change !
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pipette tips on the micropipette between antigens. The remainder of the plate can be 
loaded with the test sample(s). Add 50ul of sample one to wells 5, 6 and 7 of rows A 
to H, the second sample is placed similarly in columns 9, 10 and 11, rows A to H. if 
more than two samples are to be tested at the same time, the other ELISA plates 
should be used as follows; Dispense 50 ul of the PBST to the wells (rows A to H) of 
columns 4, 8 and 12 (buffer control columns. Note that the control antigens are not 
required on these plates. These test samples may be added in 50ul volumes in rows A 
to H to columns 1, 2, 3, 5, 6,7,9,10,11, respectively.  
6. Cover with lids and place on an orbital shaker at 37ºC for 1 hour. 
7. Wash the plates by flooding with PBS-wash three times as before and empty residual 
wash fluid. Blot the plates dry. 
8. Transfer  50ul  volumes  of  each  FMD  serotype  specific  guinea-pig  serum  diluted 
1/1000 in ELISA buffer PBST with 5% skimmed milk to each plate well in the 
appropriate order, e.g. rows A to H receive, respectively, antisera to serotypes O, A, 
C, SAT 1, SAT 2, SAT 3, Asia 1 and SVDV. 
9. Cover the plates with lids and replace on the orbital shaker. Incubate at 37ºC for 1 
hour. 
10. The plates are washed again three times, and 50ul of 1/1000 of rabbit anti-guinea-pig 
immunoglobulin conjugated to horseradish peroxidise in PBST with 5% skimmed 
milk powder is added to each well. The plates are incubated at 37ºC for 1 hour on a 
rotary shaker. 
11. The plates are washed again three times, and 50ul of substrate solution, containing 
0.05% H2O2 plus orthophenylene diamine or a suitable alternative chromogen, is 
added to each well. 
12. The reaction is stopped after 15 minutes by the addition of 50ul of 1.25M sulphuric 
acid. The plates are read at 492 nm on a spectrophotometer linked to computer. After !
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subtracting the OD value of the negative control an OD value of 0.1 and above is 
considered positive for the specific FMDV antigen serotype. 
 
Appendix 3 - RNA Extraction Procedure 
 
1. Add 0.2ml of probang samples to 0.3ml lysis/binding buffer (Roche) and mix well. 
2. Generate a random order of samples/controls for the extraction process on the MagNa 
Pure LC by opening the appropriate tracking sheet, save the tracking sheet titled with 
the WRL sheet number. 
3. Enter the first 32 sample names and controls in the worksheet entitled ‘Random’ with 
all  relevant  details  of  the  sample  (column  C).  Highlight  the  cells  containing  the 
samples and the adjacent column to the left (column B) when complete. Then click 
the ‘sort descending’ button in the toolbar to randomise the order samples. Save 
changes to the tracking sheet. 
4. In the MagNa Pure 1 worksheet, save the worksheet as text file with the proper file 
extension and click OK to save only the active sheet then close the workbook. If 
applicable repeat this process for the other 2 columns of 32 samples. Check that 
sample orders have been entered into ‘Stratagene’ worksheet and ensure that it is the 
active work sheet in the saved excel file. This excel tracking sheet will also generates 
the well names file for the Stratagene real-time PCR machines.  
5. At the extraction process, click on ‘print sample order’ to receive a printout of those 
particular 32 samples to be extracted. Click on ‘save sample order’, type the WRL 
number and save in the local drive in the diagnostic folder. 
6. Switch  on  the  MagNa  Pure  LC  computer.  Go  to  the  main  menu  and  to  ‘sample 
ordering’. !
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7. Decontaminate the inside of the MagNa Pure LC and change the ‘dropcatcher’ if 
necessary. 
8. Then load the sample order by clicking ‘sample ordering’ from the file location and 
select the extraction protocol to be used. 
9. Go to ‘stage setup’, this will show the positions of the tip stands, processing cartridges 
sample cartridges, reagent tips, reagent tubs, and identity and volumes required of 
the reagents from the total nucleic acid isolation kit. 
10. Carefully insert all components and reagents into position in any order except the 
suspension of magnetic glass particles (MGPs) which must be placed in position last 
to  prevent  clumping.  Make  sure  the  reconstituted  proteinase  K  and  MGPs  are 
vortexed thoroughly before adding to the reagent tub. 
11. In a clean area, add the required volume of the reagent kit components as presented 
in  the  screen  into  the  correct  tubs  using  disposable  syringes,  securely  fasten  the 
appropriate tub lid on top and place inside the MagNa Pure LC as indicated. 
12. Using the print-out of the sample order as a guide and ensuring that the samples are 
added in the correct orientation (well A1 through H4), carefully pipette 0.5ml of the 
samples from the tubes into the correct wells of a sample cartridge with barrier tips 
and  carefully  insert  the  cartridge  into  position  inside  the  MagNa  Pure  LC  as 
indicated by the plan in the ‘sample name’ in the 32 well cartridge. 
13.  As soon as all the components have been ticked off and the machine door is closed 
securely, an ‘OK’ sign will appear on the bottom right of the screen. Double check 
that all components are included and every item has been securely fastened into 
position. Then click ‘OK’ to begin the elution/extraction procedure. 
14. Once the 90 minute elution is completed, the screen should show that each sample 
has  ‘passed’  the  procedure.  Click  on  ‘print  result  screen’.  Carefully  remove  the 
sample cartridge containing the extracted nucleic acids (50ul volume), cover securely !
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with adhesive PCR film, label legibly and store at -70ºC if not required immediately. 
Otherwise leave the cartridge of nucleic acids inside the MagNa Pure LC. Inspect the 
original sample cartridge at the end of the extraction procedure to check whether the 
entire original test or control sample (in buffer) has been used up. 
15. Click ‘close’ icon twice to return to the main menu and click on ‘decontamination’ 
and click ‘start decontamination’. 
16. The printed results from the extraction are stored along with other documentation for 
the test. The assay performance of the test and control samples can only be judged 
upon completion of the RT-PCR process (Reid et al. 2003). 
 
Appendix 4 - Real-time RT-PCR Procedure: 
 
1. Prepare a plan showing the layout of the test and control RNA samples on the optical 
reaction plate. Diagnostic RNA samples should be tested in duplicate. 
2. In the PCR clean room, prepare the one-step RT-PCR reaction mixture in a clean tube. 
Prepare the reaction mixture in sufficient volume for the total number of samples to 
be assayed (x) plus one (x+1). 
3. Add 20ul of the one-step RT-PCR reaction mix to each well of an optical reaction 
plate for each sample to be assayed. Then add 5ul of RNA, changing the tip between 
each sample. 
4. Securely cover each well with a cap in the safety cabinet using a roller.  
5. Spin the covered optical reaction plate for 1 minute at 1,000 rpm in the large capacity 
centrifuge to mix the contents of each well. 
6. Place  the  plate  in  a  real-time  PCR  machine  for  PCR  amplification  and  run  the 
specified programme. !
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7. Reading  the  results:  Interpretation  of  the  test  results  was  based  on  an  assigned 
threshold cycle (CT) value for each PCR reaction from the amplification plots (a plot 
of the fluorescence signal versus cycle number) set by WRL for FMD. Negative test 
samples and negative controls should have a CT value at >50.0. Positive test samples 
and positive control samples should have a CT value <40. Samples with CT values 
falling  within  the  range  40-50  are  designated  “borderline”  and  can  be  retested. 
Strong positive FMD samples have a CT value below 20.0. 
 
Appendix 5 - LPBE Procedure: 
 
1. On day 1 prior to the test, choose the plate layout or design as appropriate. The spot 
test is only used for outbreak/herd surveillance sample. Half titration can be used for 
testing samples where the majorities are expected to be negative, e.g. import-export 
testing.  Full  titration  is  required  for  those  expected  to  be  positive  e.g.  when 
measuring immune status post vaccination or those giving reactions on screening. 
2. Coat the ELISA plate/plates. Prepare a 1/1000 or as appropriate working dilution of 
rabbit anti-FMDV serum (FMD serotypes O, A and Asia 1 in this study was used) 
trapping antibody in carbonate/bicarbonate coating buffer ph 9.6 (Sigma C-3041 or 
equivalent) in a volume sufficient for the number of plates required and tap the plates 
gently  to  ensure  uniform  dispersion.  Add  100ul  to  each  well  required,  cover  the 
plate/s and place in a humidity cabinet at room temperature. Coated plates can be 
stored at room temperature for up to 5 days. Alternatively, plates can be coated at 
35ºC to 39ºC for 1 hour. 
3. For addition of the control/test serum to a carrier plate for titration: In a carrier plate, 
add 50ul of PBST to all wells except the negative control wells (G, H 3+4 or as 
appropriate). Wells E, F, 3+4 or as appropriate are antigen controls. !
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4. Addition of the control sera: add 37.5ul of PBST and 12.5ul of the weak positive 
control to wells A3+4 or as appropriate. Referring to the plate layout, make a twofold 
dilution series by transferring 50uls from row to row consecutively discarding 50ul 
from the last dilution.  Add the negative control (1/16 dilution of ABS with PBST) to 
wells G, H 3+4 or as appropriate (excess dilutions maybe stored at 1ºC to 8ºC for 
several weeks or -30ºC to-50ºC for a long term. 
5. Addition of the test sera: referring to the plate layout, dispense 37.5uls of PBST and 
12.5ul of test sample to rows A (for the full titration plate layout) or A and E (for the 
half titration plate layout) 5-12 or as appropriate in duplicate. Using a multichannel 
pipette, make a twofold dilution series by mixing and transferring 50uls from row to 
row consecutively, discarding 50ul from the last dilution. 
6. For addition of the control/test serum to a carrier plate for the spot test: Addition of 
the control sera: Dilute a strong positive serum 1/16 with PBST. Add 50uls to wells 
A, B, 1+2 or as appropriate. Dilute a weak positive serum 1/16 with PBST. Add 
50uls to wells C, D, 1+2 or as appropriate. Dilute negative serum 1/16 with PBST, 
add 50uls to wells E, F, 1+2 or as appropriate. Note: The final dilution of the control 
sera after the addition of virus is 1/32. Add 50uls of PBST to wells G, H 1+2 or as 
appropriate (antigen controls). 
7. Addition of the test sera: make a 1/22 serum dilution (5uls+105uls PBST). Add 25uls 
PBST and 25uls of 1/22 dilution to duplicate wells of a carrier plate. 
8. Dilute the virus/antigen with PBST to an optimal working concentration (allowing at 
least 6mls per plate). Add 50uls to each well of the carrier plate. 
9. Stack up to five plates and cover the top plate with lid. Incubate the plates at 1ºC to 
8ºC overnight with continual shaking on an orbital shaker. Alternatively, plates can 
be incubated at 35ºC to 39ºC for 1 hour with continual shaking. !
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10. Day 2: Wash the coated ELISA plates three times using a plate washer or wash 
manually. Empty the well contents flood the plates with wash buffer. After filling, 
discharge the contents. Repeat with two more washes. Slap the inverted plates onto a 
lint-free absorbent surface to remove residual contents. 
11. Using  a  multi-channel  pipette,  transfer  50uls  of  antigen/serum  mixture  from  the 
carrier plates to the corresponding wells of the coated ELISA plates. For titrations, 
transfer row A first, followed by subsequent dilutions. 
12. Stack up to five plates and cover the top plate with lid and place into a tin or plastic 
airtight box. Incubate plates at 35ºC to 39ºC for 1 hour on an orbital shaker.  
13. Calculate the volume of blocking buffer (1 gram Marvel skim milk powder to 20mls 
PBST) needed for the plates allowing 12 mls per plate. Dilute the pre-determined 
optimal dilution of FMD serotype-specific guinea pig antiserum in blocking buffer 
(6mls per plate). 
14. Wash plates as in 10. 
15. Add 50ul of the diluted guinea pig serum to all wells of all plates. Stack up to 5 
plates and cover the top plate with a lid. Incubate plates at 35ºC to 39ºC for 1 hour on 
an orbital shaker. 
16. Dilute  the  species  horseradish  peroxidase  conjugated  rabbit  anti-guinea  pig 
immunoglobulin (DAKO-PO141, Denmark or equivalent) in blocking buffer (6mls 
per plate). 
17. Wash as in 10. 
18. Add 50uls of diluted conjugate to all wells of all plates. Stack up to 5 plates and 
cover the top plate with lid. Incubate plates at 35ºC to 39ºC for 1 hour on an orbital 
shaker. 
19. Prepare the OPD solution (6mls per plate). !
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20. Wash plates as in 10. Wash for a fourth time to ensure that the conjugate has been 
completely removed if using a plate washer. Ensure that the bottom of the plate is 
clean and dry. 
21. Just before use, add the appropriate amount of 30-33% hydrogen peroxide to the 
prepared chromogen solution. Add 50ul of substrate/chromogen solution to all wells 
of all plates including blank plates/wells. Incubate plates at room temperature for 
15+-5 minutes or until in the opinion of the operator, an OD of between 0.4 and 2.5 
is obtained in the antigen control wells. 
22. During the colour development, turn the ELISA plate reader and allow to warm if 
required. Check that the appropriate interference filter (490nm) is in place. 
23. To  stop  further  colour  development,  add  50ul  of  acid  stopper  solution  (1.35M 
sulphuric acid) to all wells of all plates including blank plates/wells in the same order 
as the addition of substrate/chromogen. 
24. Blank the plate reader as appropriate. Place an ELISA plate in the plate reader and 
initiate  the  reading  sequence.  Compare  OD  readings  with  the  actual  intensity  of 
colour development in the wells to detect any discrepancies between the OD reading 
recorded and the colour intensities observed visually. High OD readings from wells 
which have obviously been badly washed should be discarded. 
25.  Results: Calculate the median optical density (OD) of the 4 antigen control wells of 
each plate as follows; a) identify the highest and lowest OD readings and ignore 
these 2 values. b) calculate the average OD of the remaining 2 values. This is the 
median OD of the reaction (antigen) control, which represents the maximum value 
for the test i.e. the 100% control value. Divide the median OD of antigen control 
wells by 2. This is the OD value representing 50% inhibition of the reaction control. 
26. Calculate the percentage inhibition of all wells using the following formula: 
                                                     !
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      (OD of test serum well) 
Percentage Inhibition (PI) = 100- ----------------------------- x 100 
                      (median OD of antigen control) 
27. For titration test: Score the well positive of the PI is equal to or greater than 50. 
Consider the well negative if the PI is less than 50. 
28. Calculate the titres of reference sera and test samples. The end point is defined as 
that dilution at which half of the wells show 50% inhibition. 
29. Accept  the  assay  if  the  results  meet  the  following  criteria:  a)  The  titre  of  the 
reference serum should not fluctuate more than two-fold from the running mean b) 
the  negative  control  should  be<50%  inhibition  c)  the  titre  of  the  strong  positive 
control sera should be >128 d) the titre of weak positive control sera should be in the 
range of 45-128. 
30. Spot  test:  Accept  the  assay  if  the  results  meet  the  following  criteria;  a)  strong 
positives  should  give  >90%  inhibition  b)  weak  positives  should  give  50-90% 
inhibition c) the average of the negatives must give <50% inhibition. 
31. Interpretation of spot test results: Sera are considered positive if both wells show 
>50% inhibition i.e. has a titre of >1/90. Sera with only one or neither well showing 
50% inhibition are negative. Positive sera should be titrated by ELISA or confirmed 
by VNT. 
 
 
 
Appendix 6 - Ceditest FMDV-NS (Cedi-Diagnostics B.V. 8203 AG Lelystad, The 
Netherlands)  Test  Procedure.  (Subsequently  known  as  Priocheck  FMDV-NS 
after company changed to Prionics).  
 
 
The  test  is  a  blocking  ELISA.  ELISA  test  plates  have  been  coated  with  3ABC 
specific monoclonal followed by incubation with the 3ABC protein. Consequently, 
test plates of the kit contain FMDV-NS antigen captured by the coated Mab. !
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Day 1: Incubation with test serum:  
1.1 Dispense 80ul ELISA buffer to wells. 
1.2 Dispense 20ul of negative control to well A1 and B1 
1.3 Dispense 20ul of weak positive control to wells C1 and D1 
1.4 Dispense 20ul of positive control to wells E1 and F1 
1.5 Dispense 20ul of test samples to the remaining wells 
1.6 Seal the test plate(s) using the enclose plate sealers 
1.7 Shake the test plate(s) gently 
1.8 Incubate overnight (16-18hrs) at room temperature (20-25ºC) 
Day 2: Incubation with mouse monoclonal antibody to FMD 3ABC polyprotein 
conjugated  to  horseradish  peroxidase  and  subsequently  with  ready  to  use 
chromogen/substrate solution 
 
1.9 Empty the test plate(s) after the incubation period and wash the plate(s) 6 times 
with washing fluid. Tap the plate(s) firmly after the last washing 
1.10  Dispense 100ul of the working dilution of the conjugate to all wells. 
1.11  Seal the test plate(s) using the enclosed plate sealers 
1.12  Incubate 1 hour at room temperature (20-25ºC) 
1.13  Empty the test plate(s) after the incubation period and wash the plate(s) 6 
times with the washing fluid. Tap the plate(s) firmly after the last washing 
1.14  Dispense 100ul of the chromogen/substrate solution to all wells 
1.15  Incubate 20 minutes at room temperature (20-25ºC). 
1.16  Add 100ul of the ready to use stop solution to all wells 
1.17  Mix the content of the wells of the test plate(s) prior to measuring 
 !
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2.  Reading of the test plate(s) and calculating the results 
2.1 Measure  the  optical  density  (OD)  of  the  wells  at  450nm  preferable  within 
15minutes after colour development has been stopped 
2.2 Calculate the mean OD450 value of wells A1 and B1 (negative control=OD max) 
2.3 The percentage inhibition (PI) of the controls and the test sera are calculated 
according to the formula; 
2.4 The  OD450  values  of  all  samples  are  expressed  as  Percentage  Inhibition  (PI) 
relative to the mean OD450 of the negative control (OD max). 
 
                                        (OD 450 test sample) 
    PI = 100- -------------------------- x 100                                   
                                               (OD 450 max)        
       
3. Validation criteria 
3.1 The mean OD450 of the negative control (wells A1and B1=OD max must be >1.000 
3.2 The mean percentage inhibition of the weak positive control must be >50% 
3.3 The mean percentage inhibition of the positive control must be >70% 
3.4 Not meeting of these criteria is reason to discard the results of that specific plate 
 
4. Interpretation of the percentage Inhibition 
PI <50%  Negative  no antibodies against the NS protein of FMDV 
PI=>50%  Positive  antibodies against the NS protein of FMDV 
 
 
Appendix  7  -  Chekit  FMD-3ABC  Bo-Ov  (IDEXX  Laboratories  B.V. 
Koolhovenlaan 20 1119 NE Schiphol-Rijk, the Netherland) Procedure 
 
 
All reagents must be allowed to come to room temperature (18-25ºC) before use. 
Reagents should be mixed by gentle swirling or vortexing. !
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1. Predilute each sample and control 1:100 in tube using CHEKIT-FMD-3ABC sample 
diluent. For example, add 5ul of sample or control to 495ul CHEKIT-FMD-3ABC 
sample diluents.  
2. Dispense  100ul  of  prediluted  samples  and  controls  (Final  dilution=1:100)  into  the 
appropriate wells of the microtitre plate supplied that has been coated with FMD 
3ABC polyprotein. 
3. Cover the microtitre plate with a lid and incubate for 60 minutes (+10 minutes) at 
37ºC (+2ºC) in a humid chamber. 
4. Wash  each  well  with  approximately  300ul  CHEKIT  wash  solution  three  times. 
Aspirate liquid contents of all wells after each wash. Following the final aspiration, 
firmly tap residual wash fluid from each plate onto absorbent material. Avoid plate 
drying between washes and prior to the addition of the next reagent. 
5. Dispense  100ul  of  the  CHEKIT-FMD-3ABC  anti-ruminant-IgG-PO  conjugate  into 
each well. 
6. Cover and incubate the microtitre plate for 60 minutes (+10 minutes) at 37ºC (+2ºC) 
in a humid chamber. 
7. Repeat step 4. 
8. Dispense 100ul CHEKIT-TMB substrate into each well. 
9. Incubate the substrate at room temperature for 15 minutes. 
10. Stop the colour reaction by adding 100ul CHEKIT- stop solution TMB per well. The 
stop solution should be dispensed in the same order and at the same speed as the 
substrate. 
11. Read the results using a photometer at a wavelength of 450nm. 
12. Results: To validate the assay the optical density (OD) of the positive control should 
not  exceed  2.0  and  the  OD  of  the  negative  control  should  not  exceed  0.5.  The !
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difference between the positive and the negative control must be >0.4. Make sure to 
read the plates within 2 hours after the addition of the stop solution. 
13. Calculation: Analyse the sample in relation to the negative and the positive controls  
                                       (OD sample – OD neg) 
14. with the formula:  Value (%)= ----------------------------- x100% 
                                          (OD pos – OD neg)  
 
15. Interpretation of results: Value =  <20%       >20% to <30%    >30% 
              Interpretation       (negative)        (suspect)       (positive) 
 
 
Appendix  8  -  FMDV  3ABC-Trapping  ELISA  Procedure  (IZSLER 
Biotechnology Laboratory, Via A. Bianchi, 9-25124 Brescia, Italy).  
 
 
Before the test all solutions should be equilibrated at room temperature before use. 
Optimal temperature range is 18-25ºC. Samples and control sera are tested diluted 
1/100 in ELISA buffer in a final volume of 50ul/well. 
 
Assay Procedure 
Sera: Samples and control sera are tested diluted 1/100 in ELISA buffer in a final 
volume of 50ul/well. Each sample is dispensed in duplicate wells, one well of which 
contains antigen (3ABC) and one, which does not (buffer). Forty-five samples plus 
the three control sera can be examined in one ELISA plate, distributed according to 
the enclosed scheme.   
1. Open the sealed, sensitized ELISA microplate (previously coated with FMD 3ABC 
polyprotein antigen in odd columns and even columns without antigen). 
2. Distribute 40ul of ELISA buffer in each well of the ELISA microplate. !
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3. Using a multichannel micropipette (8 tips), transfer 10 ul of each sample and control 
serum  from  the  carrier  plate  into  two  appropriate  columns  of  the  ELISA  plate, 
according to the plate layout. Change tips for each column of the carrier plate. 
4. Gently shake the microplate. 
5. Cover and incubate plate for 1 hour at room temperature. 
6. Wash plate by filling the wells with 200ul washing solution. Incubate for 3 minutes at 
room temperature. 
7. Empty the wells and repeat twice (three washing cycles in total). Empty residual fluid 
from plates by tapping firmly onto a clean absorbent paper. 
8. Add 50ul per well of appropriately diluted anti-ruminant IgG HRPO conjugate. 
9. Cover and incubate the plate for 1 hour at room temperature. 
10. Wash plates as in 6 leaving the last one for 5 minutes. 
11. Distribute 50ul/well of the chromogen/substrate solution (TMB) to all wells, cover 
the plate and leave at room temperature for 20 minutes in the dark, starting timing 
when first well is filled. 
12. Stop the reaction by adding 50ul/well of the stop solution (H2SO4 0.6N), following 
the same order used for the chromogen/substrate solution. Gently shake the well 
content prior to reading. 
13. Read the optical density (OD) immediately after blocking using 450nm wavelength 
using a microplate reader. 
14. Calculation of results: calculation of test results is based on the formula: The OD of 
each test serum and control sera in the well without antigen is subtracted from the 
OD  of  the  well  containing  antigen,  giving  the  net  OD.  Absolute  OD  values  are 
subject  to  variation  from  test  to  test.  Variation  is  normalised  by  calculating  the 
percentage of positivity of each test serum compared to the positive control: 
 !
160!
!
          Net OD value of test serum  
                                (the OD of test serum in the buffer well is subtracted from the OD in the 
                                           well containing 3ABC antigen, giving the net OD)  
Percentage Positivity =  ----------------------------------- x100 
                                    Net OD value of positive control serum  
                   (the OD of positive control serum in the buffer well is subtracted from the  
                                          OD in the well containing 3ABC antigen, giving the net OD) 
          
 
Criteria for test validity:  
The positive control serum (PCS) should give a net OD value ranging from 1.0 to 2.0 
OD units; the % positivity of the weak positive control serum (WCS) must be >10% 
(usually it does not give a result over 30%); the % positivity of the negative control 
serum (NCS) must be <10% (usually it remains below 5%). 
15. Interpretation:  
The cut-off value is 10% thus: test sera giving values less than 10% are considered 
negative; test sera giving values of 10% or higher are considered positive. 
 
 
Appendix  9  -  UBI  FMDV  Non-structural  Protein  ELISA  (Cattle)  Direction 
Insert (United Biomedical, Inc. 25 Davids Drive Hauppauge, NY 11788 USA) 
Procedure 
 
 
1. Dilute  control  and  specimen  using  the  specimen  diluents  at  1:21  in  the  dilution 
microplate provided. 
2. Cut and open the foil pouch and remove the reaction microplate (previously coated 
with FMD 3B polyprotein). 
3. Transfer 100ul of the diluted controls and specimens from each well of the dilution 
microplate  to  its  corresponding  well  in  the  reaction  microplate.  Dispose  of  the 
dilution microplate and unused liquid as biohazardous waste. 
4. Cover the reaction microplate with the enclosed plate cover or equivalent and incubate 
for 60 + 5 minutes at 37ºC + 2ºC. !
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5. Prepare working conjugate solution (Anti-ruminant IgG HRP conjugate, monoclonal 
antibody conjugated with peroxidase) as described in the preparation reagents section 
prior to washing the microplates. 
6. Uncover  the  reaction  microplate  and  wash  with  diluted  wash  buffer.  Use  6  times 
washes using at least 300ul/well/wash. 
7. After washing is complete, excess liquid maybe removed from the reaction plate by 
inverting and tapping on absorbent paper until no further moisture appears on the 
paper. 
8. Add  100ul  of  the  working  conjugate  solution  (1:101)  to  all  wells  of  the  reaction 
microplate. 
9. Cover and incubate for 30 + 2 minutes at 37 + 2ºC. 
10. Uncover and repeat the wash procedure as in step 6 and 7. 
11. Add 100ul of TMB substrate solution to each well of the reaction plate. 
12. Cover and incubate in the dark for 15 +1 minute at 37ºC + 2ºC. 
13. Uncover and add 100ul of stop solution (H2SO4 0.6N) to each well of the reaction 
plate. Mix by gently tapping the side of the reaction plate.  
14. Read the absorbance of each well at 450nm. Blank on air. Absorbance should be read 
within 15 minutes of the addition of the stop solution to the reaction microplate. 
15. Criteria for valid assay: a) Mean absorbance value of non-reactive control (NRC) is 
<0.15. Mean absorbance of the NS reactive control (RC) values are >0.7 and <1.9. If 
individual RC values are not within this range, the assay is invalid. b) determine the 
mean of the FMDV non-reactive controls (NRC). c) determine the mean value of the 
FMDV NS reactive controls (RC). d) calculate the cut off value.  
16. Example of cut off value: cut off value = (0.23) x (RC)   
            = example: RC =1.213 
                                                   Cut off value = (0.23) x (1.213) = 0.280 !
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17. Interpretation of results: specimens with absorbance values less than the cut off value 
are considered non-reactive by the criteria of the UBI FMDV non structural protein 
ELISA and may be considered negative for antibodies to FMDV. Specimens with 
absorbance values greater than or equal to the cut off value are considered initially 
reactive. These specimens should be retested in duplicate before final confirmation 
of the result.  
 
Appendix 10 - Detection of IgA by ELISA 
(The salivary IgA ELISA test for FMDV Type O is described. The relevant trapping 
antisera and FMDV antigens were used for the salivary IgA ELISAs for FMDV 
Type A and Asia 1 in these studies)  
 
1. Coat  F96  maxisorp  nunc-immuno  plates  with  50ul  of  05M  carbonate-bicarbonate 
buffer with an optimal dilution (1:7000) of anti rabbit O1 manisa trapping antibody 
(only  to  odd  numbered  column  wells)  and  1:5000  of  anti-rabbit  SAT-2  trapping 
antibody (only to the even numbered column wells) over night at 2-8ºC. 
2. Blocking buffer: 5% unsweetened soya milk, 2% normal rabbit serum, 0.1% Tween 
20. 
3. Preparation of antigen: Both O1manisa and SAT-2 FMD antigen should be diluted 
with PBS (1:10) and centrifuge at 3K for 10 minutes. The supernatant should be used 
as antigen diluted with blocking buffer (1:60) and the final concentration should be 
1:600. 
4. Washing of plate: wash the plate 3 times by over flooding the PBS. Tap the plate on 
dry cloths to blot dry. !
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5. Add  50  micro  litre  of  diluted  O1  manisa  antigen  in  blocking  buffer  to  each  odd 
numbered column wells of the plate and diluted SAT-2 antigen to the even no. of 
column wells. 
6. Incubate for 1 hour in 37ºC on orbital shaker. 
7. Wash 3 times like 4. 
8. Add blocking buffer 50ul to each well for non specific blocking. 
9. Incubate for ½ hour in 37ºC on orbital shaker. 
10. Wash the plate 3 times by over flooding the PBS. Tap the plate on dry cloths to blot 
dry. 
11. Now add 43ul of blocking buffer and 7ul of saliva to each well in duplicates for each 
saliva sample (odd and even columns) in the hood if samples are infectious. In case 
of nasal secretions 48ul of blocking buffer and 2ul of samples should be added to 
each well. 
12. Incubate for 1 hour in 37ºC in orbital shaker with a lid in a sealed plastic container. 
13. Wash the plates 3 times by over flooding the PBS (in the hood if infectious). Tap the 
plate on dry cloths to blot dry. 
14. Prepare the polyclonal rabbit anti-bovine IgA HRPO conjugate 1:1500 with blocking 
buffer and add 50ul to each well. 
15. Incubate for 1 hour in 37ºC in orbital shaker with a lid in a sealed plastic container. 
16. Wash the plates 3 times by over flooding the PBS (in the hood if infectious). Tap the 
plate on dry cloths to blot dry. 
17. Develop the colour reaction by adding the chromogen and substrate (30mg of OPD 
tablet dissolve in 55ml of phosphate citrate buffer and hydrogen peroxide at the rate 
of 1/2000 to the chromogen). Colour is allowed to develop for 10 minutes at room 
temperature and the reaction stopped by addition of 1M H2SO4 .  !
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18. Read the plate using 490nm filter using the suitable ELISA programme and printing 
results. 
19. When  sufficient  saliva  samples,  which  represent  both  negative  and  positive 
populations,  have  been  tested,  perform  the  appropriate  statistical  analyses  on  the 
results in order to determine the cut-off OD. Use this cut-off in future assays to 
determine the status of individual samples. 
20. For test interpretation, if the salivary secretory IgA antibody was for FMD serotype 
O,  then  the  odd  column  gives  the  OD  value  for  the  test  samples  and  the  even 
columns for the SAT-2 antigen (to which the test animals should not have been 
exposed to) measuring background reactivity. The SAT-2 value will be subtracted 
from the serotype O reactivity.  
21. After subtracting the OD value of the SAT-2 column (background reactivity) from 
the column of the test sample (serotype O), a cut-off OD value of 0.4 was determined 
as positive IgA response. Any samples, which had an OD value of 0.4 and above, 
were defined as positive IgA response.  The cut-off OD value of 0.4 was based on 
the previous series of validation studies in cattle and for FMD negative ASB from 
Italy  conducted  at  the  FMD  World  Reference  Laboratory,  Institute  for  Animal 
Health, Pirbright, UK.  
22. Criteria for test validity: The positive control antigen should have an OD value of 0.8 
and above after subtracting the value of the background control. The background 
control (SAT-2) OD value must be less than 0.4. And the negative control must have 
an OD value of not more than 0.2.  
 
 
 
 
 
 
 
 !
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